Literature-Related Discovery (LRD)

Abstract : Discovery in science is the generation of novel, interesting, plausible, and intelligible knowledge about the objects of study. Literature-related discovery (LRD) is the linking of two or more literature concepts that have heretofore not been linked (i.e., disjoint), in order to produce novel interesting, plausible, and intelligible knowledge (i.e., potential discovery).

[1]  J. Feldon,et al.  Rotenone increases glutamate‐induced dopamine release but does not affect hydroxyl‐free radical formation in rat striatum , 2003, Synapse.

[2]  P. Lockhart,et al.  It's a double knock‐out! The quaking mouse is a spontaneous deletion of parkin and parkin co‐regulated gene (PACRG) , 2004, Movement disorders : official journal of the Movement Disorder Society.

[3]  Pierluigi Caboni,et al.  Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease. , 2004, Chemical research in toxicology.

[4]  I. Date,et al.  Age‐related decline in the dopaminergic nigrostriatal system: The oxidative hypothesis and protective strategies , 1992, Annals of neurology.

[5]  S D Varma,et al.  Implications of aldose reductase in cataracts in human diabetes. , 1979, Investigative ophthalmology & visual science.

[6]  Takeshi Usui,et al.  Pharmaceutical prospects of phytoestrogens. , 2006, Endocrine journal.

[7]  Francesco Boin,et al.  Understanding, assessing and treating Raynaud's phenomenon , 2005, Current opinion in rheumatology.

[8]  M. Schwarzschild,et al.  Neuroprotection by Caffeine and A2A Adenosine Receptor Inactivation in a Model of Parkinson's Disease , 2001, The Journal of Neuroscience.

[9]  J D Goosey,et al.  A lipid peroxidative mechanism for posterior subcapsular cataract formation in the rabbit: a possible model for cataract formation in tapetoretinal diseases. , 1984, Investigative ophthalmology & visual science.

[10]  Jose B. Cibelli,et al.  Somatic cell cloned transgenic bovine neurons for transplantation in parkinsonian rats , 1998, Nature Medicine.

[11]  Albert Hofman,et al.  Epidemiology of age-related maculopathy: a review. , 2003, European journal of epidemiology.

[12]  S Lerman.  In vivo and in vitro investigations on cataract risk factors. , 1987, Developments in ophthalmology.

[13]  H D Foster,et al.  Disease family trees: the possible roles of iodine in goitre, cretinism, multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer's and Parkinson's diseases and cancers of the thyroid, nervous system and skin. , 1987, Medical hypotheses.

[14]  M. Ediger,et al.  In vivo assessment of diabetic lenses using dynamic light scattering. , 2002, Diabetes technology & therapeutics.

[15]  A. Henriques,et al.  The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats , 2001, Phytotherapy research : PTR.

[16]  F. Granado,et al.  Nutritional and clinical relevance of lutein in human health , 2003, British Journal of Nutrition.

[17]  Ha Won Kim,et al.  Protective Effect of Sulforaphane against Dopaminergic Cell Death , 2007, Journal of Pharmacology and Experimental Therapeutics.

[18]  Yoo-Hun Suh,et al.  Increased tau Phosphorylation on Mitogen-Activated Protein Kinase Consensus Sites and Cognitive Decline in Transgenic Models for Alzheimer's Disease and FTDP-17: Evidence for Distinct Molecular Processes Underlying tau Abnormalities , 2005, Molecular and Cellular Biology.

[19]  Jeffrey H Kordower,et al.  Neural Repair Strategies for Parkinson's Disease: Insights from Primate Models , 2006, Cell transplantation.

[20]  P M Leuenberger,et al.  [Aldose-reductase inhibitors and cataract formation (author's transl)]. , 1980, Klinische Monatsblatter fur Augenheilkunde.

[21]  M. Behbehani,et al.  Deficiency in Na,K-ATPase α Isoform Genes Alters Spatial Learning, Motor Activity, and Anxiety in Mice , 2007, The Journal of Neuroscience.

[22]  K Indira Priyadarsini,et al.  Inhibition of peroxynitrite-mediated reactions by vanillin. , 2004, Journal of agricultural and food chemistry.

[23]  A Taylor,et al.  Cataract incidence and analysis of lens crystallins in the water-, urea- and SDS-soluble fractions of Emory mice fed a diet restricted by 40% in calories. , 1993, Current eye research.

[24]  Young Ho Kim,et al.  Transgenic potato expressing Aβ reduce Aβ burden in Alzheimer's disease mouse model , 2005 .

[25]  U. Kang,et al.  Potential of gene therapy for Parkinson's disease: neurobiologic issues and new developments in gene transfer methodologies. , 1998, Movement disorders : official journal of the Movement Disorder Society.

[26]  W Martin,et al.  The combined role of atheroma, cholesterol, platelets, the endothelium and fibrin in heart attacks and strokes. , 1984, Medical hypotheses.

[27]  Daniel Offen,et al.  Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage , 2006, Neuroscience Letters.

[28]  M. Horne,et al.  Effects of long‐term treatment with dopamine receptor agonists and antagonists on terminal arbor size , 2002, The European journal of neuroscience.

[29]  S. Mandel,et al.  Reduction of iron‐regulated amyloid precursor protein and β‐amyloid peptide by (–)‐epigallocatechin‐3‐gallate in cell cultures: implications for iron chelation in Alzheimer's disease , 2006, Journal of neurochemistry.

[30]  R. Cumming,et al.  Diet and cataract: the Blue Mountains Eye Study. , 2000, Ophthalmology.

[31]  Wenzhen Duan,et al.  Neuroprotective and neurorestorative signal transduction mechanisms in brain aging: modification by genes, diet and behavior , 2002, Neurobiology of Aging.

[32]  Makoto Hashimoto,et al.  β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. James Surmeier,et al.  ‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease , 2007, Nature.

[34]  Jochen Klucken,et al.  Hsp70 Reduces α-Synuclein Aggregation and Toxicity* , 2004, Journal of Biological Chemistry.

[35]  R. A. Oliveira,et al.  Catechin attenuates 6-hydroxydopamine (6-OHDA)-induced cell death in primary cultures of mesencephalic cells. , 2003, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[36]  Li Qian,et al.  Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila , 2006, Proceedings of the National Academy of Sciences.

[37]  S. Ohta,et al.  Presence of tetrahydroisoquinoline and 1-methyl-tetrahydro-isoquinoline in foods: compounds related to Parkinson's disease. , 1988, Life sciences.

[38]  F. Tsang,et al.  Interactions Between Environmental and Genetic Factors in the Pathophysiology of Parkinson's Disease , 2003, IUBMB life.

[39]  Jianxing Xu,et al.  Possible involvement of Ca2+ signaling in rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells , 2005, Neuroscience Letters.

[40]  O. Ekberg,et al.  Clinical and demographic data in 75 patients with near-fatal choking episodes , 2006, Dysphagia.

[41]  Nicola Dioguardi,et al.  The role of amino acids in corneal stromal healing: a method for evaluating cellular density and extracellular matrix distribution. , 2003, Journal of refractive surgery.

[42]  Nurulain T Zaveri,et al.  Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. , 2006, Life sciences.

[43]  Anil Kumar,et al.  Effect of BR-16A (Mentat), a polyherbal formulation on drug-induced catalepsy in mice. , 2006, Indian journal of experimental biology.

[44]  Ronald N. Kostoff,et al.  Literature-related discovery (LRD): Potential treatments for cataracts , 2008 .

[45]  Li Gan,et al.  Therapeutic potential of sirtuin-activating compounds in Alzheimer's disease. , 2007, Drug news & perspectives.

[46]  C. Tanner,et al.  Environmental factors and Parkinson's disease , 1989, Neurology.

[47]  Y. Seyama,et al.  Cholestanol induces apoptosis of cerebellar neuronal cells. , 1999, Biochemical and biophysical research communications.

[48]  R L Prewitt,et al.  Analogs of phosphatidylcholine: alpha-adrenergic antagonists from the renal medulla. , 1981, Hypertension.

[49]  C J Mathias,et al.  Postprandial hypotension and parkinsonian state in parkinson's disease , 1997, Movement disorders : official journal of the Movement Disorder Society.

[50]  Nicolas Lapointe,et al.  Rotenone induces non‐specific central nervous system and systemic toxicity , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  John Q. Trojanowski,et al.  Convergence of Heat Shock Protein 90 with Ubiquitin in Filamentous α-Synuclein Inclusions of α-Synucleinopathies , 2006 .

[52]  K Muramatsu,et al.  Effect of individual amino acid supplements on the toxicity of excess tyrosine in rats. , 1976, Journal of nutritional science and vitaminology.

[53]  Jian Feng,et al.  Microtubule: A Common Target for Parkin and Parkinson’s Disease Toxins , 2006, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[54]  Ian J. Reynolds,et al.  Dopaminergic neurotoxins require excitotoxic stimulation in organotypic cultures , 2005, Neurobiology of Disease.

[55]  Andrey Scripnikov,et al.  Effects of Ginkgo biloba Extract EGb 761® on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial , 2007, Wiener Medizinische Wochenschrift.

[56]  Hyun Ah Jung,et al.  Peroxynitrite scavenging mode of alaternin isolated from Cassia tora , 2004, The Journal of pharmacy and pharmacology.

[57]  Eric K. Richfield,et al.  Risk factors for dopaminergic neuron loss in human α‐synuclein transgenic mice , 2004 .

[58]  J. Joseph,et al.  A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects. , 2001, Free radical biology & medicine.

[59]  Beate Gerstbrein,et al.  Dying for a cause: invertebrate genetics takes on human neurodegeneration , 2003, Nature Reviews Genetics.

[60]  In-Gyu Choi,et al.  Antibacterial and antifungal effects of essential oils from coniferous trees. , 2004, Biological & pharmaceutical bulletin.

[61]  Raymond Chuen-Chung Chang,et al.  Novel neuroprotective effects of the aqueous extracts from Verbena officinalis Linn , 2006, Neuropharmacology.

[62]  T. Gómez-Isla,et al.  Abnormal alpha-synuclein interactions with Rab proteins in alpha-synuclein A30P transgenic mice. , 2004, Journal of neuropathology and experimental neurology.

[63]  Ronenn Roubenoff,et al.  The association of eating behavior with risk for morbidity in older women. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.

[64]  C. Harding,et al.  Elemental studies in rat lens during galactose cataract reversal. , 1993, Current eye research.

[65]  Jennifer D Bair,et al.  Warfarin and Ropinirole Interaction , 2001, The Annals of pharmacotherapy.

[66]  R B Vajpayee,et al.  Does milk have a cataractogenic effect. A weighing of clinical evidence. , 1989, Developments in ophthalmology.

[67]  Hye-Young Shin,et al.  Sopoongsan Inhibits Mast Cell-Mediated Anaphylactic Reactions and Inflammatory Cytokine Secretion , 2005, International Archives of Allergy and Immunology.

[68]  S. Kulkarni,et al.  Quercetin Potentiates L-Dopa Reversal of Drug-Induced Catalepsy in Rats: Possible COMT/MAO Inhibition , 2003, Pharmacology.

[69]  Isao Nishimura,et al.  Parkin Suppresses Dopaminergic Neuron-Selective Neurotoxicity Induced by Pael-R in Drosophila , 2003, Neuron.

[70]  Eric J. Murphy,et al.  Mitochondrial Lipid Abnormality and Electron Transport Chain Impairment in Mice Lacking α-Synuclein , 2005, Molecular and Cellular Biology.

[71]  A Taylor,et al.  Relationships between acetone, cataracts, and ascorbate in hairless guinea pigs. , 1993, Ophthalmic research.

[72]  Lynn E Eberly,et al.  Ginkgo biloba Use in Nursing Home Elderly with Epilepsy or Seizure Disorder , 2006, Epilepsia.

[73]  Barbara Pendry,et al.  Phytochemical Evaluation of Selected Antioxidant‐Containing Medicinal Plants for Use in the Preparation of a Herbal Formula – A Preliminary Study , 2005, Chemistry & biodiversity.

[74]  Hyoung-Chun Kim,et al.  Selenium deficiency potentiates methamphetamine-induced nigral neuronal loss; comparison with MPTP model , 2000, Brain Research.

[75]  L. Mucke,et al.  Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. , 2000, Science.

[76]  T. Hemnani,et al.  Experimental excitotoxicity provokes oxidative damage in mice brain and attenuation by extract of Asparagus racemosus , 2004, Journal of Neural Transmission.

[77]  Jürgen Götz,et al.  β‐Amyloid treatment of two complementary P301L tau‐expressing Alzheimer's disease models reveals similar deregulated cellular processes , 2006, Proteomics.

[78]  Liu Wx.  Pharmacological studies on the leaves of Callicarpa dichotoma , 1983 .

[79]  J. Feldon,et al.  Tumor necrosis factor-alpha receptor ablation in a chronic MPTP mouse model of Parkinson's disease , 2005, Neuroscience Letters.

[80]  S. Lindquist,et al.  α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models , 2006, Science.

[81]  L. Doering,et al.  Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's , 2005, Brain Research.

[82]  J. Krauze,et al.  Synergistic effect between polymorphisms of PPARA and ABCA1 genes on the premature coronary artery disease , 2007, Acta cardiologica.

[83]  Manyam Bv.  Food, dietetics and nutrition in ancient India. , 1995 .

[84]  Jun Yamakoshi,et al.  Procyanidin-rich extract from grape seeds prevents cataract formation in hereditary cataractous (ICR/f) rats. , 2002, Journal of agricultural and food chemistry.

[85]  H. H. Schild,et al.  Effects of dietary de?ciency of selective amino acids on the function of the cornea and lens in rats , 2002, Amino Acids.

[86]  Kratzer Ke,et al.  Malva rotundifolia, a potential vasodilator. , 1969 .

[87]  H. Adams,et al.  Inotropic, chronotropic and coronary vasodilator potency of forskolin. , 1985, European journal of pharmacology.

[88]  K. O’Malley,et al.  Targeted expression of BCL-2 attenuates MPP+ but not 6-OHDA induced cell death in dopaminergic neurons , 2003, Neurobiology of Disease.

[89]  In-Seon Lee,et al.  Pharmacological characterization of orally active cholinesterase inhibitory activity of Prunus persica L. Batsch in rats , 2007, Journal of Molecular Neuroscience.

[90]  P. Wei,et al.  Effects of engrafted neural stem cells derived from GFP transgenic mice in Parkinson's diseases rats , 2007, Neuroscience Letters.

[91]  A. Rutzen,et al.  Attenuation of galactose-induced cataract by pyruvate. , 1999, Free radical research.

[92]  J. Trojanowski,et al.  Impaired Glutamate Transport in a Mouse Model of Tau Pathology in Astrocytes , 2006, The Journal of Neuroscience.

[93]  J. Payton,et al.  Epitope mapping and specificity of the anti-α-synuclein monoclonal antibody Syn-1 in mouse brain and cultured cell lines , 2003, Neuroscience Letters.

[94]  L. Doering,et al.  Probing modifications of the neuronal cytoskeleton , 2007, Molecular Neurobiology.

[95]  M Toth,et al.  Adaptive Changes in Postsynaptic Dopamine Receptors Despite Unaltered Dopamine Dynamics in Mice Lacking Monoamine Oxidase B , 1999, Journal of neurochemistry.

[96]  Krista Lagus,et al.  Text Retrieval Using Self-Organized Document Maps , 2002, Neural Processing Letters.

[97]  G F Jin,et al.  Dietary curcumin prevents ocular toxicity of naphthalene in rats. , 2000, Toxicology letters.

[98]  R. Nitsch,et al.  Tau Filament Formation in Transgenic Mice Expressing P301L Tau* , 2001, The Journal of Biological Chemistry.

[99]  M. Mattson,et al.  Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease , 2007, Neurobiology of Disease.

[100]  N. Ben-Jonathan,et al.  Dopamine as a prolactin (PRL) inhibitor. , 2001, Endocrine reviews.

[101]  D. Macintyre,et al.  Stimulation of human platelets by carrageenans , 1979, The Journal of pharmacy and pharmacology.

[102]  D. Pogocki,et al.  Application of nicotine enantiomers, derivatives and analogues in therapy of neurodegenerative disorders. , 2007, European journal of pharmacology.

[103]  C. Devi,et al.  Gastroprotective action of Cissus quadrangularis extract against NSAID induced gastric ulcer: role of proinflammatory cytokines and oxidative damage. , 2006, Chemico-biological interactions.

[104]  M. Mena,et al.  Differential effects of l‐DOPA on monoamine metabolism, cell survival and glutathione production in midbrain neuronal‐enriched cultures from parkin knockout and wild‐type mice , 2005, Journal of neurochemistry.

[105]  Phyllis G. Paterson,et al.  Zinc concentration of selected ocular tissues in zinc-deficient rats , 2007, Biological Trace Element Research.

[106]  Ruben Abagyan,et al.  Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease , 2007, Science.

[107]  C F Jin,et al.  Different effects of five catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells. , 2001, Journal of agricultural and food chemistry.

[108]  Rui M. Costa,et al.  Rapid Alterations in Corticostriatal Ensemble Coordination during Acute Dopamine-Dependent Motor Dysfunction , 2006, Neuron.

[109]  L T Chylack,et al.  Differences in the susceptibility of various aldose reductases to inhibition. II. , 1980, Investigative ophthalmology & visual science.

[110]  Jeong Gu Lee,et al.  Antioxidative properties of brown algae polyphenolics and their perspectives as chemopreventive agents against vascular risk factors , 2003, Archives of pharmacal research.

[111]  P. David Mozley,et al.  Comparison of region-of-interest analysis and human observers in the diagnosis of Parkinson's disease using [99mTc]TRODAT-1 and SPECT. , 2006 .

[112]  M. Rice,et al.  Partial Mitochondrial Inhibition Causes Striatal Dopamine Release Suppression and Medium Spiny Neuron Depolarization via H2O2 Elevation, Not ATP Depletion , 2005, The Journal of Neuroscience.

[113]  Shaik Shavali,et al.  Salsolinol, a dopamine-derived tetrahydroisoquinoline, induces cell death by causing oxidative stress in dopaminergic SH-SY5Y cells, and the said effect is attenuated by metallothionein , 2004, Brain Research.

[114]  G H Du,et al.  [Prevention of galactose-induced cataractogenesis in rats by salvianolic acid A]. , 1995, Yao xue xue bao = Acta pharmaceutica Sinica.

[115]  M. Parle,et al.  Pharmacological actions of Thespesia populnea relevant to Alzheimer's disease. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[116]  C D Marsden,et al.  Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease. , 1998, Biochemical pharmacology.

[117]  J. M. Lee,et al.  Tau phosphorylation increases in symptomatic mice overexpressing A30P α-synuclein , 2005, Experimental Neurology.

[118]  A Hartley,et al.  Complex I Inhibitors Induce Dose‐Dependent Apoptosis in PC12 Cells: Relevance to Parkinson's Disease , 1994, Journal of neurochemistry.

[119]  D H Cowan,et al.  The influence of ascorbic acid on platelet structure and function. , 1975, Thrombosis et diathesis haemorrhagica.

[120]  G Debry,et al.  Lactose and cataract in humans: a review. , 1991, Journal of the American College of Nutrition.

[121]  M Filippi,et al.  Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions. , 2006, Archives of neurology.

[122]  W. H. Schuette,et al.  Apparent unilateral visual neglect in MPTP-hemiparkinsonian monkeys is due to delayed initiation of motion , 1991, Brain Research.

[123]  M. Mena,et al.  Clinical and pharmacokinetic effects of a diet rich in insoluble fiber on Parkinson disease. , 1992, Clinical neuropharmacology.

[124]  M. Chesselet,et al.  Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype α-synuclein , 2006, Neuroscience.

[125]  T. Mak,et al.  DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2 , 2006, Proceedings of the National Academy of Sciences.

[126]  Nancy M Bonini,et al.  Drosophila as a model for human neurodegenerative disease. , 2005, Annual review of genetics.

[127]  G. Rumsey,et al.  Biomicroscopic and histologic pathology of the eye in riboflavin deficient rainbow trout (Salmogairdneri). , 1981, The Cornell veterinarian.

[128]  Malcolm A Binns,et al.  Behavioral disturbances, not cognitive deterioration, are associated with altered food selection in seniors with Alzheimer's disease. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[129]  J. Parvin,et al.  Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. , 2006, Human molecular genetics.

[130]  K. Ingkaninan,et al.  Acetylcholinesterase inhibitors from Stephania venosa tuber , 2006, The Journal of pharmacy and pharmacology.

[131]  Daewoo Lee,et al.  Selective loss of dopaminergic neurons and formation of Lewy body‐like aggregations in α‐synuclein transgenic fly neuronal cultures , 2006, The European journal of neuroscience.

[132]  Sandra Pisani.  Fibres Found during Cataract Surgery , 2004, British journal of perioperative nursing : the journal of the National Association of Theatre Nurses.

[133]  Christian C. Felder,et al.  Muscarinic Acetylcholine Receptor Knockout Mice , 2004 .

[134]  Won Bok Lee,et al.  Baicalein attenuates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells. , 2005, European journal of cell biology.

[135]  Jerzy Wegiel,et al.  Walnut extract inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils. , 2004, Current Alzheimer research.

[136]  J. Salamone,et al.  Neostriatal muscarinic receptor subtypes involved in the generation of tremulous jaw movements in rodents implications for cholinergic involvement in parkinsonism. , 2001, Life sciences.

[137]  I. Räihä,et al.  GI motility disorders: diagnostic workup and use of prokinetic therapy. , 1993, Geriatrics.

[138]  Yu Yao,et al.  Protective activities of Vaccinium antioxidants with potential relevance to mitochondrial dysfunction and neurotoxicity. , 2007, Neurotoxicology.

[139]  Malcolm K Horne,et al.  Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures. , 2005, Biochemical pharmacology.

[140]  Adrian C. Williams,et al.  Nicotinamide: a double edged sword. , 2005, Parkinsonism & related disorders.

[141]  R. Emsley,et al.  Oral zinc augmentation with vitamins A and D increases plasma zinc concentration: Implications for burden of disease , 2006, Metabolic Brain Disease.

[142]  Pico Caroni,et al.  Neuropathology in Mice Expressing Human α-Synuclein , 2000, The Journal of Neuroscience.

[143]  Dean P. Jones,et al.  Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[144]  C D Thatcher,et al.  Comparison of kittens fed queen's milk with those fed milk replacers. , 1993, American journal of veterinary research.

[145]  Cheryl D. DiCarlo,et al.  Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone , 2004, Experimental Neurology.

[146]  J. Glowinski,et al.  Stimulation of postsynaptic α1b‐ and α2‐adrenergic receptors amplifies dopamine‐mediated locomotor activity in both rats and mice , 2003 .

[147]  Hans Lassmann,et al.  The Immunopathology of Multiple Sclerosis: An Overview , 2007, Brain pathology.

[148]  J. Potter,et al.  Vegetables, fruit, and cancer prevention: a review. , 1996, Journal of the American Dietetic Association.

[149]  Carlo Colosimo,et al.  Multiple system atrophy , 2004, The Lancet Neurology.

[150]  Ivan Izquierdo,et al.  Effect of lyophilised Vaccinium berries on memory, anxiety and locomotion in adult rats. , 2005, Pharmacological research.

[151]  Koji Abe,et al.  Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice. , 2005, The American journal of pathology.

[152]  J. Zigler,et al.  Alterations of lens protein synthesis in galactosemic rats. , 1979, Investigative ophthalmology & visual science.

[153]  Varsha Iyer,et al.  Differential protection against MPTP or methamphetamine toxicity in dopamine neurons by deletion of ppN/OFQ expression , 2006, Journal of neurochemistry.

[154]  Roya Saffary,et al.  Inclusion Body Formation and Neurodegeneration Are Parkin Independent in a Mouse Model of α-Synucleinopathy , 2006, The Journal of Neuroscience.

[155]  J M Roberts,et al.  The Effect of a Medicinal Chinese Herb on Platelet Function , 1982, Thrombosis and Haemostasis.

[156]  Sujata Joshi,et al.  Lycopene attenuates oxidative stress induced experimental cataract development: an in vitro and in vivo study. , 2003, Nutrition.

[157]  Lars Björklund,et al.  Context-dependent neuronal differentiation and germ layer induction of Smad4 −/− and Cripto −/− embryonic stem cells , 2005, Molecular and Cellular Neuroscience.

[158]  Alena Savonenko,et al.  Transgenic mouse models of neurodegenerative disease: Opportunities for therapeutic development , 2002, Current neurology and neuroscience reports.

[159]  P. Houghton,et al.  Natural Products and Derivatives Affecting Neurotransmission Relevant to Alzheimer’s and Parkinson’s Disease , 2005, Neurosignals.

[160]  R. Levine,et al.  Synergistic neurotoxicity of carbon tetrachloride/carbon disulfide (80/20 fumigants) and other pesticides in grain storage workers. , 2009, Acta pharmacologica et toxicologica.

[161]  M. Unosson,et al.  Food Habits and Intake of Nutrients in Elderly Patients with Parkinson’s Disease , 2006, Gerontology.

[162]  M. Palkovits,et al.  Nigrostriatal innervation is preserved in Nurr1-null mice, although dopaminergic neuron precursors are arrested from terminal differentiation. , 2000, Brain research. Molecular brain research.

[163]  Wei Duan,et al.  Early induction of calpains in rotenone-mediated neuronal apoptosis , 2006, Neuroscience Letters.

[164]  Shahin Akhondzadeh,et al.  Herbal medicine in the treatment of Alzheimer's disease , 2006, American journal of Alzheimer's disease and other dementias.

[165]  Karl Lederis,et al.  Pharmacological Effects of Urotensins , 1975 .

[166]  P. Carvey,et al.  Progressive Dopamine Neuron Loss in Parkinson's Disease: The Multiple Hit Hypothesis , 2006, Cell transplantation.

[167]  L. H. Kuller,et al.  Benefits of fatty fish on dementia risk are stronger for those without APOE ε4 , 2005, Neurology.

[168]  L. Golbe,et al.  Follow‐up study of early‐life protective and risk factors in Parkinson's disease , 1990, Movement disorders : official journal of the Movement Disorder Society.

[169]  V. Uversky,et al.  Pesticides directly accelerate the rate of α‐synuclein fibril formation: a possible factor in Parkinson's disease , 2001, FEBS letters.

[170]  Werner Poewe,et al.  High dose levodopa therapy is not toxic in multiple system atrophy: Experimental evidence , 2007, Movement disorders : official journal of the Movement Disorder Society.

[171]  G. Cole,et al.  Docosahexaenoic Acid Protects from Amyloid and Dendritic Pathology in an Alzheimer's Disease Mouse Model , 2006, Nutrition and health.

[172]  Sung-Jin Lee,et al.  Regulation of p53 by Activated Protein Kinase C-δ during Nitric Oxide-induced Dopaminergic Cell Death* , 2006, Journal of Biological Chemistry.

[173]  Richard Murray,et al.  Increased vulnerability of dopaminergic neurons in MPTP‐lesioned interleukin‐6 deficient mice , 2002, Journal of neurochemistry.

[174]  R J Miller,et al.  The selective toxicity of 1-methyl-4-phenylpyridinium to dopaminergic neurons: the role of mitochondrial complex I and reactive oxygen species revisited. , 2000, Molecular pharmacology.

[175]  Shun Shimohama,et al.  Possible involvement of both mitochondria- and endoplasmic reticulum-dependent caspase pathways in rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells , 2002, Neuroscience Letters.

[176]  M. Bucan,et al.  Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice , 2002, Molecular Psychiatry.

[177]  Dustin Johnson,et al.  Assessment of India's Research Literature , 2007 .

[178]  Rémi Quirion,et al.  Neuroprotective effects of green and black teas and their catechin gallate esters against β‐amyloid‐induced toxicity , 2006, The European journal of neuroscience.

[179]  G Williamson,et al.  Quercetin inhibits hydrogen peroxide-induced oxidation of the rat lens. , 1999, Free radical biology & medicine.

[180]  Hoyt Ja,et al.  Reproductive and developmental toxicity of the dopamine agonist pergolide mesylate in mice. , 1994 .

[181]  B Rosner,et al.  Nutrient intake and cataract extraction in women: a prospective study. , 1992, BMJ.

[182]  A. Fung,et al.  Microwave-superheated Vics Vapo Rub: an ocular public health danger. , 2004, American journal of ophthalmology.

[183]  J. Correale,et al.  The blood–brain-barrier in multiple sclerosis: Functional roles and therapeutic targeting , 2007, Autoimmunity.

[184]  T. Tanaka,et al.  Studies of anti-cataract drugs from natural sources. I. Effects of a methanolic extract and the alkaloidal components from Corydalis tuber on in vitro aldose reductase activity. , 1994, Biological & pharmaceutical bulletin.

[185]  P. Bickford,et al.  Brain-Derived Neurotrophic Factor Is Required for the Establishment of the Proper Number of Dopaminergic Neurons in the Substantia Nigra Pars Compacta , 2005, The Journal of Neuroscience.

[186]  Bin Zhang,et al.  Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform , 1999, Neuron.

[187]  Ronald N. Kostoff,et al.  Database tomography for information retrieval , 1997, J. Inf. Sci..

[188]  T. Menovsky,et al.  Heat shock protein. , 1997, Journal of neurosurgery.

[189]  Jean Féger,et al.  The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy , 2005, Journal of neurochemistry.

[190]  J. van Staden,et al.  Inhibition of [3H]citalopram binding to the rat brain serotonin transporter by Amaryllidaceae alkaloids. , 2006, Planta medica.

[191]  W. Pfau,et al.  Exposure to beta-carbolines norharman and harman. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[192]  P I Polimeni,et al.  Enhancement of aortic blood flow with a linear anionic macropolymer of extraordinary molecular length. , 1985, Journal of molecular and cellular cardiology.

[193]  Makoto Hashimoto,et al.  Neurological and Neurodegenerative Alterations in a Transgenic Mouse Model Expressing Human α-Synuclein under Oligodendrocyte Promoter: Implications for Multiple System Atrophy , 2005, The Journal of Neuroscience.

[194]  David Morgan,et al.  Green Tea Epigallocatechin-3-Gallate (EGCG) Modulates Amyloid Precursor Protein Cleavage and Reduces Cerebral Amyloidosis in Alzheimer Transgenic Mice , 2005, The Journal of Neuroscience.

[195]  W C Willett,et al.  Health implications of Mediterranean diets in light of contemporary knowledge. 2. Meat, wine, fats, and oils. , 1995, The American journal of clinical nutrition.

[196]  U. Das,et al.  Essential fatty acids: biochemistry, physiology and pathology , 2006, Biotechnology journal.

[197]  R. Palmiter,et al.  Parkin-deficient mice are not a robust model of parkinsonism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[198]  M. Huotari,et al.  Tissue histopathology, clinical chemistry and behaviour of adult comt‐gene‐disrupted mice , 2003, Journal of applied toxicology : JAT.

[199]  Salvatore Mazza,et al.  Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: An overview , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[200]  L. Dragsted,et al.  Ex-vivo and in vitro protective effects of kolaviron against oxygen-derived radical-induced DNA damage and oxidative stress in human lymphocytes and rat liver cells , 2004, Cell Biology and Toxicology.

[201]  B. Aggarwal,et al.  Curcumin: Getting Back to the Roots , 2005, Annals of the New York Academy of Sciences.

[202]  Carol V Robinson,et al.  Phosphorylation of αB-Crystallin Alters Chaperone Function through Loss of Dimeric Substructure* , 2004, Journal of Biological Chemistry.

[203]  J. Kinoshita,et al.  Flavonoids as inhibitors of lens aldose reductase. , 1975, Science.

[204]  A. Tomac,et al.  A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra , 2006, Experimental Neurology.

[205]  D Spiegelman,et al.  Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk , 2002, Neurology.

[206]  J. Block,et al.  Raynaud's phenomenon , 2001, The Lancet.

[207]  N R Biswas,et al.  Comparative double blind multicentric randomised placebo controlled clinical trial of a herbal preparation of eye drops in some ocular ailments. , 1996, Journal of the Indian Medical Association.

[208]  Toshiharu Nagats,et al.  Genes for human catecholamine-synthesizing enzymes , 1991, Neuroscience Research.

[209]  Erik M. van Mulligen,et al.  Constructing an associative concept space for literature-based discovery , 2004, J. Assoc. Inf. Sci. Technol..

[210]  Joseph Jankovic,et al.  Dopaminergic Properties and Experimental Anti-Parkinsonian Effects of IPX750 in Rodent Models of Parkinson Disease , 2004, Clinical neuropharmacology.

[211]  D. Guastella,et al.  Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[212]  P. Aebischer,et al.  α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[213]  Kwok-Fai So,et al.  Neuroprotective effects of anti-aging oriental medicine Lycium barbarum against β-amyloid peptide neurotoxicity , 2005, Experimental Gerontology.

[214]  Toshio Nakaki,et al.  Rotenone Induces Apoptosis via Activation of Bad in Human Dopaminergic SH-SY5Y Cells , 2004, Journal of Pharmacology and Experimental Therapeutics.

[215]  Haruhiko Koseki,et al.  Model mice for tissue-specific deletion of the manganese superoxide dismutase (MnSOD) gene. , 2002, Biochemical and biophysical research communications.

[216]  K. Miyake,et al.  Prophylaxis of aphakic cystoid macular edema using topical indomethacin. , 1978, Journal - American Intra-Ocular Implant Society.

[217]  Takashi Uehara,et al.  A ubiquitin ligase HRD1 promotes the degradation of Pael receptor, a substrate of Parkin , 2006, Journal of neurochemistry.

[218]  T Kamitani,et al.  Local specificity in responses of canine coronary vessels to oxygen deficiency and antianginal drugs. , 1977, Archives internationales de pharmacodynamie et de therapie.

[219]  S. Hegewisch,et al.  Effects of guar on plasma viscosity and related parameters in diabetic children , 1981, European Journal of Pediatrics.

[220]  G D Thapar.  Approach to the problems of the aged. , 2004, Journal of the Indian Medical Association.

[221]  Eduardo D. Martín,et al.  Stressor‐related impairment of synaptic transmission in hippocampal slices from α‐synuclein knockout mice , 2004, The European journal of neuroscience.

[222]  Gang Hu,et al.  Systematic administration of iptakalim, an ATP‐sensitive potassium channel opener, prevents rotenone‐induced motor and neurochemical alterations in rats , 2005, Journal of neuroscience research.

[223]  P. Sen,et al.  Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. , 1999, Indian journal of experimental biology.

[224]  G. Lemke,et al.  Schwann cell differentiation. , 1996, Current opinion in cell biology.

[225]  H. Zoghbi,et al.  Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. , 2001, Human molecular genetics.

[226]  Gary W. Miller,et al.  Reduced Vesicular Storage of Dopamine Causes Progressive Nigrostriatal Neurodegeneration , 2007, The Journal of Neuroscience.

[227]  Leslie Michels Thompson,et al.  A Rapid Cellular FRET Assay of Polyglutamine Aggregation Identifies a Novel Inhibitor , 2003, Neuron.

[228]  D M Snodderly,et al.  Iris color and age-related changes in lens optical density. , 2000, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.

[229]  M Palta,et al.  Vitamin supplement use and incident cataracts in a population-based study. , 2000, Archives of ophthalmology.

[230]  M. Traber,et al.  Vitamin E in humans: demand and delivery. , 1996, Annual review of nutrition.

[231]  Helen Kim,et al.  New nutrition, proteomics, and how both can enhance studies in cancer prevention and therapy. , 2005, The Journal of nutrition.

[232]  E. Masliah,et al.  Enhanced substantia nigra mitochondrial pathology in human α-synuclein transgenic mice after treatment with MPTP 1 1 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 2004, Experimental Neurology.

[233]  S Moncada,et al.  Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. , 1979, The New England journal of medicine.

[234]  S. Ray,et al.  Pre-exposure to a novel nutritional mixture containing a series of phytochemicals prevents acetaminophen-induced programmed and unprogrammed cell deaths by enhancing BCL-XL expression and minimizing oxidative stress in the liver , 2006, Molecular and Cellular Biochemistry.

[235]  Takashi Uehara,et al.  Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[236]  Erwan Bezard,et al.  Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway. , 2005, Free radical biology & medicine.

[237]  Y. Sugita,et al.  Studies on subfractions of hemoglobin A1b and hemoglobin A1c in diabetic subjects. , 1984, Endocrinologia japonica.

[238]  G. Cooke,et al.  A review of the animal models used to investigate the health benefits of soy isoflavones. , 2006, Journal of AOAC International.

[239]  Masahiro Ono,et al.  Radioiodinated Flavones for in Vivo Imaging of β-Amyloid Plaques in the Brain , 2005 .

[240]  C. Estrada,et al.  GABA receptors mediate cerebral vasodilation in the unanesthetized goat , 1984, Brain Research.

[241]  J. Costentin,et al.  Adenosine A2A receptors and depression , 2003, Neurology.

[242]  Jun Wang,et al.  Moderate consumption of Cabernet Sauvignon attenuates A� neuropathology in a mouse model of Alzheimer's disease , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[243]  H. Widner,et al.  Simultaneous inhibition of B7 and LFA‐1 signaling prevents rejection of discordant neural xenografts in mice lacking CD40L , 2002, Xenotransplantation.

[244]  G. Abbott,et al.  Activation of mitochondrial ATP‐sensitive potassium channels increases cell viability against rotenone‐induced cell death , 2003, Journal of neurochemistry.

[245]  Ming Zhan,et al.  Mitochondrial UCP4 mediates an adaptive shift in energy metabolism and increases the resistance of neurons to metabolic and oxidative stress , 2007, NeuroMolecular Medicine.

[246]  C. P. Richter,et al.  Cataracts Produced in Rats by Yogurt , 1970, Science.

[247]  J. Feldon,et al.  Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[248]  Yoo-Hun Suh,et al.  Amyloid Precursor Protein, Presenilins, and α-Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease , 2002, Pharmacological Reviews.

[249]  C. Sundari,et al.  Antioxidant properties of green and black tea, and their potential ability to retard the progression of eye lens cataract. , 2001, Experimental eye research.

[250]  N. Wolf,et al.  The relationships of animal age and caloric intake to cellular replication in vivo and in vitro: a review. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.

[251]  R. Jope,et al.  Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3β and attenuated by lithium , 2001, Brain Research.

[252]  James M. Krueger,et al.  Sleep disturbances in the rotenone animal model of Parkinson disease , 2005, Brain Research.

[253]  K. Mohanakumar,et al.  Melatonin protects against rotenone‐induced oxidative stress in a hemiparkinsonian rat model , 2007, Journal of pineal research.

[254]  Sabrina Moret,et al.  HPLC determination of free nitrogenous compounds of Centaurea solstitialis (Asteraceae), the cause of equine nigropallidal encephalomalacia. , 2005, Toxicon : official journal of the International Society on Toxinology.

[255]  Johannes Schwarz,et al.  Expression of mutant &agr;-synucleins enhances dopamine transporter-mediated MPP+ toxicity in vitro , 2002, Neuroreport.

[256]  S Shibata,et al.  VASORELAXANT ACTION OF CAROVERINE FUMARATE (A QUINOXALINE DERIVATIVE), A CALCIUM‐BLOCKING AGENT , 1980, British journal of pharmacology.

[257]  J. Bergmanson,et al.  Does sunlight cause premature aging of the crystalline lens? , 1989, Journal of the American Optometric Association.

[258]  J K Wilkin,et al.  Oral thermal-induced flushing in erythematotelangiectatic rosacea. , 1981, The Journal of investigative dermatology.

[259]  J. Jakubowski,et al.  Evidence for the mechanism by which eicosapentaenoic acid inhibits human platelet aggregation and secretion - implications for the prevention of vascular disease. , 1979, Thrombosis research.

[260]  Bin Zhang,et al.  Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[261]  K. Castagnoli,et al.  Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobacco. , 2001, Chemical research in toxicology.

[262]  G.L. Boccaccio,et al.  Multiple sclerosis: From a myelin point of view , 1996, Journal of neuroscience research.

[263]  G. Uhl,et al.  Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression. , 1999, Brain research. Molecular brain research.

[264]  M. Ebadi,et al.  Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons. , 2003, Antioxidants & redox signaling.

[265]  M. Feany,et al.  α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease , 2005, Nature Neuroscience.

[266]  Nicolas Simon,et al.  Circadian Rhythms of Oxidative Phosphorylation: Effects of Rotenone and Melatonin on Isolated Rat Brain Mitochondria , 2003, Chronobiology international.

[267]  Vadim V. Sumbayev.  Mitogen-activated protein kinase kinase kinase 5 , 2008 .

[268]  J A Zadunaisky,et al.  Lens opacification and H2O2 elevation induced by a tumor promoter. , 1992, Lens and eye toxicity research.

[269]  Tore Syversen,et al.  Iron deficient and manganese supplemented diets alter metals and transporters in the developing rat brain. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[270]  S P Wolff,et al.  Pro-oxidant activation of ocular reductants. 2. Lens epithelial cell cytotoxicity of a dietary quinone is associated with a stable free radical formed with glutathione in vitro. , 1987, Experimental eye research.

[271]  T. R. Forbes,et al.  Steroid compounds and the dilatation of ovarian and uterine veins in the mouse. , 1972, American journal of obstetrics and gynecology.

[272]  P. O'Brien,et al.  Coenzyme Q Cytoprotective Mechanisms for Mitochondrial Complex I Cytopathies Involves NAD(P)H: Quinone Oxidoreductase 1(NQO1) , 2002, Free radical research.

[273]  Munday Ka,et al.  Platelet aggregation in rats in relation to hyperuricaemia induced by dietary single-cell protein and to protein deficiency. , 1978 .

[274]  R. Milton,et al.  Prevalence and aetiology of cataract in Punjab. , 1982, The British journal of ophthalmology.

[275]  J. J. Wang,et al.  Diabetes, fasting blood glucose and age-related maculopathy: The Blue Mountains Eye Study. , 1999, Australian and New Zealand journal of ophthalmology.

[276]  N J Unakar,et al.  Prefeeding of aldose reductase inhibitor and galactose cataractogenesis. , 1989, Current eye research.

[277]  Kuresh Youdim,et al.  Roles of vitamins E and C on neurodegenerative diseases and cognitive performance. , 2002, Nutrition reviews.

[278]  Ammar Al-Chalabi,et al.  Neurofilaments and neurological disease. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[279]  Vincenzo Silani,et al.  Stem therapy for ALS: hope and reality. , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[280]  Cao Fei,et al.  Experimental study on inhibition of neuronal toxical effect of Levodopa by Ginkgo Biloba Extract on Parkinson disease in rats , 2008, Journal of Huazhong University of Science and Technology [Medical Sciences].

[281]  J. Cadet,et al.  Molecular neurotoxicological models of Parkinsonism: focus on genetic manipulation of mice. , 2001, Parkinsonism & related disorders.

[282]  A. Salazar,et al.  Amyotrophic lateral sclerosis and parkinsonian syndromes in high incidence among the Auyu and Jakai people of West New Guinea , 1982, Neurology.

[283]  S. Shin,et al.  Formation and Removal of α-Synuclein Aggregates in Cells Exposed to Mitochondrial Inhibitors* , 2002, The Journal of Biological Chemistry.

[284]  Sergey Zelenin,et al.  Brain mitochondria contain aquaporin water channels: evidence for the expression of a short AQP9 isoform in the inner mitochondrial membrane , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[285]  Tae-Ryong Hahn,et al.  Prolyl endopeptidase inhibitory activity of unsaturated fatty acids. , 2006, Journal of agricultural and food chemistry.

[286]  Heidi Phillips,et al.  Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System , 2000, Neuron.

[287]  A. Grosmark,et al.  Dopaminergic Control of Sleep–Wake States , 2006, The Journal of Neuroscience.

[288]  Marc W Fariss,et al.  Vitamin E therapy in Parkinson's disease. , 2003, Toxicology.

[289]  R. Quirion,et al.  Natural antioxidants and neurodegenerative diseases. , 2004, Frontiers in bioscience : a journal and virtual library.

[290]  V Sreenivas,et al.  A rural population based case-control study of senile cataract in India. , 1999, Journal of epidemiology.

[291]  Mohammed Khysar Pasha,et al.  Increased myocardial N-myristoyltransferase activity in rotenone model of Parkinsonism. , 2005, International journal of molecular medicine.

[292]  Eva Lindqvist,et al.  Normal nigrostriatal innervation but dopamine dysfunction in mice carrying hypomorphic tyrosine hydroxylase alleles , 2003, Journal of neuroscience research.

[293]  Andrew J Lees,et al.  Atypical unclassifiable parkinsonism on Guadeloupe: An environmental toxic hypothesis , 2005, Movement disorders : official journal of the Movement Disorder Society.

[294]  J. Lucas,et al.  Chronic lithium administration to FTDP‐17 tau and GSK‐3β overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre‐formed neurofibrillary tangles do not revert , 2006, Journal of neurochemistry.

[295]  W. Gong,et al.  The grape component resveratrol interferes with the function of chemoattractant receptors on phagocytic leukocytes. , 2004, Cellular & molecular immunology.

[296]  Patrizia Rizzu,et al.  Drosophila DJ-1 Mutants Are Selectively Sensitive to Environmental Toxins Associated with Parkinson’s Disease , 2005, Current Biology.

[297]  D. Sulzer,et al.  Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease , 2007, Trends in Neurosciences.

[298]  F. Granado,et al.  Lutein, but not alpha-tocopherol, supplementation improves visual function in patients with age-related cataracts: a 2-y double-blind, placebo-controlled pilot study. , 2003, Nutrition.

[299]  M. Iinuma,et al.  Study on anti-cataract drugs from natural sources. II. Effects of buddlejae flos on in vitro aldose reductase activity. , 1995, Biological & pharmaceutical bulletin.

[300]  Shirley Hansen,et al.  Exposure to cigarette smoke does not decrease the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice , 1987, Neuroscience Letters.

[301]  Paul Alan Cox,et al.  Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[302]  Kexiang Xu,et al.  Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging , 2006, Proceedings of the National Academy of Sciences.

[303]  C H Ngim,et al.  Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson's disease. , 1989, Neuroepidemiology.

[304]  M. C. Leske,et al.  Recent epidemiologic studies on nutrition and cataract in India, Italy and the United States. , 1993, Journal of the American College of Nutrition.

[305]  Z. Madar,et al.  EFFECT OF MIGLITOL AND ACARBOSE ON STARCH DIGESTION, DAILY PLASMA GLUCOSE PROFILES AND CATARACT FORMATION , 1993, Journal of basic and clinical physiology and pharmacology.

[306]  J. Cooper,et al.  Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins , 1998, Brain Research.

[307]  James A. Weyhenmeyer,et al.  Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death , 2005, Brain Research.

[308]  Julie A Schneider,et al.  Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.

[309]  M. Schwartzman,et al.  Renal cytochrome P450-related arachidonate metabolite inhibits (Na+ + K+)ATPase , 1985, Nature.

[310]  Zhongpeng Lu,et al.  [Protective effects of Panax notoginseng saponins against pathological lesion of cholinergic neuron in rat model with Alzheimer' s disease]. , 2005, Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials.

[311]  D. Kirik,et al.  Viral Vector Mediated Overexpression of Human α-Synuclein in the Nigrostriatal Dopaminergic Neurons: A New Model for Parkinson's Disease , 2005, CNS Spectrums.

[312]  P Champy,et al.  The mitochondrial complex i inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism , 2003, Neuroscience.

[313]  Yu Luo,et al.  VIP is a transcriptional target of Nurr1 in dopaminergic cells , 2007, Experimental Neurology.

[314]  P D Richardson,et al.  THE VASODILATOR ACTIONS OF ISOPRENALINE, HISTAMINE, PROSTAGLANDIN E2, GLUCAGON AND SECRETIN ON THE HEPATIC ARTERIAL VASCULAR BED OF THE DOG , 1976, British journal of pharmacology.

[315]  E D Day,et al.  Myelin basic protein. , 1981, Contemporary topics in molecular immunology.

[316]  Claire Henchcliffe,et al.  Recent advances in Parkinson’s disease therapy: use of monoamine oxidase inhibitors , 2005, Expert review of neurotherapeutics.

[317]  E. Servienė,et al.  Yeast genome-wide screen reveals dissimilar sets of host genes affecting replication of RNA viruses. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[318]  Won-Seok Choi,et al.  Activation of c-Jun N-terminal protein kinase is a common mechanism underlying paraquat- and rotenone-induced dopaminergic cell apoptosis. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[319]  S. F. Arruda,et al.  Carotenoids from malanga (Xanthosoma sagittifolium) leaves protect cells against oxidative stress in rats. , 2005, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[320]  J. Volkmann.  DEEP BRAIN STIMULATION II Deep Brain Stimulation for the Treatment of Parkinson’s Disease , 2004 .

[321]  Belinda Wilson,et al.  Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[322]  Akihiko Takashima,et al.  Formation of Filamentous Tau Aggregations in Transgenic Mice Expressing V337M Human Tau , 2001, Neurobiology of Disease.

[323]  S. Kang,et al.  Neuroprotective effects of naturally occurring biflavonoids. , 2005, Bioorganic & medicinal chemistry letters.

[324]  J. C. Greene,et al.  Immune responses , 2004 .

[325]  J Cambar,et al.  Influence of theophylline on the diameter of the afferent glomerular arteriole of the rat. , 1978, Acta anatomica.

[326]  Katsuko Komatsu,et al.  Search for Natural Products Related to Regeneration of the Neuronal Network , 2005, Neurosignals.

[327]  Olga Pletnikova,et al.  Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function. , 2005, Human molecular genetics.

[328]  K. Soliman,et al.  Ibuprofen and apigenin induce apoptosis and cell cycle arrest in activated microglia , 2005, Neuroscience Letters.

[329]  Jochen Klucken,et al.  Dopaminergic neuron loss and up‐regulation of chaperone protein mRNA induced by targeted over‐expression of alpha‐synuclein in mouse substantia nigra , 2007, Journal of neurochemistry.

[330]  K. Lindsten,et al.  A transgenic mouse model of the ubiquitin/proteasome system , 2003, Nature Biotechnology.

[331]  Richard E. Carson,et al.  Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[332]  L. Golbe,et al.  Case-control study of early life dietary factors in Parkinson's disease. , 1988, Archives of neurology.

[333]  A. J. Lees,et al.  Deprenyl administration in man: A selective monoamine oxidase B inhibitor without the ‘cheese effect’ , 1978, Psychopharmacology.

[334]  NANCY W. STEAD,et al.  Effect of Selenium Supplementation on Selenium Balance in the Dependent Elderly , 1985, The American journal of the medical sciences.

[335]  N. Wattanapenpaiboon,et al.  Phytonutrient deficiency: the place of palm fruit. , 2003, Asia Pacific journal of clinical nutrition.

[336]  G. Ravalico,et al.  Postoperative cellular reaction on various intraocular lens materials. , 1997, Ophthalmology.

[337]  D. Dexter,et al.  Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease , 2005, Free radical research.

[338]  Gerard E. Dallal,et al.  Dietary calorie restriction in the Emory mouse: effects on lifespan, eye lens cataract prevalence and progression, levels of ascorbate, glutathione, glucose, and glycohemoglobin, tail collagen breaktime, DNA and RNA oxidation, skin integrity, fecundity, and cancer , 1995, Mechanisms of Ageing and Development.

[339]  Dongzhi Wei,et al.  Protective effects of hyperoside (quercetin-3-o-galactoside) to PC12 cells against cytotoxicity induced by hydrogen peroxide and tert-butyl hydroperoxide. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[340]  H. Taylor,et al.  External factors in the development of cataract , 2005, Eye.

[341]  Raúl E. Valdés-Pérez,et al.  Principles of Human Computer Collaboration for Knowledge Discovery in Science , 1999, Artif. Intell..

[342]  M. A. V. Van Duyn,et al.  Overview of the health benefits of fruit and vegetable consumption for the dietetics professional: selected literature. , 2000, Journal of the American Dietetic Association.

[343]  Ronald N. Kostoff,et al.  Literature-related discovery (LRD): Lessons learned, and future research directions , 2008 .

[344]  John Q. Trojanowski,et al.  -synuclein modulates -synuclein neurotoxicity by reducing -synuclein protein expression , 2006 .

[345]  G. Sahin,et al.  Effects of some probable antioxidants on selenite-induced cataract formation and oxidative stress-related parameters in rats. , 1999, Toxicology.

[346]  K. Marder,et al.  Dietary iron, animal fats, and risk of Parkinson's disease. , 1998, Movement disorders : official journal of the Movement Disorder Society.

[347]  K. Murros,et al.  Low plasma uric acid level in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[348]  H. Hidaka,et al.  A novel vascular relaxing agent, N-(6--aminohexyl)-5-chloro-1-naphthalensulfonamide which affects vascular smooth muscle actomyosin. , 1978, The Journal of pharmacology and experimental therapeutics.

[349]  E. Shahar,et al.  Extrapyramidal parkinsonism complicating acute organophosphate insecticide poisoning. , 2005, Pediatric neurology.

[350]  Hirotaka Yoshida,et al.  Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein , 2002, The Journal of Neuroscience.

[351]  S. Ackerman,et al.  Protein accumulation and neurodegeneration in the woozy mutant mouse is caused by disruption of SIL1, a cochaperone of BiP , 2005, Nature Genetics.

[352]  O. Conneely,et al.  Selective Agenesis of Mesencephalic Dopaminergic Neurons in Nurr1-Deficient Mice , 1999, Experimental Neurology.

[353]  Steven J Schwartz,et al.  Assessment of lutein bioavailability from meals and a supplement using simulated digestion and caco-2 human intestinal cells. , 2004, The Journal of nutrition.

[354]  Charles J. Epstein,et al.  Quantitative autoradiographic distribution of [3H]mazindol-labeled dopamine uptake sites in the brains of superoxide dismutase transgenic mice , 1990, Brain Research Bulletin.

[355]  E Méndez-Alvarez,et al.  Interaction of 1,2,3,4-tetrahydroisoquinoline with some components of cigarette smoke: potential implications for Parkinson's Disease. , 1996, Biochemical and biophysical research communications.

[356]  D A Redman,et al.  Ruscus aculeatus (butcher's broom) as a potential treatment for orthostatic hypotension, with a case report. , 2000, Journal of alternative and complementary medicine.

[357]  Anne Eckert,et al.  Stabilization of Mitochondrial Membrane Potential and Improvement of Neuronal Energy Metabolism by Ginkgo Biloba Extract EGb 761 , 2005, Annals of the New York Academy of Sciences.

[358]  Michael J Thun,et al.  Consumption of dairy products and risk of Parkinson's disease. , 2007, American journal of epidemiology.

[359]  N. Biswas,et al.  Anti-cataract activity of Pterocarpus marsupium bark and Trigonella foenum-graecum seeds extract in alloxan diabetic rats. , 2004, Journal of ethnopharmacology.

[360]  N R Smalheiser,et al.  Using ARROWSMITH: a computer-assisted approach to formulating and assessing scientific hypotheses. , 1998, Computer methods and programs in biomedicine.

[361]  Sue Thomas,et al.  Parkinson's disease, palliative care and older people: Part 1. , 2004, Nursing older people.

[362]  Joseph Jankovic,et al.  Role of nitric oxide in rotenone‐induced nigro‐striatal injury , 2003, Journal of neurochemistry.

[363]  C. A. Gilbert,et al.  Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: A comparison with hydralazine , 1975, Clinical pharmacology and therapeutics.

[364]  Luigi Aloe,et al.  TNF-α expressed in the brain of transgenic mice lowers central tyroxine hydroxylase immunoreactivity and alters grooming behavior , 1997, Neuroscience Letters.

[365]  Naoaki Saito,et al.  Protein Kinase Cγ (PKCγ): Function of Neuron Specific Isotype , 2002 .

[366]  A Taylor,et al.  Dose-response characteristics of galactose-induced cataract in the rat. , 1994, Ophthalmic research.

[367]  R A Rajewski,et al.  Ongoing in vivo studies with cytoskeletal drugs in tau transgenic mice. , 2006, Current Alzheimer research.

[368]  J. Joseph,et al.  Essential fatty acids and the brain: possible health implications , 2000, International Journal of Developmental Neuroscience.

[369]  F. Simoons,et al.  A geographic approach to senile cataracts , 1982, Digestive Diseases and Sciences.

[370]  Mira Jun,et al.  Plant phenolics as prolyl endopeptidase inhibitors , 2007, Archives of pharmacal research.

[371]  A Taylor,et al.  Delay of UV-induced eye lens protein damage in guinea pigs by dietary ascorbate. , 1986, Journal of free radicals in biology & medicine.

[372]  Xin Gong,et al.  Antioxidant enzyme activities in lens, liver and kidney of calorie restricted Emory mice , 1997, Mechanisms of Ageing and Development.

[373]  Erdem Buyukbingol,et al.  Recent studies of aldose reductase enzyme inhibition for diabetic complications. , 2003, Current medicinal chemistry.

[374]  J R Goldsmith,et al.  A Case-Referent Study of Extrapyramidal Signs (Preparkinsonism) in Rural Communities of Israel , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[375]  K C Agarwal,et al.  Inhibition of Human and Rat Platelet Aggregation by Extracts of Mo-er (Auricularia auricula) , 1982, Thrombosis and Haemostasis.

[376]  Walter C Willett,et al.  Overall adherence to the dietary guidelines for americans is associated with reduced prevalence of early age-related nuclear lens opacities in women. , 2004, The Journal of nutrition.

[377]  Manfred Uhr,et al.  The anti-Parkinson drug budipine is exported actively out of the brain by P-glycoprotein in mice , 2005, Neuroscience Letters.

[378]  G. Gerhardt,et al.  Neurochemical investigations of dopamine neuronal systems in iron-regulatory protein 2 (IRP-2) knockout mice. , 2005, Brain research. Molecular brain research.

[379]  A. Ludolph,et al.  Slow toxins, biologic markers, and long‐latency neurodegenerative disease in the western Pacific region , 1991, Neurology.

[380]  Jun Wang,et al.  Neuronal SIRT1 Activation as a Novel Mechanism Underlying the Prevention of Alzheimer Disease Amyloid Neuropathology by Calorie Restriction* , 2006, Journal of Biological Chemistry.

[381]  M. Mattson,et al.  Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. , 2002, Physiological reviews.

[382]  T. Dawson,et al.  Identification of Far Upstream Element-binding Protein-1 as an Authentic Parkin Substrate* , 2006, Journal of Biological Chemistry.

[383]  S. Mandel,et al.  Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders. , 2006, Molecular nutrition & food research.

[384]  Edmond Rock,et al.  Short-term supplementation with lutein affects biomarkers of lutein status similarly in young and elderly subjects , 2003, Experimental Gerontology.

[385]  A. Herman,et al.  Isolation and pharmacological characterization of vernolepin. , 1983, Journal of natural products.

[386]  A K Sim,et al.  The antithrombotic activity of viquidil, a cerebral vasodilator. , 1979, Arzneimittel-Forschung.

[387]  Jean-Pierre Julien,et al.  Neurofilaments in health and disease. , 1998, Progress in nucleic acid research and molecular biology.

[388]  E. Hirsch,et al.  Animal models of Parkinson's disease in rodents induced by toxins: an update. , 2003, Journal of neural transmission. Supplementum.

[389]  G. Cathelineau,et al.  Disturbed galactose metabolism in elderly and diabetic humans is associated with cataract formation. , 1993, The Journal of nutrition.

[390]  P. Kidd,et al.  Neurodegeneration from mitochondrial insufficiency: nutrients, stem cells, growth factors, and prospects for brain rebuilding using integrative management. , 2005, Alternative medicine review : a journal of clinical therapeutic.

[391]  P. Bywood,et al.  Mitochondrial Complex Inhibitors Preferentially Damage Substantia Nigra Dopamine Neurons in Rat Brain Slices , 2003, Experimental Neurology.

[392]  Jin-Rong Zhou,et al.  Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. , 2003, The Journal of nutrition.

[393]  Jung-Soo Han,et al.  Ulva conglobata, a marine algae, has neuroprotective and anti-inflammatory effects in murine hippocampal and microglial cells , 2006, Neuroscience Letters.

[394]  P. Marrack,et al.  T‐cell survival , 1998, Immunological reviews.

[395]  A. Reunanen,et al.  Flavonoid intake and risk of chronic diseases. , 2002, The American journal of clinical nutrition.

[396]  Jin Won Hyun,et al.  Cytoprotective effects of KIOM-79 on streptozotocin induced cell damage by inhibiting ERK and AP-1. , 2007, Biological & pharmaceutical bulletin.

[397]  Stefan M Pulst,et al.  Identification and expression of the gene for human ataxin-2-related protein on chromosome 16 , 2003, Experimental Neurology.

[398]  Trust Beta,et al.  High-amylose corn exhibits better antioxidant activity than typical and waxy genotypes. , 2007, Journal of agricultural and food chemistry.

[399]  R. Yunes,et al.  Antispasmodic effects of an alkaloid extracted from Phyllanthus sellowianus: a comparative study with papaverine. , 1984, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[400]  P. Fraker,et al.  The many roles of apoptosis in immunity as modified by aging and nutritional status. , 2004, The journal of nutrition, health & aging.

[401]  N. Maidment,et al.  Genetics of parkin-linked disease , 2004, Human Genetics.

[402]  T. Iwatsubo,et al.  Familial Parkinson Mutant α-Synuclein Causes Dopamine Neuron Dysfunction in Transgenic Caenorhabditis elegans* , 2006, Journal of Biological Chemistry.

[403]  Shubo Han,et al.  The Flavonoid Baicalein Inhibits Fibrillation of α-Synuclein and Disaggregates Existing Fibrils* , 2004, Journal of Biological Chemistry.

[404]  Saburo Hara,et al.  Mulberry leaf extract prevents amyloid beta-peptide fibril formation and neurotoxicity , 2007, Neuroreport.

[405]  Young Joo Lee,et al.  The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice , 2006, Neuroscience Letters.

[406]  K Villako,et al.  Clinical picture of hypolactasia and lactose intolerance. , 1994, Scandinavian journal of gastroenterology. Supplement.

[407]  D. Price,et al.  Stabilization of α-Synuclein Protein with Aging and Familial Parkinson's Disease-Linked A53T Mutation , 2004, The Journal of Neuroscience.

[408]  H Ujike,et al.  VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[409]  R. Ramsay,et al.  Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria. , 1986, The Journal of biological chemistry.

[410]  Peter Bruza,et al.  Towards Operational Abduction from a Cognitive Perspective , 2006, Log. J. IGPL.

[411]  J. Menéndez,et al.  Midbrain neuronal cultures from parkin mutant mice are resistant to nitric oxide-induced toxicity , 2006, Neuropharmacology.

[412]  Gang Hao,et al.  Intrastriatal grafting of glomus cells ameliorates behavioral defects of Parkinsonian rats , 2002, Physiology & Behavior.

[413]  P. Calabresi,et al.  Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: Role of Na+/K+ ATPase , 2006, Neurobiology of Disease.

[414]  K. Macleod,et al.  Biomarkers of oxidative stress are significantly elevated in Down syndrome. , 1998, Free radical biology & medicine.

[415]  Ronald N. Kostoff,et al.  Information content in Medline record fields , 2004, Int. J. Medical Informatics.

[416]  Carmia Borek,et al.  Garlic reduces dementia and heart-disease risk. , 2006, The Journal of nutrition.

[417]  S. Joshi,et al.  Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. , 2000, Toxicology.

[418]  Charles Ramassamy,et al.  Ginkgo biloba extract (EGb 761) in Alzheimer's disease: is there any evidence? , 2007, Current Alzheimer research.

[419]  M C Tarrés,et al.  [Relationship of diet, biomass and expression of diabetes in eSS rats]. , 1990, Medicina.

[420]  R. Clayton,et al.  Cytochrome c release from rat brain mitochondria is proportional to the mitochondrial functional deficit: implications for apoptosis and neurodegenerative disease , 2005, Journal of neurochemistry.

[421]  A. Dikalova,et al.  Comparison of Antioxidants in the Ability to Prevent Cataract in Prematurely Aging OXYS Rats , 2004, Bulletin of Experimental Biology and Medicine.

[422]  L T Chylack,et al.  Nutritional status in persons with and without senile cataract: blood vitamin and mineral levels. , 1988, The American journal of clinical nutrition.

[423]  U. Andley,et al.  Phototoxicity in Human Lens Epithelial Cells Promoted by St. John's Wort¶ , 2004, Photochemistry and photobiology.

[424]  Wayne R Matson,et al.  Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice. , 2006, Biochimica et biophysica acta.

[425]  N. Chauhan,et al.  Amelioration of early cognitive deficits by aged garlic extract in Alzheimer's transgenic mice , 2007, Phytotherapy research : PTR.

[426]  Stephen Barnes,et al.  Proteomics analysis of the actions of grape seed extract in rat brain: technological and biological implications for the study of the actions of psychoactive compounds. , 2006, Life sciences.

[427]  Teresa Audesirk,et al.  Estradiol and raloxifene protect cultured SN4741 neurons against oxidative stress , 2005, Neuroscience Letters.

[428]  Federico V Pallardó,et al.  Mitochondrial oxidant signalling in Alzheimer's disease. , 2007, Journal of Alzheimer's disease : JAD.

[429]  C. Link,et al.  Transgenic invertebrate models of age-associated neurodegenerative diseases , 2001, Mechanisms of Ageing and Development.

[430]  Robert Burke,et al.  Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[431]  Charles J. Epstein,et al.  Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease , 1995, Nature Medicine.

[432]  Padmini Srinivasan,et al.  Mining MEDLINE for implicit links between dietary substances and diseases , 2004, ISMB/ECCB.

[433]  E. Hirsch,et al.  The rotenone model of parkinsonism--the five years inspection. , 2006, Journal of neural transmission. Supplementum.

[434]  C. Shaw,et al.  Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator. , 2006, Medical hypotheses.

[435]  Marc G Caron,et al.  Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice , 2003, Neuron.

[436]  C. Colosimo,et al.  Epidemiology of progressive supranuclear palsy , 2001, Neurological Sciences.

[437]  H. Shill,et al.  Case of neuroleptic malignant‐like syndrome precipitated by abrupt fava bean discontinuance , 2005, Movement disorders : official journal of the Movement Disorder Society.

[438]  E Ernst,et al.  Interactions between herbal medicines and prescribed drugs: a systematic review. , 2001, Drugs.

[439]  L T Chylack,et al.  Antioxidant vitamins and nuclear opacities: the longitudinal study of cataract. , 1998, Ophthalmology.

[440]  J. Morrow,et al.  Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment , 2005, Annals of neurology.

[441]  Jean Féger,et al.  Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats , 2003, Journal of neurochemistry.

[442]  Robert C. Malenka,et al.  Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models , 2007, Nature.

[443]  A. Brice,et al.  Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function , 2005, Journal of neurochemistry.

[444]  Swee-Hock Yeo,et al.  Surface bio-magnetism on bacterial cells adhesion and surface proteins secretion. , 2005, Colloids and surfaces. B, Biointerfaces.

[445]  William Fenical,et al.  Multiple defensive roles for triterpene glycosides from two Caribbean sponges , 2002, Oecologia.

[446]  Koji Nakanishi,et al.  Terpene trilactones from Gingko biloba: from ancient times to the 21st century. , 2005, Bioorganic & medicinal chemistry.

[447]  C M Leach,et al.  A comparison of the inhibitory effects of melatonin and indomethacin on platelet aggregation and thromboxane release. , 1980, Prostaglandins.

[448]  S. Sieri,et al.  Protein intake in Parkinsonian patients using the EPIC food frequency questionnaire , 2006, Movement disorders : official journal of the Movement Disorder Society.

[449]  J. Dyerberg,et al.  Personal reflections on the incidence of ischaemic heart disease in Oslo during the Second World War. , 2009, Acta medica Scandinavica.

[450]  K. Inagaki,et al.  Inhibition of aldose reductases from rat and bovine lenses by flavonoids. , 1982, Biochemical pharmacology.

[451]  Peter Bruza,et al.  Abduction in Semantic Space: Towards a Logic of Discovery , 2004, Log. J. IGPL.

[452]  S. Roh,et al.  Anticholinesterase activity of plastoquinones from Sargassum sagamianum: lead compounds for alzheimer's disease therapy , 2007, Phytotherapy research : PTR.

[453]  Hamid Mirzaei,et al.  Identification of rotenone-induced modifications in alpha-synuclein using affinity pull-down and tandem mass spectrometry. , 2006, Analytical chemistry.

[454]  M. Frosini,et al.  Cytochrome P450-dependent N-dealkylation of L-deprenyl in C57BL mouse liver microsomes: effects of in vivo pretreatment with ethanol, phenobarbital, beta-naphthoflavone and L-deprenyl. , 2000, European journal of pharmacology.

[455]  Jonathan D. Wren,et al.  Knowledge discovery by automated identification and ranking of implicit relationships , 2004, Bioinform..

[456]  Moses Rodriguez,et al.  Effectors of Demyelination and Remyelination in the CNS: Implications for Multiple Sclerosis , 2007, Brain pathology.

[457]  Peter Davies,et al.  Tomoregulin‐2 is found extensively in plaques in Alzheimer's disease brain , 2006, Journal of neurochemistry.

[458]  C. Hertzman,et al.  A case‐control study of Parkinson's disease in a horticultural region of British Columbia , 1994, Movement disorders : official journal of the Movement Disorder Society.

[459]  P S Spencer,et al.  Long-latency neurodegenerative disease in the western Pacific. , 1991, Geriatrics.

[460]  Alfio V Parisi,et al.  Variation of the enhanced biologically damaging solar UV due to clouds , 2004, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[461]  Walter Paulus,et al.  Dyskinesias due to intravenous apomorphine abuse in a patient without basal ganglia disorder , 2005, Movement disorders : official journal of the Movement Disorder Society.

[462]  Patrick F. Chinnery,et al.  Mitochondrial DNA polymerase-γ and human disease , 2006 .

[463]  Ronald V. Maier,et al.  Mitogen-activated protein kinases. , 2002, Critical care medicine.

[464]  C M Peterson,et al.  Inhibition of Platelet Function with 2,3‐Dihydroxybenzoic Acid , 1977, British journal of haematology.

[465]  D. Miller,et al.  Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: Implications for Parkinson's disease , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[466]  Yasuhiko Izumi,et al.  Dopamine is involved in selectivity of dopaminergic neuronal death by rotenone , 2003, Neuroreport.

[467]  Todd B. Sherer,et al.  Chronic reduction in complex I function alters calcium signaling in SH-SY5Y neuroblastoma cells , 2001, Brain Research.

[468]  K. Ashe,et al.  Altered short-term hippocampal synaptic plasticity in mutant &agr;-synuclein transgenic mice , 2003, Neuroreport.

[469]  Paul Alan Cox,et al.  Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam. , 2002, Neurology.

[470]  A. Boulton,et al.  Irreversible inhibition of monoamine oxidase by some components of cigarette smoke. , 1987, Life sciences.

[471]  J Q Trojanowski,et al.  Selective Degeneration of Purkinje Cells with Lewy Body-Like Inclusions in Aged NFHLACZ Transgenic Mice , 1997, The Journal of Neuroscience.

[472]  B. Giardina,et al.  Protective effect of rhubarb derivatives on amyloid beta (1–42) peptide-induced apoptosis in IMR-32 cells: A case of nutrigenomic , 2006, Brain Research Bulletin.

[473]  U. Das,et al.  Essential Fatty acids - a review. , 2006, Current pharmaceutical biotechnology.

[474]  N L Richardson,et al.  Influence of dietary calcium, phosphorus, zinc and sodium phytate level on cataract incidence, growth and histopathology in juvenile chinook salmon (Oncorhynchus tshawytscha). , 1985, The Journal of nutrition.

[475]  Georg Auburger,et al.  Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation , 2003, Molecular and Cellular Neuroscience.

[476]  W. Satariano,et al.  Risk factors for age-related cataracts. , 1995, Epidemiologic reviews.

[477]  W. Schmidt,et al.  Controversies on new animal models of Parkinson's disease pro and con: the rotenone model of Parkinson's disease (PD). , 2006, Journal of neural transmission. Supplementum.

[478]  Bryan L Roth,et al.  Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons* , 2003, Journal of Biological Chemistry.

[479]  I. Miyazaki,et al.  Rotenone induces aggregation of γ-tubulin protein and subsequent disorganization of the centrosome: Relevance to formation of inclusion bodies and neurodegeneration , 2005, Neuroscience.

[480]  Belen Gago,et al.  Uncoupling protein‐2 promotes nigrostriatal dopamine neuronal function , 2006, The European journal of neuroscience.

[481]  Seung-Jae Lee,et al.  Membrane-bound α-Synuclein Has a High Aggregation Propensity and the Ability to Seed the Aggregation of the Cytosolic Form* , 2002, The Journal of Biological Chemistry.

[482]  W. Schmidt,et al.  The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA , 2004, Behavioural Brain Research.

[483]  Miguel A Hernán,et al.  Weight loss in Parkinson's disease , 2003, Annals of neurology.

[484]  Sunhong Kim,et al.  Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin , 2006, Nature.

[485]  Christian Haass,et al.  Pathological properties of the Parkinson’s disease-associated protein DJ-1 in α-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick’s disease , 2004, Acta Neuropathologica.

[486]  M. Smidt,et al.  Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons , 2003, The European journal of neuroscience.

[487]  Guangjun Nie,et al.  Protective effects of green tea polyphenols and their major component, (–)-epigallocatechin-3-gallate (EGCG), on 6-hydroxydopamine-induced apoptosis in PC12 cells , 2002, Redox report : communications in free radical research.

[488]  M T Lin,et al.  Effects of Chinese herb, Huang Chin (Scutellaria baicalensis George) on thermoregulation in rats. , 1980, Japanese journal of pharmacology.

[489]  R H Moore,et al.  Effects of enkephalins on perfusion pressure in isolated hindlimb preparations. , 1982, Life sciences.

[490]  G. Gobe,et al.  Apoptosis in brain and gut tissue of mice fed a seed preparation of the cycad Lepidozamia peroffskyana. , 1994, Biochemical and biophysical research communications.

[491]  Toshiaki Mito,et al.  BAK alters neuronal excitability and can switch from anti- to pro-death function during postnatal development. , 2003, Developmental cell.

[492]  Marc Weeber,et al.  Using concepts in literature-based discovery: simulating Swanson's Raynaud-fish oil and migraine-magnesium discoveries , 2001 .

[493]  Gang Hu,et al.  Effects of iptakalim on rotenone-induced cytotoxicity and dopamine release from PC12 cells , 2004, Neuroscience Letters.

[494]  Todd R. Flower,et al.  α-Synuclein, oxidative stress and apoptosis from the perspective of a yeast model of Parkinson's disease , 2006 .

[495]  Judith P Golden,et al.  RET Is Dispensable for Maintenance of Midbrain Dopaminergic Neurons in Adult Mice , 2006, The Journal of Neuroscience.

[496]  D. Dickson,et al.  Analysis of tauopathies with transgenic mice. , 2001, Trends in molecular medicine.

[497]  Karen Marder,et al.  Dietary lipids and antioxidants in Parkinson's disease: A population‐based, case‐control study , 1996, Annals of neurology.

[498]  Nils Brose,et al.  Profound ataxia in complexin I knockout mice masks a complex phenotype that includes exploratory and habituation deficits. , 2005, Human molecular genetics.

[499]  Rebecca A. Betensky,et al.  α-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[500]  Laurent Kodjikian,et al.  Intraocular lenses, bacterial adhesion and endophthalmitis prevention: a review. , 2004, Bio-medical materials and engineering.

[501]  Xiaoping Pu,et al.  Neuroprotective effects of phenylethanoid glycosides from Cistanches salsa against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity in C57 mice. , 2004, Biological & pharmaceutical bulletin.

[502]  D Kromhout,et al.  The inverse relation between fish consumption and 20-year mortality from coronary heart disease. , 1985, The New England journal of medicine.

[503]  P. Kempster,et al.  Dietary factors in the management of Parkinson's disease. , 1994, Nutrition reviews.

[504]  Zheng Feng,et al.  Long-term melatonin or 17beta-estradiol supplementation alleviates oxidative stress in ovariectomized adult rats. , 2005, Free radical biology & medicine.

[505]  Hitoshi Kimura,et al.  Combined effect of vitamin E and insulin on cataracts of diabetic rats fed a high cholesterol diet. , 2004, Biological & pharmaceutical bulletin.

[506]  R. Reiter,et al.  Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. , 2002, Current topics in medicinal chemistry.

[507]  S. Yehuda,et al.  Possible anti-Parkinson properties of N-(α-linolenoyl) tyrosine A new molecule , 2002, Pharmacology Biochemistry and Behavior.

[508]  Hiroshi Uchida,et al.  An application of a new planar positron imaging system (PPIS) in a small animal: MPTP-induced Parkinsonism in mouse , 2004, Annals of nuclear medicine.

[509]  Rhoda Au,et al.  Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. , 2006, Archives of neurology.

[510]  M. Thun,et al.  Smokeless tobacco use and the risk of Parkinson's disease mortality , 2005, Movement disorders : official journal of the Movement Disorder Society.

[511]  Hiroshi Kase,et al.  Rescue of Locomotor Impairment in Dopamine D2 Receptor-Deficient Mice by an Adenosine A2A Receptor Antagonist , 2000, The Journal of Neuroscience.

[512]  Thomas Floss,et al.  Sensitivity to Oxidative Stress in DJ-1-Deficient Dopamine Neurons: An ES- Derived Cell Model of Primary Parkinsonism , 2004, PLoS biology.

[513]  Y. Moon,et al.  Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10 , 2005, Journal of neurochemistry.

[514]  R. Palmiter,et al.  Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity , 2005, BMC Neuroscience.

[515]  Division on Earth.  Review of the Desalination and Water Purification Technology Roadmap , 2004 .

[516]  Hernan Cardenas,et al.  Compromised reactive microgliosis in MPTP-lesioned IL-6 KO mice , 2003, Brain Research.

[517]  D. Rubinsztein,et al.  Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease. , 2005, Human molecular genetics.

[518]  I. Myara,et al.  Metabolic studies of a sustained galactose overload in rat. , 1987, Annals of nutrition & metabolism.

[519]  Jin-Min Yang,et al.  Interactions of 1-methyl-4-phenylpyridinium and other compounds with P-glycoprotein: relevance to toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine , 2001, Brain Research.

[520]  H Checkoway,et al.  Dietary factors in Parkinson's disease: The role of food groups and specific foods , 1999, Movement disorders : official journal of the Movement Disorder Society.

[521]  Yoriko Hayasaka,et al.  Effects of kakkon-to and sairei-to on aqueous flare elevation after complicated cataract surgery. , 2002, The American journal of Chinese medicine.

[522]  Wenhua Liu,et al.  Selective Vulnerability of Dopaminergic Neurons to Microtubule Depolymerization* , 2005, Journal of Biological Chemistry.

[523]  Albert C Ludolph,et al.  On the decline and etiology of high‐incidence motor system disease in West Papua (southwest New Guinea) , 2005, Movement disorders : official journal of the Movement Disorder Society.

[524]  Miguel A Hernán,et al.  Dietary intakes of fat and risk of Parkinson's disease. , 2003, American journal of epidemiology.

[525]  Gary W Miller,et al.  Paraquat neurotoxicity is distinct from that of MPTP and rotenone. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[526]  Goust Jm,et al.  Major histocompatibility complex. , 1990 .

[527]  Joyce A. Mitchell,et al.  Using literature-based discovery to identify disease candidate genes , 2005, Int. J. Medical Informatics.

[528]  Harvey Checkoway,et al.  Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. , 2002, American journal of epidemiology.

[529]  Dan Zhang,et al.  Dactylorhin B reduces toxic effects of β-amyloid fragment (25–35) on neuron cells and isolated rat brain mitochondria , 2006, Naunyn-Schmiedeberg's Archives of Pharmacology.

[530]  V. Lee,et al.  Parkin and the Molecular Pathways of Parkinson's Disease , 2001, Neuron.

[531]  Naoya Nakai,et al.  Acanthopanax senticosus Harms as a prophylactic for MPTP-induced Parkinson's disease in rats. , 2005, Journal of ethnopharmacology.

[532]  S. Heptinstall,et al.  EXTRACTS OF FEVERFEW INHIBIT GRANULE SECRETION IN BLOOD PLATELETS AND POLYMORPHONUCLEAR LEUCOCYTES , 1985, The Lancet.

[533]  M. Mohanasundari,et al.  Enhanced neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against MPTP-induced neurotoxicity in mice , 2006, Journal of the Neurological Sciences.

[534]  D. Robertson,et al.  Epiretinal membranes and cystoid macular edema in gyrate atrophy of the choroid and retina. , 1989, Retina.

[535]  J. Almeida,et al.  Antiparkinsonian-like effects of Plumbago scandens on tremorine-induced tremors methodology , 2004, Pharmacology Biochemistry and Behavior.

[536]  B. Bernard,et al.  Toxicology and carcinogenesis studies of dietary titanium dioxide-coated mica in male and female Fischer 344 rats. , 1989, Journal of toxicology and environmental health.

[537]  J. Andersen,et al.  Genetically engineered mice and their use in aging research , 2001, Molecular biotechnology.

[538]  J. Langston,et al.  Increased striatal dopamine turnover following acute administration of rotenone to mice , 2000, Brain Research.

[539]  Lloyd A Greene,et al.  Endoplasmic Reticulum Stress and the Unfolded Protein Response in Cellular Models of Parkinson's Disease , 2002, The Journal of Neuroscience.

[540]  L J An,et al.  Protocatechuic acid from Alpinia oxyphylla against MPP+-induced neurotoxicity in PC12 cells. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[541]  P. Ince,et al.  Return of the cycad hypothesis – does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health? , 2005, Neuropathology and applied neurobiology.

[542]  D. Cohen,et al.  Dementia, depression, and nutritional status. , 1994, Primary care.

[543]  M. Díez,et al.  Hydrosoluble fiber (Plantago ovata husk) and levodopa II: Experimental study of the pharmacokinetic interaction in the presence of carbidopa , 2005, European Neuropsychopharmacology.

[544]  N D Stull,et al.  Induction of a dopaminergic phenotype in cultured striatal neurons by bone morphogenetic proteins. , 2001, Brain research. Developmental brain research.

[545]  C. Greenwood,et al.  Energy‐Containing Nutritional Supplements Can Affect Usual Energy Intake Postsupplementation in Institutionalized Seniors with Probable Alzheimer's Disease , 2006, Journal of the American Geriatrics Society.

[546]  K. Tsutsumi,et al.  Acceleration of development of diabetic cataract by hyperlipidemia and low high-density lipoprotein in rats. , 1999, Biological & pharmaceutical bulletin.

[547]  Cristina Geroldi,et al.  Drug prescription in mild cognitive impairment: the physicians' perspective in Italy , 2006, International journal of geriatric psychiatry.

[548]  Borodin Ea,et al.  Extraction of cholesterol from biological membranes with positively charged micelles of phosphatidylcholine , 1985 .

[549]  John Q. Trojanowski,et al.  Distinct cleavage patterns of normal and pathologic forms of α‐synuclein by calpain I in vitro , 2003 .

[550]  Catherine Y Y Liu,et al.  Stimulation of baculovirus transcriptome expression in mammalian cells by baculoviral transcriptional activators. , 2007, The Journal of general virology.

[551]  Andrei Surguchov,et al.  Protein Aggregation in Retinal Cells and Approaches to Cell Protection , 2005, Cellular and Molecular Neurobiology.

[552]  Joachim Klose,et al.  Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice* , 2004, Journal of Biological Chemistry.

[553]  Kanghyun KIM,et al.  Memory-Enhancing Effect of a Supercritical Carbon Dioxide Fluid Extract of the Needles of Abies koreana on Scopolamine-Induced Amnesia in Mice , 2006, Bioscience, biotechnology, and biochemistry.

[554]  P. Foley,et al.  Beans, roots and leaves: a brief history of the pharmacological therapy of parkinsonism. , 2003, Wurzburger medizinhistorische Mitteilungen.

[555]  He Ys.  [Clinical and experimental study on anti-platelet aggregation effect of d-catechin]. , 1982 .

[556]  Bernardino Ghetti,et al.  Pathological Changes in Dopaminergic Nerve Cells of the Substantia Nigra and Olfactory Bulb in Mice Transgenic for Truncated Human α-Synuclein(1–120): Implications for Lewy Body Disorders , 2006, The Journal of Neuroscience.

[557]  H. Robertson,et al.  Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease , 2003, Experimental Neurology.

[558]  T. Landauer,et al.  Indexing by Latent Semantic Analysis , 1990 .

[559]  Naoki Sugihara,et al.  Relationship between number of present teeth and nutritional intake in institutionalized elderly. , 2005, The Bulletin of Tokyo Dental College.

[560]  G Auricchio,et al.  The physiologic and pharmacologic factors protecting the lens transparency and the update approach to the prevention of experimental cataracts: a review. , 1983, Metabolic, pediatric, and systemic ophthalmology.

[561]  T D Buckman,et al.  Interaction of 1-methyl-4-phenylpyridinium ion with human platelets. , 1988, Biochemical and biophysical research communications.

[562]  O. A. Bocharova,et al.  Effect of complex phytoadaptogen on MPTP-induced parkinson's syndrome in mice , 2006, Bulletin of Experimental Biology and Medicine.

[563]  Makoto Hashimoto,et al.  Expression of alpha-synuclein, a presynaptic protein implicated in Parkinson's disease, in erythropoietic lineage. , 2007, Biochemical and biophysical research communications.

[564]  D. Dexter,et al.  The antioxidant drink “effective microorganism‐X (EM‐X)” pre‐treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6‐hydroxydopamine‐lesion rat model of Parkinson's disease , 2004, The Journal of pharmacy and pharmacology.

[565]  Santiago Canals,et al.  Nitric Oxide Triggers the Toxicity due to Glutathione Depletion in Midbrain Cultures through 12-Lipoxygenase* , 2003, Journal of Biological Chemistry.

[566]  Guan-Hong Li,et al.  Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage through inhibition of microglia activation and proinflammatory factors generation , 2007, Neuroscience Letters.

[567]  K. Davies.  Oxidative stress: the paradox of aerobic life. , 1995, Biochemical Society symposium.

[568]  A. Mackay-Sim,et al.  Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[569]  J S Hothersall,et al.  The effect of diabetes and dietary ascorbate supplementation on the oxidative modification of rat lens beta L crystallin. , 1993, Biochemical medicine and metabolic biology.

[570]  A. Cincotta,et al.  Bromocriptine improves glycaemic control and serum lipid profile in obese Type 2 diabetic subjects: a new approach in the treatment of diabetes. , 1999, Expert opinion on investigational drugs.

[571]  B. Weinshenker,et al.  The epidemiology of multiple sclerosis. , 1997, Mayo Clinic proceedings.

[572]  N. Banik,et al.  The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats , 2007, Neuroscience.

[573]  C M Jacque,et al.  Glial Fibrillary Acidic Protein , 2020, Definitions.

[574]  Ulrich Pohl,et al.  Reactive Oxygen Species: Players in the Platelet Game , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[575]  Kazuki Kanazawa,et al.  Halocynthiaxanthin and Peridinin Sensitize Colon Cancer Cell Lines to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand , 2007, Molecular Cancer Research.

[576]  G E Dallal,et al.  Dietary restriction delays cataract and reduces ascorbate levels in Emory mice. , 1995, Experimental eye research.

[577]  R. Blakely,et al.  The high-affinity choline transporter: a critical protein for sustaining cholinergic signaling as revealed in studies of genetically altered mice. , 2006, Handbook of experimental pharmacology.

[578]  Mark D Thornquist,et al.  Diet and lifestyle correlates of lutein in the blood and diet. , 2002, The Journal of nutrition.

[579]  E. Wolters,et al.  Enhanced sensitivity of dopaminergic neurons to rotenone-induced toxicity with aging. , 2006, Parkinsonism & related disorders.

[580]  Abraham Grossman,et al.  Pathogenic chaperone-like RNA induces congophilic aggregates and facilitates neurodegeneration in Drosophila , 2007, Cell stress & chaperones.

[581]  F Simonelli,et al.  Cataract formation in diabetic patients and galactose-1-phosphate uridyltransferase deficiency. , 1987, Ophthalmic research.

[582]  Robert E. Burke,et al.  Lack of α‐synuclein does not alter apoptosis of neonatal catecholaminergic neurons , 2004 .

[583]  Bertrand Bloch,et al.  Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter , 1999, The European journal of neuroscience.

[584]  Qingqing Wu,et al.  Quantification of huperzine A in Huperzia serrata by HPLC-UV and identification of the major constituents in its alkaloid extracts by HPLC-DAD-MS-MS. , 2006, Journal of pharmaceutical and biomedical analysis.

[585]  E. Estape,et al.  Prevention and reversal of cataracts in genetically hypertensive rats through sodium restriction. , 1989, Investigative ophthalmology & visual science.

[586]  K Kawanishi,et al.  Aldose reductase inhibitors from the nature. , 2003, Current medicinal chemistry.

[587]  S. Lorenzl,et al.  A pivotal role of matrix metalloproteinase‐3 activity in dopaminergic neuronal degeneration via microglial activation , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[588]  Yoshiji Ohta,et al.  Cataract Development in 12-Month-Old Rats Fed a 25% Galactose Diet and Its Relation to Osmotic Stress and Oxidative Damage , 1999, Ophthalmic Research.

[589]  K. C. Srivastava,et al.  Aqueous extracts of onion, garlic and ginger inhibit platelet aggregation and alter arachidonic acid metabolism. , 1984, Biomedica biochimica acta.

[590]  S D Varma,et al.  Prevention of cataracts by nutritional and metabolic antioxidants. , 1995, Critical reviews in food science and nutrition.

[591]  N Sonnenberg,et al.  Metabolism in the artificially reared rat pup: effect of an atypical rat milk substitute. , 1982, The Journal of nutrition.

[592]  N J Unakar,et al.  In utero and milk-mediated effect of aldose reductase inhibitor on galactose cataracts. , 1991, Experimental eye research.

[593]  Gary Fiskum,et al.  Regulation of hydrogen peroxide production by brain mitochondria by calcium and Bax , 2002, Journal of neurochemistry.

[594]  Yu Wang,et al.  Bioassay‐guided isolation of antiatherosclerotic phytochemicals from Artocarpus altilis , 2006, Phytotherapy research : PTR.

[595]  Kiyoshi Fukui,et al.  Attenuation of MPTP‐induced neurotoxicity and locomotor dysfunction in Nucling‐deficient mice via suppression of the apoptosome pathway , 2006, Journal of neurochemistry.

[596]  V Petkov,et al.  Plants and hypotensive, antiatheromatous and coronarodilatating action. , 1979, The American journal of Chinese medicine.

[597]  M. Breen,et al.  Weight changes with depot neuroleptic maintenance therapy , 1979, Acta psychiatrica Scandinavica.

[598]  J. Casida,et al.  Interaction of 1‐Methyl‐4‐Phenylpyridinium Ion (MPP+) and Its Analogs with the Rotenone/Piericidin Binding Site of NADH Dehydrogenase , 1991, Journal of neurochemistry.

[599]  Francesca Pallotti,et al.  Chronic intestinal pseudo-obstruction. , 2008, World journal of gastroenterology.

[600]  M C Ahuja,et al.  Antibiotic associated diarrhoea: a controlled study comparing plain antibiotic with those containing protected lactobacilli. , 2002, Journal of the Indian Medical Association.

[601]  Tianhong Pan,et al.  Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration. , 2005, Biochemical and biophysical research communications.

[602]  Han-Bor Fam,et al.  Evaluation of biofilm formation on nylon sutures removed from clinically noninfected eyes after cataract surgery , 2004, Journal of cataract and refractive surgery.

[603]  A Kamei,et al.  The evaluation of therapeutic efficacy of hachimi-jio-gan (traditional Chinese medicine) to rat galactosemic cataract. , 1987, Journal of ocular pharmacology.

[604]  Shaik Shavali,et al.  Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease. , 2005, Brain research. Molecular brain research.

[605]  Li Xy,et al.  The effect of intravenous puerarin on acute myocardial infarction , 1985 .

[606]  Robert Anton,et al.  Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: Structure-activity relationships , 1982, Agents and Actions.

[607]  B. L. O’dell,et al.  Low copper status of rats affects polyunsaturated fatty acid composition of brain phospholipids, unrelated to neuropathology. , 1992, The Journal of nutrition.

[608]  David E. Williams,et al.  Behavioral and neurological correlates of ALS-parkinsonism dementia complex in adult mice fed washed cycad flour , 2007, NeuroMolecular Medicine.

[609]  H Kehl,et al.  Structure-activity studies of hydroxamic acids as direct vasodilators. , 1978, Arzneimittel-Forschung.

[610]  Gang Hu,et al.  The regulation of rotenone-induced inflammatory factor production by ATP-sensitive potassium channel expressed in BV-2 cells , 2006, Neuroscience Letters.

[611]  F. Giblin,et al.  The effect of aqueous humor ascorbate on ultraviolet-B-induced DNA damage in lens epithelium. , 1998, Investigative ophthalmology & visual science.

[612]  Sarah Morrow,et al.  The safety and efficacy of IFN-β products for the treatment of multiple sclerosis , 2007 .

[613]  Adam S Cockrell,et al.  HIV-1 vectors: fulfillment of expectations, further advancements, and still a way to go. , 2003, Current HIV research.

[614]  Giuseppe Battaglia,et al.  Endogenous Activation of mGlu5 Metabotropic Glutamate Receptors Contributes to the Development of Nigro-Striatal Damage Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in Mice , 2004, The Journal of Neuroscience.

[615]  C. Broeckhoven,et al.  The role of tau (MAPT) in frontotemporal dementia and related tauopathies , 2004, Human mutation.

[616]  Jae-Chun Ryu,et al.  Identification of new urinary metabolites of byakangelicin, a component ofAngelicae dahuricae Radix, in Rats , 2003, Archives of pharmacal research.

[617]  Anders Björklund,et al.  Functional properties and synaptic integration of genetically labelled dopaminergic neurons in intrastriatal grafts , 2005, The European journal of neuroscience.

[618]  Colin K. Combs,et al.  α-Synuclein Expression Modulates Microglial Activation Phenotype , 2006, The Journal of Neuroscience.

[619]  K. Mohanakumar,et al.  Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion , 2005, Brain Research.

[620]  Yaakov Stern,et al.  Mediterranean diet and risk for Alzheimer's disease , 2006, Annals of neurology.

[621]  Michael Barras,et al.  Teaching people with Parkinson's disease about their medication. , 2005, Nursing older people.

[622]  Gary W Miller,et al.  L-DOPA does not cause neurotoxicity in VMAT2 heterozygote knockout mice. , 2002, Neurotoxicology.

[623]  J. Cadet,et al.  Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice , 1998, Neuroscience.

[624]  V. Monnier,et al.  Suppression of Pentosidine Formation in Galactosemic Rat Lens by an Inhibitor of Aldose Reductase , 1994, Diabetes.

[625]  José López-Barneo,et al.  Neuroprotection by Transgenic Expression of Glucose-6-Phosphate Dehydrogenase in Dopaminergic Nigrostriatal Neurons of Mice , 2006, The Journal of Neuroscience.

[626]  X-M Li,et al.  Protective effect of Lycium barbarum polysaccharides on streptozotocin-induced oxidative stress in rats. , 2007, International journal of biological macromolecules.

[627]  L. Novotný,et al.  Flavonoids as chemoprotective agents in civilization diseases. , 2001, Neoplasma.

[628]  P R Kastl,et al.  X-ray affinity and photoaffinity inhibitor of aldose reductase. , 1986, Journal of ocular pharmacology.

[629]  N B Chauhan.  Multiplicity of garlic health effects and Alzheimer's disease. , 2005, The journal of nutrition, health & aging.

[630]  K Watanabe,et al.  [Effects of oxybutynin on the cardiovascular system in dogs]. , 1984, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[631]  T. Dawson,et al.  Molecular Pathways of Neurodegeneration in Parkinson's Disease , 2003, Science.

[632]  K. Lim,et al.  Loss of locus coeruleus neurons and reduced startle in parkin null mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[633]  Neil R. Smalheiser.  The Arrowsmith Project: 2005 Status Report , 2005, Discovery Science.

[634]  Ehud Gazit,et al.  Inhibition of Amyloid Fibril Formation by Polyphenols: Structural Similarity and Aromatic Interactions as a Common Inhibition Mechanism , 2006, Chemical biology & drug design.

[635]  Yoshinobu Hirose,et al.  Modifying effects of dietary capsaicin and rotenone on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. , 2002, Carcinogenesis.

[636]  O. Andreassen,et al.  Mice Deficient in Group IV Cytosolic Phospholipase A2 Are Resistant to MPTP Neurotoxicity , 1998, Journal of neurochemistry.

[637]  Y. Niwa,et al.  Successful treatment of severe atopic dermatitis-complicated cataract and male infertility with a natural product antioxidant. , 1998, International journal of tissue reactions.

[638]  Ning Peng,et al.  Epigallocatechin gallate protects dopaminergic neurons against 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by inhibiting microglial cell activation. , 2006, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[639]  Miguel A Hernán,et al.  Diet and Parkinson's disease: A potential role of dairy products in men , 2002, Annals of neurology.

[640]  D. Kennedy,et al.  The psychopharmacology of European herbs with cognition-enhancing properties. , 2006, Current pharmaceutical design.

[641]  Songsong Cao,et al.  Torsin-Mediated Protection from Cellular Stress in the Dopaminergic Neurons of Caenorhabditis elegans , 2005, The Journal of Neuroscience.

[642]  F E Dewhirst,et al.  Structure-activity relationships for inhibition of prostaglandin cyclooxygenase by phenolic compounds. , 1980, Prostaglandins.

[643]  J. Loscalzo,et al.  N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. , 1985, The Journal of clinical investigation.

[644]  F Drago,et al.  Biochemical changes induced by pyrphenoxone in the lens of rabbits and rats. , 1995, Pharmacological research.

[645]  S Shizukuishi,et al.  Bioenergetics in clinical medicine. XVI. Reduction of hypertension in patients by therapy with coenzyme Q10. , 1981, Research communications in chemical pathology and pharmacology.

[646]  M. Ansari,et al.  Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats , 2005, Human & experimental toxicology.

[647]  H Nagura,et al.  Facilitated Transport of the Neurotoxin, β‐N‐Methylamino‐l‐Alanine, Across the Blood‐Brain Barrier , 1992, Journal of neurochemistry.

[648]  M. Chesselet,et al.  Alpha-synuclein and transgenic mouse models , 2004, Neurobiology of Disease.

[649]  P. J. Koudstaal,et al.  Dietary fatty acids and the risk of Parkinson disease , 2005, Neurology.

[650]  George E. Marzloff,et al.  Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally , 2006, Brain Research.

[651]  Jun-Tian Zhang,et al.  Protection of PC12 cells from hydrogen peroxide-induced cytotoxicity by salvianolic acid B, a new compound isolated from Radix Salviae miltiorrhizae. , 2007, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[652]  Chun Luo,et al.  Enhanced De Novo Neurogenesis and Dopaminergic Neurogenesis in the Substantia Nigra of 1‐Methyl‐4‐phyenyl‐1,2,3,6‐Tetrahydropyridine‐Induced Parkinson's Disease‐Like Mice , 2006, Stem cells.

[653]  Suzy V. Torti,et al.  Mouse brains deficient in H‐ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress , 2003, Journal of neuroscience research.

[654]  S. Srivastava,et al.  Green Tea (Camellia sinensis) Protects against Selenite-Induced Oxidative Stress in Experimental Cataractogenesis , 2002, Ophthalmic Research.

[655]  Hervé Tricoire,et al.  Control of oxidative stress resistance by IP3 kinase in Drosophila melanogaster. , 2002, Free radical biology & medicine.

[656]  Alexander M Klibanov,et al.  Surpassing nature: rational design of sterile-surface materials. , 2005, Trends in biotechnology.

[657]  K. Chandrasekaran,et al.  Molecular and cellular assessment of ginkgo biloba extract as a possible ophthalmic drug. , 2002, Experimental eye research.

[658]  Feng Chen,et al.  Posttranslational modifications of tau--role in human tauopathies and modeling in transgenic animals. , 2004, Current drug targets.

[659]  E O Ojofeitimi,et al.  Dietary and Lifestyle Patterns in the Aetiology of Cataracts in Nigerian Patients , 1999, Nutrition and health.

[660]  K. Tang,et al.  Dopamine-dependent synaptic plasticity in striatum during in vivo development. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[661]  J. Kuszak,et al.  Optical dysfunction of the crystalline lens in aquaporin-0-deficient mice , 2001 .

[662]  K. Ashe,et al.  Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy , 2007, The Journal of Neuroscience.

[663]  E. H. Blaine,et al.  Cardiovascular responses to an isosterically modified prostaglandin analog in conscious dogs. , 1984, Prostaglandins.

[664]  Michael Bader,et al.  Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain , 2007, Neurobiology of Learning and Memory.

[665]  Merle Ruberg,et al.  Toxicity of Annonaceae for dopaminergic neurons: Potential role in atypical parkinsonism in Guadeloupe , 2002, Movement disorders : official journal of the Movement Disorder Society.

[666]  Mark Benson,et al.  Use of herbal preparations in the treatment of oxidant-mediated inflammatory disorders. , 2007, Complementary therapies in medicine.

[667]  Andreas Hartmann,et al.  Role of TNF-α Receptors in Mice Intoxicated with the Parkinsonian Toxin MPTP , 2002, Experimental Neurology.

[668]  Sebastian Brandner,et al.  Neuroprotective Role of the Reaper-Related Serine Protease HtrA2/Omi Revealed by Targeted Deletion in Mice , 2004, Molecular and Cellular Biology.

[669]  Joachim Klose,et al.  Comparative proteomics in neurodegenerative and non-neurodegenerative diseases suggest nodal point proteins in regulatory networking. , 2006, Journal of proteome research.

[670]  D. Ryglewicz,et al.  Taste responses in patients with Parkinson’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[671]  V N Reddy,et al.  Effect of sodium iodate injection on the development of galactose cataract in the rat. , 1988, Ophthalmic research.

[672]  J. Timothy Greenamyre,et al.  [3H]Dihydrorotenone Binding to NADH: Ubiquinone Reductase (Complex I) of the Electron Transport Chain: An Autoradiographic Study , 1996, The Journal of Neuroscience.

[673]  Nuri Bakan,et al.  Effects of Oral Ginkgo biloba Supplementation on Cataract Formation and Oxidative Stress Occurring in Lenses of Rats Exposed to Total Cranium Radiotherapy , 2004, Japanese Journal of Ophthalmology.

[674]  Giuseppe Battaglia,et al.  Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[675]  A M Avunduk,et al.  Cadmium and iron accumulation in rat lens after cigarette smoke exposure and the effect of vitamin E (alpha-tocopherol) treatment. , 1999, Current eye research.

[676]  Roman Kaliszan,et al.  Binding of an Oxindole Alkaloid from Uncaria tomentosa to Amyloid Protein (Aβ1-40) , 2006, Zeitschrift fur Naturforschung. C, Journal of biosciences.

[677]  F Beermann,et al.  New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain. , 1998, Brain research. Molecular brain research.

[678]  Hideki Hayakawa,et al.  Dopaminergic neuronal loss in transgenic mice expressing the Parkinson's disease-associated UCH-L1 I93M mutant , 2007, Neurochemistry International.

[679]  Carlos Santos-Burgoa,et al.  Motor alterations associated with exposure to manganese in the environment in Mexico. , 2006, The Science of the total environment.

[680]  W. Lands,et al.  The effect of dietary supplementation of fish oil on experimental myocardial infarction. , 1980, Prostaglandins.

[681]  C. Chu,et al.  Sustained extracellular signal‐regulated kinase activation by 6‐hydroxydopamine: implications for Parkinson's disease , 2001, Journal of neurochemistry.

[682]  I. Birlouez-Aragon,et al.  The effects of 5% and 25% galactose diets on lens polyols, glutathione and protein glycation in male and female pigs. , 1989, Current eye research.

[683]  Ning Qiao,et al.  High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. , 2005, The American journal of clinical nutrition.

[684]  G. Zeevalk,et al.  Energy status, ubiquitin proteasomal function, and oxidative stress during chronic and acute complex I inhibition with rotenone in mesencephalic cultures. , 2005, Antioxidants & redox signaling.

[685]  P. Saftig,et al.  Control of Peripheral Nerve Myelination by the ß-Secretase BACE1 , 2006, Science.

[686]  Michael J. Grusby,et al.  Absence of MHC class ii molecules reduces CNS demyelination, microglial/macrophage infiltration, and twitching in murine globoid cell leukodystrophy , 1994, Cell.

[687]  Yong Je Chung,et al.  Molecular characterization of a thiJ-like gene in Chinese cabbage. , 2004, Journal of biochemistry and molecular biology.

[688]  Ling Wang,et al.  Morphological abnormalities in the brains of estrogen receptor β knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[689]  Erica L. Unger,et al.  Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human α-synuclein in mice , 2006, Neurobiology of Disease.

[690]  T. Morgan,et al.  Anti-inflammatory mechanisms of dietary restriction in slowing aging processes. , 2007, Interdisciplinary topics in gerontology.

[691]  F. Huppert,et al.  WITHDRAWN: Dehydroepiandrosterone (DHEA) supplementation for cognitive function. , 2007, The Cochrane database of systematic reviews.

[692]  H. Joshi,et al.  Antiamnesic effects of Desmodium gangeticum in mice. , 2006, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[693]  S. B. Heymsfield,et al.  Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study , 2005, Neurology.

[694]  Le Jian,et al.  beta-amyloid or its precursor protein is found in epithelial cells of the small intestine and is stimulated by high-fat feeding. , 2007, The Journal of nutritional biochemistry.

[695]  Tianhong Pan,et al.  Valproic acid‐mediated Hsp70 induction and anti‐apoptotic neuroprotection in SH‐SY5Y cells , 2005, FEBS letters.

[696]  R. Mayeux,et al.  Glycemic load and risk of Alzheimer's disease. , 2007, The journal of nutrition, health & aging.

[697]  P. Suryanarayana,et al.  Cumulative antioxidant defense against oxidative challenge in galactose-induced cataractogenesis in Wistar rats. , 2006, Indian journal of experimental biology.

[698]  K Teschke,et al.  Reproductive effects of paternal exposure to chlorophenate wood preservatives in the sawmill industry. , 1996, Scandinavian journal of work, environment & health.

[699]  H. V. N. Júnior,et al.  Amburoside A, a glucoside from Amburana cearensis, protects mesencephalic cells against 6-hydroxydopamine-induced neurotoxicity , 2005, Neuroscience Letters.

[700]  Matthew Keifer,et al.  Mortality among a Cohort of Banana Plantation Workers in Costa Rica , 2006, International journal of occupational and environmental health.

[701]  Oscar Gonzalez-Perez,et al.  Therapeutic perspectives on the combination of α-lipoic acid and vitamin E , 2006 .

[702]  R Winkler,et al.  [Effect of hexobendine and pentoxifylline on the viscosity of erythrocyte suspension]. , 1983, Wiener klinische Wochenschrift.

[703]  Olga Pletnikova,et al.  Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[704]  C. S. Yang,et al.  Effects of tea consumption on nutrition and health. , 2000, The Journal of nutrition.

[705]  Byeoung-Soo Park,et al.  Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. , 2005, Journal of agricultural and food chemistry.

[706]  Daniel Offen,et al.  Role of DJ-1 in Parkinson's disease , 2007, Journal of Molecular Neuroscience.

[707]  S Usuki,et al.  Successful treatment of a senile diabetic woman with cataract with goshajinkigan. , 1991, The American journal of Chinese medicine.

[708]  H. Singh,et al.  Effects of dietary supplements of selenium, vitamin E or combinations of the two on antibody responses of broilers , 2006, British poultry science.

[709]  Kousuke Negishi,et al.  Manganese-induced Parkinsonism in a patient undergoing maintenance hemodialysis. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[710]  J. Goudreau,et al.  Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration. , 2004, Neurotoxicology.

[711]  S. Srivastava,et al.  Susceptibility of aldehyde and aldose reductases of human tissues to aldose reductase inhibitors. , 1982, Current eye research.

[712]  Ted M. Dawson,et al.  Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease , 1999, Nature Medicine.

[713]  M A Province,et al.  Relation between dietary linolenic acid and coronary artery disease in the National Heart, Lung, and Blood Institute Family Heart Study. , 2001, The American journal of clinical nutrition.

[714]  T. Dawson,et al.  Lessons from Drosophila models of DJ-1 deficiency. , 2006, Science of aging knowledge environment : SAGE KE.

[715]  Ronald N. Kostoff,et al.  Literature-Related Discovery (LRD): Potential treatments for Parkinson's Disease , 2008 .

[716]  S Li,et al.  Growth inhibition, induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in cultured rabbit lens epithelial cells. , 2000, Yan ke xue bao = Eye science.

[717]  S. Joo,et al.  Reciprocal Activity of Ginsenosides in the Production of Proinflammatory Repertoire, and their Potential Roles in Neuroprotection in vitro , 2005, Planta medica.

[718]  M. Herman,et al.  High cholesterol content in neurons increases BACE, β-amyloid, and phosphorylated tau levels in rabbit hippocampus , 2006, Experimental Neurology.

[719]  Hideyuki Okano,et al.  Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[720]  M. Beal,et al.  Caspase-9 Activation Results in Downstream Caspase-8 Activation and Bid Cleavage in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson's Disease , 2001, The Journal of Neuroscience.

[721]  Helen Kim,et al.  Attenuation of neurodegeneration-relevant modifications of brain proteins by dietary soy. , 2000, BioFactors.

[722]  A Babický,et al.  Nutritional dependence of the incidence of selenite-induced cataracts in rats. , 1984, Physiologia Bohemoslovaca.

[723]  S. Müller-lissner,et al.  General geriatrics and gastroenterology: constipation and faecal incontinence. , 2002, Best practice & research. Clinical gastroenterology.

[724]  Jasna Jurasović,et al.  Reproductive toxicity of low-level lead exposure in men. , 2007, Environmental research.

[725]  E Sylvester Vizi,et al.  Increased sensitivity of striatal dopamine release to H2O2 upon chronic rotenone treatment. , 2005, Free radical biology & medicine.

[726]  Abdelouahed Khalil,et al.  Marrubium vulgare extract inhibits human-LDL oxidation and enhances HDL-mediated cholesterol efflux in THP-1 macrophage. , 2006, Life sciences.

[727]  John Steele,et al.  Geographic isolates of atypical Parkinsonism and tauopathy in the tropics: Possible synergy of neurotoxins , 2006, Movement disorders : official journal of the Movement Disorder Society.

[728]  Yoko Hirata,et al.  Rehmannia glutinosa induces glial cell line-derived neurotrophic factor gene expression in astroglial cells via cPKC and ERK1/2 pathways independently. , 2006, Pharmacological research.

[729]  David K. C. Cooper,et al.  Xenotransplantation--state of the art--update 1999. , 1999 .

[730]  V. Peters,et al.  Intra-uterine growth retardation after prenatal administration of Ginkgo biloba to rats. , 2007, Reproductive toxicology.

[731]  Y. Nagaki,et al.  Effects of traditional Sino-Japanese herbal medicines on aqueous flare elevation after small-incision cataract surgery. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[732]  George Roth,et al.  Calorie restriction attenuates Alzheimer's disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus). , 2006, Journal of Alzheimer's disease : JAD.

[733]  D. Nicholls,et al.  Spare Respiratory Capacity Rather Than Oxidative Stress Regulates Glutamate Excitotoxicity after Partial Respiratory Inhibition of Mitochondrial Complex I with Rotenone , 2007, The Journal of Neuroscience.

[734]  J. Náñez,et al.  Smoking and lens optical density , 1999, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.

[735]  Shuichi Ueda,et al.  Degeneration of dopaminergic neurons in the substantia nigra of zitter mutant rat and protection by chronic intake of Vitamin E , 2005, Neuroscience Letters.

[736]  P. Sinet,et al.  Cellular clones and transgenic mice overexpressing copper-zinc superoxide dismutase: models for the study of free radical metabolism and aging. , 1992, EXS.

[737]  S. Mandel,et al.  Green tea polyphenol (−)-epigallocatechin-3-gallate protects rat PC12 cells from apoptosis induced by serum withdrawal , 2009, Neurotoxicity Research.

[738]  S Kitagawa,et al.  Inhibition of ADP-induced aggregation of bovine platelets by saturated fatty acids and its relation with the change of membrane surface charge. , 1984, Biochimica et biophysica acta.

[739]  M. F. Porter,et al.  An algorithm for suffix stripping , 1997 .

[740]  J. Sivak,et al.  Methionine intake in rainbow trout (Oncorhynchus mykiss), relationship to cataract formation and the metabolism of methionine. , 1992, The Journal of nutrition.

[741]  Y. Cha,et al.  Effect of genistein with carnitine administration on lipid parameters and obesity in C57Bl/6J mice fed a high-fat diet. , 2006, Journal of medicinal food.

[742]  Karen Ritchie,et al.  Is Antioxidant Therapy a Viable Alternative for Mild Cognitive Impairment? Examination of the Evidence , 2007, Dementia and Geriatric Cognitive Disorders.

[743]  Nancy A. Jenkins,et al.  Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[744]  Alan Apter,et al.  Environmental Enrichment Augments the Efficacy of Idiotype Vaccination for B-cell Lymphoma , 2007, Journal of immunotherapy.

[745]  Santiago Canals,et al.  Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. , 2003, Human molecular genetics.

[746]  G. Nappi,et al.  Quantitative study of mitochondrial complex I in platelets of parkinsonian patients , 1998, Movement disorders : official journal of the Movement Disorder Society.

[747]  C D Marsden,et al.  Nigral dopaminergic cell loss in vitamin E deficient rats. , 1994, Neuroreport.

[748]  B. Liss,et al.  Alternative sulfonylurea receptor expression defines metabolic sensitivity of K‐ATP channels in dopaminergic midbrain neurons , 1999, The EMBO journal.

[749]  Zhen Yan,et al.  Activation of Group III Metabotropic Glutamate Receptors Attenuates Rotenone Toxicity on Dopaminergic Neurons through a Microtubule-Dependent Mechanism , 2006, The Journal of Neuroscience.

[750]  M Wynn,et al.  Can Improved Diet Contribute to the Prevention of Cataract? , 1996, Nutrition and health.

[751]  P. Houghton,et al.  Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism , 2003, Pharmacology Biochemistry and Behavior.

[752]  Sonia Ramos,et al.  Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. , 2007, The Journal of nutritional biochemistry.

[753]  J. Turnbull,et al.  Structural Determinants of Heparan Sulphate Modulation of GDNF Signalling , 2003, Growth factors.

[754]  P. Shanthi,et al.  Restorative and synergistic efficacy of Kalpaamruthaa, a modified Siddha preparation, on an altered antioxidant status in adjuvant induced arthritic rat model. , 2007, Chemico-biological interactions.

[755]  Muliar La,et al.  Effect of complete fasting on the coagulative and antioxidative properties of blood , 1984 .

[756]  Lorraine Iacovitti,et al.  Purified mouse dopamine neurons thrive and function after transplantation into brain but require novel glial factors for survival in culture , 2005, Molecular and Cellular Neuroscience.

[757]  Francis C. Lau,et al.  Nutritional Intervention in Brain Aging , 2007 .

[758]  B Andallu,et al.  Control of hyperglycemia and retardation of cataract by mulberry (Morus indica L.) leaves in streptozotocin diabetic rats. , 2002, Indian journal of experimental biology.

[759]  Hua-qing Liu,et al.  A delivery strategy for rotenone microspheres in an animal model of Parkinson's disease. , 2006, Biomaterials.

[760]  M. Collins,et al.  Alkaloids, alcohol and Parkinson's disease. , 2002, Parkinsonism & related disorders.

[761]  K. Chergui,et al.  Adenosine-dopamine interactions revealed in knockout mice , 2007, Journal of Molecular Neuroscience.

[762]  T Seal,et al.  Screening of antioxidant activity of three Indian medicinal plants, traditionally used for the management of neurodegenerative diseases. , 2003, Journal of ethnopharmacology.

[763]  Howard J Federoff,et al.  Convergent Pathobiologic Model of Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.

[764]  H. Staehelin,et al.  Micronutrients and Alzheimer's disease , 2005, Proceedings of the Nutrition Society.

[765]  Guy A Rouleau,et al.  Genetics of familial and sporadic amyotrophic lateral sclerosis. , 2006, Biochimica et biophysica acta.

[766]  David S. Park,et al.  Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[767]  K. Fong,et al.  Retrobulbar haemorrhage associated with chronic Gingko biloba ingestion , 2003, Postgraduate medical journal.

[768]  Rüdiger Klein,et al.  The neuregulin receptor, ErbB4, is not required for normal development and adult maintenance of the substantia nigra pars compacta , 2004, Journal of neurochemistry.

[769]  Khaled Radad,et al.  Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration , 2006, Neurochemistry International.

[770]  Jung-Hee Jang,et al.  Attenuation of Aβ‐Induced Apoptosis of Plant Extract (Saengshik) Mediated by the Inhibition of Mitochondrial Dysfunction and Antioxidative Effect , 2007, Annals of the New York Academy of Sciences.

[771]  C. Gerfen,et al.  D1 Dopamine Receptor Supersensitivity in the Dopamine-Depleted Striatum Animal Model of Parkinson’s Disease , 2003, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[772]  I. A. Ross,et al.  Mangifera indica L. , 2003 .

[773]  Piali Mukherjee,et al.  Gene expression profiling of the tau mutant (P301L) transgenic mouse brain , 2001, Neuroscience Letters.

[774]  Ruedi Aebersold,et al.  Analysis of α-Synuclein-associated Proteins by Quantitative Proteomics*[boxs] , 2004, Journal of Biological Chemistry.

[775]  N. Bazan,et al.  Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection , 2007, Current opinion in clinical nutrition and metabolic care.

[776]  Y. Christen,et al.  Amyloid-β-Induced Pathological Behaviors Are Suppressed by Ginkgo biloba Extract EGb 761 and Ginkgolides in Transgenic Caenorhabditis elegans , 2006, The Journal of Neuroscience.

[777]  Harry Rothman,et al.  An experiment in science mapping for research planning , 1986 .

[778]  M. C. Gracia,et al.  A possible cause and corresponding treatment for inflammatory, auto-immune or auto-aggressive diseases. , 2007, Medical hypotheses.

[779]  Akihiko Takashima,et al.  Uncaria rhynchophylla, a Chinese medicinal herb, has potent antiaggregation effects on Alzheimer's β‐amyloid proteins , 2006, Journal of neuroscience research.

[780]  Sun Shenggang,et al.  Experimental study on the protective effect of puerarin to Parkinson disease , 2003, Journal of Huazhong University of Science and Technology [Medical Sciences].

[781]  Soon-Ho Kwon,et al.  β-Secretase (BACE1) inhibitors from Sanguisorbae Radix , 2005 .

[782]  Tianhong Pan,et al.  Potential Therapeutic Properties of Green Tea Polyphenols in Parkinson’s Disease , 2003, Drugs & aging.

[783]  Jesse A. Stump,et al.  The structure and infrastructure of the global nanotechnology literature , 2006 .

[784]  Theeshan Bahorun,et al.  Neuroprotection by bioactive components in medicinal and food plant extracts. , 2003, Mutation research.

[785]  J. M. Fuentes,et al.  Heat shock proteins protect both MPP+ and paraquat neurotoxicity , 2005, Brain Research Bulletin.

[786]  G. Halliday,et al.  An inflammatory review of Parkinson’s disease , 2002, Progress in Neurobiology.

[787]  H. Younes,et al.  Effects of two fermentable carbohydrates (inulin and resistant starch) and their combination on calcium and magnesium balance in rats , 2001, British Journal of Nutrition.

[788]  M. Polissiou,et al.  Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. , 2006, Journal of agricultural and food chemistry.

[789]  Z. Rymaszewski,et al.  Coffee extracts inhibit platelet aggregation in vivo and in vitro. , 1987, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[790]  Y. Lou,et al.  Neuroprotective effects of icaritin against beta amyloid-induced neurotoxicity in primary cultured rat neuronal cells via estrogen-dependent pathway , 2007, Neuroscience.

[791]  P. K. Mohan,et al.  Association of l-DOPA with recovery following Ayurveda medication in Parkinson’s disease , 2000, Journal of the Neurological Sciences.

[792]  L. Martin,et al.  Transgenic Mice with Human Mutant Genes Causing Parkinson's Disease and Amyotrophic Lateral Sclerosis Provide Common Insight into Mechanisms of Motor Neuron Selective Vulnerability to Degeneration , 2007, Reviews in the neurosciences.

[793]  O. Aruoma,et al.  Methodological considerations for characterizing potential antioxidant actions of bioactive components in plant foods. , 2003, Mutation research.

[794]  T. Tamaki,et al.  Effects of a synthetic human atrial natriuretic polypeptide on regional blood flow in rats. , 1985, European journal of pharmacology.

[795]  D. Butterfield,et al.  Redox regulation of cellular stress response in neurodegenerative disorders. , 2006, The Italian journal of biochemistry.

[796]  Vladimir N. Uversky,et al.  Neurotoxicant-induced animal models of Parkinson’s disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration , 2004, Cell and Tissue Research.

[797]  P. Suryanarayana,et al.  Inhibition of aldose reductase by tannoid principles of Emblica officinalis: implications for the prevention of sugar cataract. , 2004, Molecular vision.

[798]  Peter Bruza,et al.  Text Based Knowledge Discovery with Information Flow Analysis , 2006, APWeb.

[799]  Patrick Aebischer,et al.  Lentivirus-mediated expression of glutathione peroxidase: Neuroprotection in murine models of Parkinson's disease , 2006, Neurobiology of Disease.

[800]  Michael Aschner,et al.  Manganese , 2006, Toxicological reviews.

[801]  Zhong-Xin Zhao,et al.  The impact of synapsins on synaptic plasticity and cognitive behaviors. , 2006, Neuroscience bulletin.

[802]  Meinhard Kieser,et al.  A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type. , 2005, Current Alzheimer research.

[803]  D. Duval,et al.  Pharmacological findings on cetiedil. , 1978, Arzneimittel-Forschung.

[804]  Frank M LaFerla,et al.  Dietary Docosahexaenoic Acid and Docosapentaenoic Acid Ameliorate Amyloid-β and Tau Pathology via a Mechanism Involving Presenilin 1 Levels , 2007, The Journal of Neuroscience.

[805]  Hans Wohlmuth,et al.  Antioxidant capacity of 55 medicinal herbs traditionally used to treat the urinary system: a comparison using a sequential three-solvent extraction process. , 2007, Journal of alternative and complementary medicine.

[806]  K. Unsicker,et al.  FGF‐2 deficiency does not alter vulnerability of the dopaminergic nigrostriatal system towards MPTP intoxication in mice , 2006, The European journal of neuroscience.

[807]  Vivek Misra,et al.  Evolving therapies for multiple sclerosis. , 2007, International review of neurobiology.

[808]  Bin Liu,et al.  NADPH Oxidase Mediates Lipopolysaccharide-induced Neurotoxicity and Proinflammatory Gene Expression in Activated Microglia* , 2004, Journal of Biological Chemistry.

[809]  Vilho Myllylä,et al.  Safety of Selegiline (Deprenyl) in the Treatment of Parkinson’s Disease , 1998, Drug safety.

[810]  G. Fraser,et al.  Variables associated with cognitive function in elderly California Seventh-day Adventists. , 1996, American journal of epidemiology.

[811]  J. Bourre,et al.  Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. , 2006, The journal of nutrition, health & aging.

[812]  Alison G Abraham,et al.  The new epidemiology of cataract. , 2006, Ophthalmology clinics of North America.

[813]  Tamas L. Horvath,et al.  Uncoupling Protein-2 Is Critical for Nigral Dopamine Cell Survival in a Mouse Model of Parkinson's Disease , 2005, The Journal of Neuroscience.

[814]  P K Siegl,et al.  Cardiovascular responses to an isosterically modified prostaglandin analog in the anesthetized dog. , 1985, European journal of pharmacology.

[815]  R. Blakely,et al.  Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human α‐synuclein , 2003, Journal of neurochemistry.

[816]  H. Sheardown,et al.  Incorporation of cell-adhesion peptides into collagen scaffolds promotes corneal epithelial stratification , 2007, Journal of biomaterials science. Polymer edition.

[817]  B. Jiang,et al.  Protocatechuic acid suppresses MPP+ -induced mitochondrial dysfunction and apoptotic cell death in PC12 cells. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[818]  C Steeds,et al.  Fasting regimens for regional ophthalmic anaesthesia , 2001, Anaesthesia.

[819]  Stephen A Morse,et al.  The Seminal Literature of Anthrax Research , 2007, Critical reviews in microbiology.

[820]  A. Ruder,et al.  Update: cohort mortality study of workers highly exposed to polychlorinated biphenyls (PCBs) during the manufacture of electrical capacitors, 1940-1998 , 2006, Environmental health : a global access science source.

[821]  Moussa B. H. Youdim,et al.  Neuroprotective Strategies in Parkinson’s Disease , 2003, CNS drugs.

[822]  P. Bria,et al.  Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo‐controlled double‐blind study , 2006, European journal of neurology.

[823]  Bernhard Hemmer,et al.  Treatment and treatment trials in multiple sclerosis , 2007, Current opinion in neurology.

[824]  H. Robertson,et al.  Neuroprotective properties of cultured neural progenitor cells are associated with the production of sonic hedgehog , 2005, Neuroscience.

[825]  Abdul Malik,et al.  Withanolides, a new class of natural cholinesterase inhibitors with calcium antagonistic properties. , 2005, Biochemical and biophysical research communications.

[826]  E F Domino,et al.  Effects of talipexole on contraversive rotation and functional impairment in MPTP-induced chronic hemiparkinsonian monkeys. , 1998, Japanese journal of pharmacology.

[827]  A. Martin-Villalba,et al.  JunB and Bcl-2 overexpression results in protection against cell death of nigral neurons following axotomy. , 2002, Brain research. Molecular brain research.

[828]  M. Garg,et al.  Vitamin E supplementation in the mitigation of carbon tetrachloride induced oxidative stress in rats. , 2003, The Journal of nutritional biochemistry.

[829]  S. Shankar,et al.  Billionfold difference in the toxic potencies of two excitatory plant amino acids, L-BOAA and L-BMAA: biochemical and morphological studies using mouse brain slices , 1993, Neuroscience Research.

[830]  H. Anisman,et al.  Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice , 2003, Neurobiology of Disease.

[831]  Richard Weindruch,et al.  A TrkA-to-p75NTR molecular switch activates amyloid beta-peptide generation during aging. , 2005, The Biochemical journal.

[832]  K. Schey,et al.  Photooxidation of Lens α-Crystallin by Hypericin (Active Ingredient in St. John's Wort)¶ , 2000 .

[833]  C. Tohda,et al.  Characterization of anti-neurodegenerative effects of Polygala tenuifolia in Abeta(25-35)-treated cortical neurons. , 2006, Biological & pharmaceutical bulletin.

[834]  Yuan-Shiun Chang,et al.  Inhibition of reactive nitrogen species in vitro and ex vivo by trypsin inhibitor from sweet potato 'Tainong 57' storage roots. , 2007, Journal of agricultural and food chemistry.

[835]  Hidekazu Tomimoto,et al.  Gluten sensitivity in Japanese patients with adult-onset cerebellar ataxia. , 2006, Internal medicine.

[836]  O A Candia,et al.  Altered lens short-circuit current in adult cataract-prone Dahl hypertensive rats. , 1996, Hypertension.

[837]  Z. Xia,et al.  Basic Fibroblast Growth Factor Protects against Rotenone-Induced Dopaminergic Cell Death through Activation of Extracellular Signal-Regulated Kinases 1/2 and Phosphatidylinositol-3 Kinase Pathways , 2006, The Journal of Neuroscience.

[838]  Ronald N. Kostoff,et al.  Literature-related discovery (LRD): Methodology , 2008 .

[839]  F. Vaglini,et al.  Involvement of cytochrome P450 2E1 in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced mouse model of Parkinson's disease , 2004, Journal of neurochemistry.

[840]  Jesús Avila,et al.  Sodium tungstate decreases the phosphorylation of tau through GSK3 inactivation , 2006, Journal of neuroscience research.

[841]  Tilman Grune,et al.  Ferritin oxidation and proteasomal degradation: Protection by antioxidants , 2006, Free radical research.

[842]  P Mata,et al.  International conference on the healthy effect of virgin olive oil , 2005, European journal of clinical investigation.

[843]  I Litvan,et al.  Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[844]  H. Phillips,et al.  Impaired water maze learning performance without altered dopaminergic function in mice heterozygous for the GDNF mutation , 2001, The European journal of neuroscience.

[845]  Marc Weeber,et al.  Literature-based Discovery , 2008 .

[846]  A. K. Agrawal,et al.  Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease , 2006, Neurobiology of Disease.

[847]  D. Dluzen,et al.  Striatal dopamine output is compromised within +/− BDNF mice , 2002, Synapse.

[848]  W. Watson,et al.  Endogenous rhythms of locomotion in the American horseshoe crab, Limulus polyphemus , 2007 .

[849]  Sujata Joshi,et al.  Ocimum sanctum Modulates Selenite-Induced Cataractogenic Changes and Prevents Rat Lens Opacification , 2005, Current eye research.

[850]  C. Hay,et al.  EFFECT OF FISH OIL ON PLATELET KINETICS IN PATIENTS WITH ISCHAEMIC HEART DISEASE , 1982, The Lancet.

[851]  Sarah Rauscher,et al.  Proline and glycine control protein self-organization into elastomeric or amyloid fibrils. , 2006, Structure.

[852]  Katsuhiro Okuda,et al.  Neuroprotective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on cultured rat mesencephalic neurons in the presence or absence of various neurotoxins , 2005, Brain Research.

[853]  John Q Trojanowski,et al.  Transgenic animal models of tauopathies. , 2005, Biochimica et biophysica acta.

[854]  J. Bourre,et al.  Dietary omega-3 fatty acids for women. , 2007, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[855]  P. Sokoloff,et al.  Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice. , 2005, Life sciences.

[856]  Harvey F Lodish,et al.  Docosahexaenoic acid, fatty acid-interacting proteins, and neuronal function: breastmilk and fish are good for you. , 2005, Annual review of cell and developmental biology.

[857]  P. Millac,et al.  Dietary modification of Parkinson's disease. , 1991, European journal of clinical nutrition.

[858]  Anders Björklund,et al.  Modeling CNS neurodegeneration by overexpression of disease-causing proteins using viral vectors , 2003, Trends in Neurosciences.

[859]  Xiaoping Pu,et al.  Tubuloside B from Cistanche salsa rescues the PC12 neuronal cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis and oxidative stress. , 2002, Planta medica.

[860]  C S Tsao,et al.  Effect of dietary ascorbic acid on heat-induced eye lens protein damage in guinea pigs. , 1990, Ophthalmic research.

[861]  M. Smeyne,et al.  Method for culturing postnatal substantia nigra as an in vitro model of experimental Parkinson's disease. , 2002, Brain research. Brain research protocols.

[862]  T. Guilarte,et al.  In vivo modulation of the Parkinsonian phenotype by Nrf2. , 2006, Neurotoxicology.

[863]  O Higashi,et al.  Effects of riboflavin-2',3',4',5'-tetrabutyrate and flavin adenine dinucleotide on the platelet aggregation induced by hydrogen peroxide. , 1978, The Tohoku journal of experimental medicine.

[864]  W. Wouters-Wesseling,et al.  Early nutritional supplementation immediately after diagnosis of infectious disease improves body weight in psychogeriatric nursing home residents , 2006, Aging clinical and experimental research.

[865]  Ole A. Andreassen,et al.  Mice with a Partial Deficiency of Manganese Superoxide Dismutase Show Increased Vulnerability to the Mitochondrial Toxins Malonate, 3-Nitropropionic Acid, and MPTP , 2001, Experimental Neurology.

[866]  W. Schmidt,et al.  l-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats , 2004, Behavioural Brain Research.

[867]  C. Howden,et al.  Management of acid-related disorders in patients with dysphagia. , 2004, The American journal of medicine.

[868]  Howard J. Federoff,et al.  Wild-type and mutant α-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD , 2007, Experimental Neurology.

[869]  M. Beal,et al.  Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice , 1998, Brain Research.

[870]  Sarah J Tabrizi,et al.  Models of Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[871]  R. Fincham,et al.  Parkinsonism Treatment: Part III—Update , 1992, The Annals of pharmacotherapy.

[872]  H. Nishizaki,et al.  Influences of The Great Hanshin-Awaji Earthquake on glycemic control in diabetic patients. , 1997, Diabetes research and clinical practice.

[873]  P. Calabresi,et al.  Distinct Roles of D1 and D5 Dopamine Receptors in Motor Activity and Striatal Synaptic Plasticity , 2003, The Journal of Neuroscience.

[874]  M Partinen,et al.  Selegiline in the treatment of narcolepsy , 1994, Neurology.

[875]  Michael E Ernst,et al.  Antioxidants, Supplements, and Parkinson's Disease , 2006, The Annals of pharmacotherapy.

[876]  K. Vafeiadou,et al.  Neuroinflammation and its modulation by flavonoids. , 2007, Endocrine, metabolic & immune disorders drug targets.

[877]  N. Zawia,et al.  Environmental and dietary risk factors in Alzheimer’s disease , 2007, Expert review of neurotherapeutics.

[878]  B. Fredholm,et al.  Adenosine receptors as targets for drug development. , 2003, Drug news & perspectives.

[879]  L. Stanford,et al.  Maturation but not survival of dopaminergic nigrostriatal neurons is affected in developing and aging BDNF-deficient mice , 2005, Brain Research.

[880]  Alan Crozier,et al.  Evaluation of phenolic compounds in commercial fruit juices and fruit drinks. , 2007, Journal of agricultural and food chemistry.

[881]  R O Guerrero,et al.  Inhibition of xanthine oxidase by Puerto Rican plant extracts. , 1998, Puerto Rico health sciences journal.

[882]  Manisha Patel,et al.  Iron‐sulfur enzyme mediated mitochondrial superoxide toxicity in experimental Parkinson's disease , 2004, Journal of neurochemistry.

[883]  Claudia Kappen,et al.  Mutation of a putative nuclear receptor binding site abolishes activity of the nestin midbrain enhancer. , 2003, Biochimica et biophysica acta.

[884]  Cristina Cosi,et al.  Progressive sensorimotor impairment is not associated with reduced dopamine and high energy phosphate donors in a model of ataxia‐telangiectasia , 2004, Journal of neurochemistry.

[885]  B. Morris,et al.  A forkhead in the road to longevity: the molecular basis of lifespan becomes clearer , 2005, Journal of hypertension.

[886]  Y Ohta,et al.  Preventive effect of vitamin E-containing liposome instillation on cataract progression in 12-month-old rats fed a 25% galactose diet. , 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[887]  D. Schoon,et al.  Lenticular lesions in harbour seals (Phoca vitulina). , 1992, Journal of comparative pathology.

[888]  Xia Li,et al.  Neuroprotective effects of Polygonum multiflorum on nigrostriatal dopaminergic degeneration induced by paraquat and maneb in mice , 2005, Pharmacology Biochemistry and Behavior.

[889]  D. Guastella,et al.  NMDA But Not Non-NMDA Excitotoxicity is Mediated by Poly(ADP-Ribose) Polymerase , 2000, The Journal of Neuroscience.

[890]  Jürgen Götz,et al.  Tau and transgenic animal models , 2001, Brain Research Reviews.

[891]  Michael Aschner,et al.  Nutritional aspects of manganese homeostasis. , 2005, Molecular aspects of medicine.

[892]  Gerard D Schellenberg,et al.  Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans. , 2006, Human molecular genetics.

[893]  S. Milstien,et al.  Preferential Resistance of Dopaminergic Neurons to the Toxicity of Glutathione Depletion Is Independent of Cellular Glutathione Peroxidase and Is Mediated by Tetrahydrobiopterin , 2000, Journal of neurochemistry.

[894]  J. Roth,et al.  Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese. , 2003, Biochemical pharmacology.

[895]  Rhonda R. Voskuhl,et al.  Gender issues and multiple sclerosis , 2002, Current neurology and neuroscience reports.

[896]  P. Jacques,et al.  The potential preventive effects of vitamins for cataract and age-related macular degeneration. , 1999, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[897]  S B Xu,et al.  Hypotensive effect of dehydroevodiamine from Evodiae Fructus. , 1982, The American journal of Chinese medicine.

[898]  K. Hensley,et al.  Interaction of α‐Phenyl‐N‐tert‐Butyl Nitrone and Alternative Electron Acceptors with Complex I Indicates a Substrate Reduction Site Upstream from the Rotenone Binding Site , 1998, Journal of neurochemistry.

[899]  Charles Duyckaerts,et al.  Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. , 2002, Brain : a journal of neurology.

[900]  Derek Stewart,et al.  The inhibitory effects of berry polyphenols on digestive enzymes , 2005, BioFactors.

[901]  Andrea Mauri,et al.  Special low‐protein foods ameliorate postprandial off in patients with advanced Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[902]  M Bovingdon,et al.  Diurnal differences in response to oral levodopa. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[903]  D L Price,et al.  Genetic neurodegenerative diseases: the human illness and transgenic models. , 1998, Science.

[904]  F J Haddy,et al.  Peripheral vascular resistance. , 1968, Annual review of medicine.

[905]  S. Saveliev,et al.  Chimeric brain: theoretical and clinical aspects. , 1997, The International journal of developmental biology.

[906]  Kenji Nakashima,et al.  D‐β‐hydroxybutyrate protects dopaminergic SH‐SY5Y cells in a rotenone model of Parkinson's disease , 2006 .

[907]  Y. Chan,et al.  Neuroprotective effects of ginsenoside-Rg1 in primary nigral neurons against rotenone toxicity , 2007, Neuropharmacology.

[908]  J. Takahashi,et al.  Stem cell therapy for Parkinson’s disease , 2007, Ernst Schering Research Foundation workshop.

[909]  Ali H Rajput,et al.  Alpha-synuclein and tyrosine hydroxylase expression in acute rotenone toxicity. , 2007, International journal of molecular medicine.

[910]  Leopold Flohé,et al.  Selenium, selenoproteins and vision. , 2005, Developments in ophthalmology.

[911]  A. Lang,et al.  Practical application of a low‐protein diet for Parkinson's disease , 1988, Neurology.

[912]  S Shimohama,et al.  The parkinsonian models: invertebrates to mammals. , 2000, Japanese journal of pharmacology.

[913]  Jin Won Hyun,et al.  Rhapontigenin from Rheum undulatum Protects Against Oxidative-Stress-Induced Cell Damage Through Antioxidant Activity , 2007, Journal of toxicology and environmental health. Part A.

[914]  M. Beal,et al.  Coenzyme Q10 as a possible treatment for neurodegenerative diseases. , 2002, Free radical research.

[915]  T. Hamazaki,et al.  Studies on the mechanism of antiaggregatory effect of Moutan Cortex. , 1983, Thrombosis research.

[916]  Ronald N. Kostoff,et al.  Factor matrix text filtering and clustering , 2005, J. Assoc. Inf. Sci. Technol..

[917]  Randy D Blakely,et al.  Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice. , 2003, Molecular pharmacology.

[918]  V. Lee,et al.  Alpha-synuclein: normal function and role in neurodegenerative diseases. , 2004, Current topics in developmental biology.

[919]  R. Frank Kooy,et al.  Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS) , 2005, Behavioural Brain Research.

[920]  K. Mohanakumar,et al.  Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine , 2006, Pharmacology Biochemistry and Behavior.

[921]  Jörg B Schulz,et al.  Silencing of the Pink1 Gene Expression by Conditional RNAi Does Not Induce Dopaminergic Neuron Death in Mice , 2007, International journal of biological sciences.

[922]  A Bordia,et al.  Effect of garlic on human platelet aggregation in vitro. , 1978, Atherosclerosis.

[923]  Tiffany Mathews,et al.  Age-dependent Motor Deficits and Dopaminergic Dysfunction in DJ-1 Null Mice* , 2005, Journal of Biological Chemistry.

[924]  Fabrizio Gardoni,et al.  New targets for pharmacological intervention in the glutamatergic synapse. , 2006, European journal of pharmacology.

[925]  F. Crews,et al.  Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration , 2007, Glia.

[926]  K. Mohanakumar,et al.  l-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats , 2006, Neurochemistry International.

[927]  Susumu Tonegawa,et al.  Dopamine D2 Long Receptor-Deficient Mice Display Alterations in Striatum-Dependent Functions , 2000, The Journal of Neuroscience.

[928]  J. Pincus,et al.  Protein redistribution diet restores motor function in patients with dopa‐resistant “off” periods , 1988, Neurology.

[929]  A Ujiie,et al.  [Studies on the inhibitory effect of etafenone hydrochloride on platelet aggregation]. , 1983, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[930]  L. Grégoire,et al.  Docosahexaenoic acid reduces levodopa‐induced dyskinesias in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine monkeys , 2006, Annals of neurology.

[931]  Jin Tae Hong,et al.  Inhibitory effect of green tea extract on beta-amyloid-induced PC12 cell death by inhibition of the activation of NF-kappaB and ERK/p38 MAP kinase pathway through antioxidant mechanisms. , 2005, Brain research. Molecular brain research.

[932]  Tony Wyss-Coray,et al.  Transforming growth factor-β signaling pathway as a therapeutic target in neurodegeneration , 2007, Journal of Molecular Neuroscience.

[933]  F Bracco,et al.  Protein redistribution diet and antiparkinsonian response to levodopa. , 1991, European neurology.

[934]  R. Haranaka,et al.  Pharmacological action of hachimijiogan (Ba-wei-wan) on the metabolism of aged subjects. , 1986, The American journal of Chinese medicine.

[935]  Philippe Amouyel,et al.  Evidence of a role for lactadherin in Alzheimer's disease. , 2007, The American journal of pathology.

[936]  Jun Hu,et al.  Inhibition of α‐synuclein fibrillization by dopamine analogs via reaction with the amino groups of α‐synuclein , 2005 .

[937]  Theo Hagg,et al.  D3 dopamine receptors do not regulate neurogenesis in the subventricular zone of adult mice , 2005, Neurobiology of Disease.

[938]  Susan T. Dumais,et al.  Using Latent Semantic Indexing for Literature Based Discovery , 1998, J. Am. Soc. Inf. Sci..

[939]  Wen-Lang Lin,et al.  Deletion of the Ubiquitin Ligase CHIP Leads to the Accumulation, But Not the Aggregation, of Both Endogenous Phospho- and Caspase-3-Cleaved Tau Species , 2006, The Journal of Neuroscience.

[940]  F. Mcdowell,et al.  Decrease of the 3,4-dihydroxyphenylalanine (DOPA) decarboxylase activities in human erythrocytes and mouse tissues after administration of DOPA. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[941]  C. Chinopoulos,et al.  Mitochondria deficient in complex I activity are depolarized by hydrogen peroxide in nerve terminals: relevance to Parkinson's disease , 2001, Journal of neurochemistry.

[942]  Carlo Cattaneo,et al.  Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity. , 2004, Pharmacological research.

[943]  Paul Alan Cox,et al.  Biomagnification of cycad neurotoxins in flying foxes , 2003, Neurology.

[944]  O. Napryeyenko,et al.  Ginkgo biloba Special Extract in Dementia with Neuropsychiatric Features , 2007, Arzneimittelforschung.

[945]  A. Vercesi,et al.  Ca2+‐induced oxidative stress in brain mitochondria treated with the respiratory chain inhibitor rotenone , 2003, FEBS letters.

[946]  C. Johansen.  Exposure to Electromagnetic Fields and Risk of Central Nervous System Disease in Utility Workers , 2000, Epidemiology.

[947]  Shigeyoshi Itohara,et al.  Distinct Mechanistic Roles of Calpain and Caspase Activation in Neurodegeneration as Revealed in Mice Overexpressing Their Specific Inhibitors* , 2005, Journal of Biological Chemistry.

[948]  William T Dauer,et al.  α-Synuclein Is Required for the Fibrillar Nature of Ubiquitinated Inclusions Induced by Proteasomal Inhibition in Primary Neurons* , 2004, Journal of Biological Chemistry.

[949]  Marc G Caron,et al.  DDD mice, a novel acute mouse model of Parkinson’s disease , 2006, Neurology.

[950]  M. Nydahl,et al.  Meals and snacks among elderly self-managing and disabled women , 2003, Appetite.

[951]  Marten P. Smidt,et al.  Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice , 2006, Proceedings of the National Academy of Sciences.

[952]  D. Rubinsztein,et al.  Microtubule disruption inhibits autophagosome-lysosome fusion: implications for studying the roles of aggresomes in polyglutamine diseases. , 2004, The international journal of biochemistry & cell biology.

[953]  P. Calabresi,et al.  Abnormal Synaptic Plasticity in the Striatum of Mice Lacking Dopamine D2 Receptors , 1997, The Journal of Neuroscience.

[954]  S. Diekmann,et al.  Identification of molecular compounds critical to Alzheimer's‐like plaque formation , 2007, Journal of neuroscience research.

[955]  J. Zigler,et al.  Effect of smoke condensate on the physiological integrity and morphology of organ cultured rat lenses. , 1995, Current eye research.

[956]  Joseph Martin Alisky,et al.  Neurotransmitter depletion may be a cause of dementia pathology rather than an effect. , 2006, Medical hypotheses.

[957]  L T Chylack,et al.  The Lens Opacities Case-Control Study. Risk factors for cataract. , 1991, Archives of ophthalmology.

[958]  N. Chattipakorn,et al.  Tabernaemontana divaricata extract inhibits neuronal acetylcholinesterase activity in rats. , 2007, Journal of ethnopharmacology.

[959]  Steven N. Roper,et al.  A method for a more complete in vitro Parkinson's model: Slice culture bioassay for modeling maintenance and repair of the nigrostriatal circuit , 2006, Journal of Neuroscience Methods.

[960]  Harald Steiner,et al.  PEN-2 Is an Integral Component of the γ-Secretase Complex Required for Coordinated Expression of Presenilin and Nicastrin* , 2002, The Journal of Biological Chemistry.

[961]  B. Sperlágh,et al.  Chromatographic analysis of dopamine metabolism in a Parkinsonian model. , 2006, Journal of chromatography. A.

[962]  Hideo Fujiwara,et al.  Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies. , 2002, The Journal of clinical investigation.

[963]  R. Wickett,et al.  Structure and function of the epidermal barrier , 2006 .

[964]  Masato Ogata,et al.  Effect of sesamin in Acanthopanax senticosus HARMS on behavioral dysfunction in rotenone-induced parkinsonian rats. , 2005, Biological & pharmaceutical bulletin.

[965]  Leonidas Stefanis,et al.  α-Synuclein Overexpression in PC12 and Chromaffin Cells Impairs Catecholamine Release by Interfering with a Late Step in Exocytosis , 2006, The Journal of Neuroscience.

[966]  J. Feng,et al.  Nutraceutical interventions may delay aging and the age-related diseases , 2000, Experimental Gerontology.

[967]  S A Book,et al.  Developmental toxicity of L-selenomethionine in Macaca fascicularis. , 1991, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[968]  M Onitsuka,et al.  New platelet aggregation inhibitors from Tan-Shen; radix of Salvia miltiorrhiza Bunge. , 1983, Chemical & pharmaceutical bulletin.

[969]  Mark P Mattson,et al.  Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders. , 2006, Antioxidants & redox signaling.

[970]  M C Michailov,et al.  Effects of buphenin on the rat portal vein. , 1979, Indian journal of physiology and pharmacology.

[971]  Y. Sagara,et al.  Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. , 2001, Free radical biology & medicine.

[972]  T. Maher,et al.  Use of guinea pigs as model to study galactose-induced cataract formation. , 1978, Journal of pharmaceutical sciences.

[973]  J Takeuchi,et al.  [Details and indications of pallidotomy and thalamotomy for Parkinson's disease]. , 2000, Nihon rinsho. Japanese journal of clinical medicine.

[974]  Thomas C. Südhof,et al.  α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration , 2005, Cell.

[975]  R. Uauy,et al.  Nutrition in brain development and aging: role of essential fatty acids. , 2006, Nutrition reviews.

[976]  George R Jackson,et al.  A Drosophila Model of Mutant Human Parkin-Induced Toxicity Demonstrates Selective Loss of Dopaminergic Neurons and Dependence on Cellular Dopamine , 2007, The Journal of Neuroscience.

[977]  W. Longstreth,et al.  Parkinson’s disease risks associated with dietary iron, manganese, and other nutrient intakes , 2003, Neurology.

[978]  Wei Zhang,et al.  The role of microglia in paraquat-induced dopaminergic neurotoxicity. , 2005, Antioxidants & redox signaling.

[979]  G. Marsh,et al.  Employment as a Welder and Parkinson Disease Among Heavy Equipment Manufacturing Workers , 2006, Journal of occupational and environmental medicine.

[980]  S D Varma,et al.  Ophthalmoscopic and morphogenetic changes in rat lens induced by galactose: attenuation by pyruvate , 2004, Diabetes, obesity & metabolism.

[981]  Erwan Bezard,et al.  Absence of MPTP-Induced Neuronal Death in Mice Lacking the Dopamine Transporter , 1999, Experimental Neurology.

[982]  Jun Li,et al.  Flavonoids possess neuroprotective effects on cultured pheochromocytoma PC12 cells: a comparison of different flavonoids in activating estrogenic effect and in preventing beta-amyloid-induced cell death. , 2007, Journal of agricultural and food chemistry.

[983]  R. Pendleton,et al.  Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster. , 2002, The Journal of pharmacology and experimental therapeutics.

[984]  Sanjay Gupta,et al.  A review of antioxidants and Alzheimer's disease. , 2005, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[985]  A. H. V. Schapira,et al.  α-Synuclein expression in HEK293 cells enhances the mitochondrial sensitivity to rotenone , 2003, Neuroscience Letters.

[986]  Yoshiji Ohta,et al.  Short-term ascorbic acid deficiency does not impair antioxidant status in lens of guinea pigs. , 2004, Journal of nutritional science and vitaminology.

[987]  B. Halliwell,et al.  Role of Free Radicals in the Neurodegenerative Diseases , 2001, Drugs & aging.

[988]  Pincus Jh,et al.  Dietary method for reducing fluctuations in Parkinson's disease. , 1987 .

[989]  T Stephens,et al.  Galactose metabolism in relation to cataract formation in marsupials. , 1975, The Australian journal of experimental biology and medical science.

[990]  Daniel Tarsy,et al.  Initial treatment of parkinson’s disease , 2006, Current treatment options in neurology.

[991]  Philip Thomas,et al.  A review of genome mutation and Alzheimer's disease. , 2006, Mutagenesis.

[992]  D. Lévesque,et al.  Nur77 Gene Knockout Alters Dopamine Neuron Biochemical Activity and Dopamine Turnover , 2006, Biological Psychiatry.

[993]  Makoto Hashimoto,et al.  Effects of the cholesterol‐lowering compound methyl‐β‐cyclodextrin in models of α‐synucleinopathy , 2006 .

[994]  T. Nobori,et al.  Effects of the Japanese herbal medicine 'Inchinko-to' (TJ-135) on concanavalin A-induced hepatitis in mice. , 2000, Clinical science.

[995]  T. Itoh,et al.  Effects of 2-nicotinamidoethyl nitrate (nicorandil; SG-75) and its derivative on smooth muscle cells of the canine mesenteric artery. , 1984, The Journal of pharmacology and experimental therapeutics.

[996]  M Fischer.  [A vasodilator agent from the leaves of the ginvgoree]. , 1967, Der Landarzt.

[997]  Gang Hu,et al.  Activation of mitochondrial ATP-sensitive potassium channels improves rotenone-related motor and neurochemical alterations in rats. , 2005, The international journal of neuropsychopharmacology.

[998]  He-Jin Lee,et al.  Clearance of α-Synuclein Oligomeric Intermediates via the Lysosomal Degradation Pathway , 2004, The Journal of Neuroscience.

[999]  Noriyuki Matsukawa,et al.  Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction , 2006, Neuroscience Research.

[1000]  Murali Gopalakrishnan,et al.  Distinct Profiles of α7 nAChR Positive Allosteric Modulation Revealed by Structurally Diverse Chemotypes , 2007, Molecular Pharmacology.

[1001]  Ronald N. Kostoff,et al.  Systematic acceleration of radical discovery and innovation in science and technology , 2006 .

[1002]  A SCRIABINE,et al.  ANTISPASMODIC AND VASOLIDATOR ACTIVITIES OF DOXEPIN. , 1964, The Journal of new drugs.

[1003]  N. Wolf,et al.  Age-related telomere shortening occurs in lens epithelium from old rats and is slowed by caloric restriction. , 2001, Experimental eye research.

[1004]  Yanyan Wang,et al.  Alterations in D1/D2 synergism may account for enhanced stereotypy and reduced climbing in mice lacking dopamine D2L receptor , 2003, Brain Research.

[1005]  Douglas S Kim,et al.  Adenosine receptor blockade reverses hypophagia and enhances locomotor activity of dopamine-deficient mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[1006]  J Wójcicki,et al.  [Platelet aggregation in workers chronically exposed to carbon disulfide and subjected to prophylactic treatment with Cynarex]. , 1981, Medycyna pracy.

[1007]  Tongguang Wang,et al.  Femtomolar concentrations of dextromethorphan protect mesencephalic dopaminergic neurons from inflammatory damage , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[1008]  Darrell Laham,et al.  From paragraph to graph: Latent semantic analysis for information visualization , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[1009]  Yung-Sheng Huang,et al.  Gamma linolenic acid: an antiinflammatory omega-6 fatty acid. , 2006, Current pharmaceutical biotechnology.

[1010]  H Yamasaki,et al.  Pharmacology of sinomenine, an anti-rheumatic alkaloid from Sinomenium acutum. , 1976, Acta medica Okayama.

[1011]  Yan Leng,et al.  Prostaglandin A1 inhibits rotenone‐induced apoptosis in SH‐SY5Y cells , 2002, Journal of neurochemistry.

[1012]  Makoto Hashimoto,et al.  Effects of α-Synuclein Immunization in a Mouse Model of Parkinson’s Disease , 2005, Neuron.

[1013]  Andreas Schober,et al.  GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-β for its neuroprotective action , 2007, Neurobiology of Disease.

[1014]  B. Kriem,et al.  Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid‐β oligomers , 2006, Journal of neurochemistry.

[1015]  Robert E. Burke,et al.  Pitx3 is required for development of substantia nigra dopaminergic neurons , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[1016]  Klaus-Armin Nave,et al.  Inactivation of ether lipid biosynthesis causes male infertility, defects in eye development and optic nerve hypoplasia in mice. , 2003, Human molecular genetics.

[1017]  Leonidas Stefanis,et al.  Application of proteasomal inhibitors to mouse sympathetic neurons activates the intrinsic apoptotic pathway , 2004, Journal of neurochemistry.

[1018]  Eric K. Richfield,et al.  Overexpression of Superoxide Dismutase or Glutathione Peroxidase Protects against the Paraquat + Maneb-induced Parkinson Disease Phenotype* , 2005, Journal of Biological Chemistry.

[1019]  F Vaglini,et al.  Cytochrome P450 and Parkinson's disease: protective role of neuronal CYP 2E1 from MPTP toxicity. , 2006, Journal of neural transmission. Supplementum.

[1020]  J. Trevithick,et al.  Modelling cortical cataractogenesis. XVIII. In vitro diabetic cataract reduction by venoruton. A flavonoid which prevents lens opacification. , 2009, Acta ophthalmologica Scandinavica.

[1021]  Natsuki Kobayashi,et al.  Pyrroloquinoline quinone (PQQ) prevents fibril formation of α-synuclein , 2006 .

[1022]  M. Melzig,et al.  Induction of neutral endopeptidase (NEP) activity of SK‐N‐SH cells by natural compounds from green tea , 2006, The Journal of pharmacy and pharmacology.

[1023]  Phillip Nagley,et al.  Rotenone and MPP+ preferentially redistribute apoptosis-inducing factor in apoptotic dopamine neurons , 2007, Neuroreport.

[1024]  K C Yeh,et al.  Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies. , 1989, Neurology.

[1025]  Paul Alan Cox,et al.  A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[1026]  A Vijayalakshmi,et al.  Effect of long-term dietary manipulation on the aggregation of rat lens crystallins: role of alpha-crystallin chaperone function. , 2002, Molecular vision.

[1027]  N. Biswas,et al.  Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts , 2002, Phytotherapy research : PTR.

[1028]  M Palta,et al.  Serum carotenoids and tocopherols and severity of nuclear and cortical opacities. , 1995, Investigative ophthalmology & visual science.

[1029]  M. Lew,et al.  Gait and balance dysfunction in adults , 2003, Current treatment options in neurology.

[1030]  A Bordia,et al.  Effect of Vitamin C on Platelet Adhesiveness and Platelet Aggregation in Coronary Artery Disease Patients , 1985, Clinical cardiology.

[1031]  Heikki Arola,et al.  Galactitol is not a cause of senile cataract , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[1032]  H. Kuerer,et al.  Strain difference in galactokinase level and susceptibility to the teratogenic effect of dietary galactose in mice: I. Teratogenic and embryopathic effect. , 1988, Teratology.

[1033]  Nijole Savickiene,et al.  [Importance of biologically active components and plants in the prevention of complications of diabetes mellitus]. , 2002, Medicina.

[1034]  M Marshall.  [Varicose vein drugs--new attempts at objectivation of the effects of therapy]. , 1984, Fortschritte der Medizin.

[1035]  A. Fagan,et al.  Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease , 2006, Neurobiology of Disease.

[1036]  Anna Piantanelli,et al.  Aging Reversibility: from Thymus Graft to Vegetable Extract Treatment – Application to Cure an Age-associated Pathology , 2005, Biogerontology.

[1037]  Walter C Willett,et al.  Long-term intake of vitamins and carotenoids and odds of early age-related cortical and posterior subcapsular lens opacities. , 2002, The American journal of clinical nutrition.

[1038]  Thomas E. Hinkebein,et al.  Progress with the desalination and water purification technologies US roadmap , 2005 .

[1039]  C. Markham,et al.  Deficits in operant behaviour in monkeys treated with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). , 1988, Brain : a journal of neurology.

[1040]  Serebriakova Tn,et al.  Anticoagulating properties of fungal proteases tricholysine (triase) and longolytin , 1984 .

[1041]  Todd Sherer,et al.  Rotenone Model of Parkinson Disease , 2005, Journal of Biological Chemistry.

[1042]  J. Vane,et al.  EICOSAPENTAENOIC ACID AND PREVENTION OF THROMBOSIS AND ATHEROSCLEROSIS? , 1978, The Lancet.

[1043]  P. M. Chan,et al.  Mice with Very Low Expression of the Vesicular Monoamine Transporter 2 Gene Survive into Adulthood: Potential Mouse Model for Parkinsonism , 2001, Molecular and Cellular Biology.

[1044]  A. Makheja,et al.  Effects of onion (Allium cepa) extract on platelet aggregation and thromboxane synthesis. , 1979, Prostaglandins and medicine.

[1045]  D King,et al.  A study of the nutritional status of elderly patients with Parkinson's disease. , 1994, Age and ageing.

[1046]  M. Feany,et al.  Aggregated α-Synuclein Mediates Dopaminergic Neurotoxicity In Vivo , 2007, The Journal of Neuroscience.

[1047]  M. Schultzberg,et al.  High cholesterol diet results in increased expression of interleukin-6 and caspase-1 in the brain of apolipoprotein E knockout and wild type mice , 2005, Journal of Neuroimmunology.

[1048]  J. Fernstrom,et al.  Dietary precursors and brain neurotransmitter formation. , 1981, Annual review of medicine.

[1049]  Neal Castagnoli,et al.  Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke. , 2006, Bioorganic & medicinal chemistry.

[1050]  A Turturro,et al.  Normal mouse and rat strains as models for age-related cataract and the effect of caloric restriction on its development. , 2000, Experimental eye research.

[1051]  G. E. Mirza,et al.  Postoperative endophthalmitis caused by an Enterobacter species. , 1994, The Journal of hospital infection.

[1052]  Ralph Green,et al.  Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. , 2007, Archives of neurology.

[1053]  Richard Mayeux,et al.  Diet and Parkinson's disease , 1997, Neurology.

[1054]  Ger J. A. Ramakers,et al.  Improved Long-Term Potentiation and Memory in Young Tau-P301L Transgenic Mice before Onset of Hyperphosphorylation and Tauopathy , 2006, The Journal of Neuroscience.

[1055]  F C Greenslade,et al.  Heterogeneity of biochemical actions among vasodilators. , 1982, Journal of pharmaceutical sciences.

[1056]  Kayoko Kujirai,et al.  Autoradiographic distribution of [3H]neurotensin receptors in the brains of superoxide dismutase transgenic mice , 1993, Synapse.

[1057]  C. Griffin,et al.  Immunochemical comparison of the major intrinsic protein of eye-lens fibre cell membranes in mice with hereditary cataracts. , 1991, Biochimica et biophysica acta.

[1058]  Heikki Tanila,et al.  Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human α-synuclein , 2005, Neurobiology of Disease.

[1059]  C. Zetterström,et al.  Cataracts in children , 2005, Journal of cataract and refractive surgery.

[1060]  J. Shih,et al.  Monoamine oxidase: from genes to behavior. , 1999, Annual review of neuroscience.

[1061]  J. López-Barneo,et al.  Selective Glial Cell Line-Derived Neurotrophic Factor Production in Adult Dopaminergic Carotid Body Cells In Situ and after Intrastriatal Transplantation , 2005, The Journal of Neuroscience.

[1062]  Philip Scheltens,et al.  The impact of diagnostic disclosure in dementia: a qualitative case analysis , 2005, International Psychogeriatrics.

[1063]  S Kitagawa,et al.  Effects of long-chain cis-unsaturated fatty acids and their alcohol analogs on aggregation of bovine platelets and their relation with membrane fluidity change. , 1985, Biochimica et biophysica acta.

[1064]  Christian Geny,et al.  Microglial chimaerism in human xenografts to the rat brain , 1995, Brain Research Bulletin.

[1065]  Peter J Houghton,et al.  Acetylcholinesterase inhibitors from plants. , 2007, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[1066]  A. Levey,et al.  Selective enrichment of DJ‐1 protein in primate striatal neuronal processes: Implications for Parkinson's disease , 2007, The Journal of comparative neurology.

[1067]  Matthew R Chapman,et al.  Curli biogenesis and function. , 2006, Annual review of microbiology.

[1068]  Deirdre DeVine,et al.  B vitamins and berries and age-related neurodegenerative disorders. , 2006, Evidence report/technology assessment.

[1069]  G. Mchedlishvili,et al.  Arteriolar resistance and hemorheological disorders related to Raynaud's phenomenon. , 2001, Microvascular research.

[1070]  Giovanni Pennisi,et al.  Redox Regulation of Cellular Stress Response in Aging and Neurodegenerative Disorders: Role of Vitagenes , 2007, Neurochemical Research.

[1071]  Remmet Jonges,et al.  Tryptophan deficiency arrests chromatin breakdown in secondary lens fibers of rats. , 2004, Experimental eye research.

[1072]  V N Reddy,et al.  Scanning electron microscopy of X-ray-induced cataract in mice on normal and galactose diet. , 1983, Ophthalmic research.

[1073]  W Wesemann.  Therapy of Morbus Parkinson and radical-induced neurotoxicity in the rat--in vivo voltammetric studies. , 1992, Journal of neural transmission. Supplementum.

[1074]  W. Schmidt,et al.  Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats , 2002, Behavioural Brain Research.

[1075]  Declan P Naughton,et al.  Dietary chelators as antioxidant enzyme mimetics: implications for dietary intervention in neurodegenerative diseases. , 2006, Behavioural pharmacology.

[1076]  M. Youdim,et al.  Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax , 2004, Neuropharmacology.

[1077]  R. M. Simpson,et al.  The combination of GM-CSF and IL-2 as local adjuvant shows synergy in enhancing peptide vaccines and provides long term tumor protection. , 2007, Vaccine.

[1078]  Roberto Cappai,et al.  The redox chemistry of the Alzheimer's disease amyloid β peptide , 2007 .

[1079]  M. Beal,et al.  Neurotoxicity and behavioral deficits associated with Septin 5 accumulation in dopaminergic neurons , 2005, Journal of neurochemistry.

[1080]  L Teare,et al.  Cannabis for dyskinesia in Parkinson disease , 2004, Neurology.

[1081]  Mei-Hsien Lee,et al.  Monoamine oxidase B (MAO-B) inhibition by active principles from Uncaria rhynchophylla. , 2005, Journal of ethnopharmacology.

[1082]  Kenneth M. Rosen,et al.  Parkin Protects against Mitochondrial Toxins and β-Amyloid Accumulation in Skeletal Muscle Cells* , 2006, Journal of Biological Chemistry.

[1083]  C. Rice-Evans,et al.  Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein. , 2000, Free radical biology & medicine.

[1084]  Stuart Maudsley,et al.  Caloric restriction and intermittent fasting: Two potential diets for successful brain aging , 2006, Ageing Research Reviews.

[1085]  M. Chesselet,et al.  Behavioral phenotypes and pharmacology in genetic mouse models of Parkinsonism , 2006, Behavioural pharmacology.

[1086]  J. Growdon,et al.  Current pharmacotherapy for Alzheimer's disease. , 2006, Annual review of medicine.

[1087]  Scott Sands,et al.  Overexpression of the α1B-adrenergic receptor causes apoptotic neurodegeneration: Multiple system atrophy , 2000, Nature Medicine.

[1088]  Robert Nitsch,et al.  Selenium and brain function: a poorly recognized liaison , 2004, Brain Research Reviews.

[1089]  L T Chylack,et al.  Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. , 1991, The American journal of clinical nutrition.

[1090]  C. Gong,et al.  Concurrent alterations of O‐GlcNAcylation and phosphorylation of tau in mouse brains during fasting , 2006, The European journal of neuroscience.

[1091]  D. Allan Butterfield,et al.  Mitochondrial associated metabolic proteins are selectively oxidized in A30P α-synuclein transgenic mice—a model of familial Parkinson's disease , 2005, Neurobiology of Disease.

[1092]  Kenjiro Ono,et al.  Antioxidant compounds have potent anti‐fibrillogenic and fibril‐destabilizing effects for α‐synuclein fibrils in vitro , 2006, Journal of neurochemistry.

[1093]  Carine Nizard,et al.  Algae Extract Protection Effect on Oxidized Protein Level in Human Stratum Corneum , 2004, Annals of the New York Academy of Sciences.

[1094]  H MORIN,et al.  [PHARMACOLOGICAL AND TOXICOLOGICAL STUDY OF A CORONARY VASODILATOR: ETHYL FLAVONE-7-OXYACETATE]. , 1964, Therapie.

[1095]  Takeshi Kumazawa,et al.  Increased stress response and β–phenylethylamine in MAOB–deficient mice , 1997, Nature Genetics.

[1096]  M SalvadorVázquez,et al.  [Effect of a diet supplemented with unsaturated fatty acids (Arachis hypogaea: peanuts) on blood coagulation]. , 1982 .

[1097]  Xiaorui Cheng,et al.  The effects of Liuwei Dihuang decoction on the gene expression in the hippocampus of senescence-accelerated mouse. , 2007, Fitoterapia.

[1098]  L. Ignarro,et al.  Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. , 1981, The Journal of pharmacology and experimental therapeutics.

[1099]  A. Saiardi,et al.  Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors , 1995, Nature.

[1100]  C. Shaw,et al.  Analysis of neurological disease in four dimensions: insight from ALS-PDC epidemiology and animal models , 2003, Neuroscience & Biobehavioral Reviews.

[1101]  Yong-Ki Park,et al.  Inhibition of gene expression and production of iNOS and TNF-alpha in LPS-stimulated microglia by methanol extract of Phellodendri cortex. , 2007, International immunopharmacology.

[1102]  B. Zlokovic,et al.  Liver and lens glutathione and cysteine regulation in galactose-fed guinea pigs. , 1997, Current eye research.

[1103]  Chang-Ling Li,et al.  Protective effect of verbascoside on 1-methyl-4-phenylpyridinium ion-induced neurotoxicity in PC12 cells. , 2002, European journal of pharmacology.

[1104]  J. Pincus,et al.  Influence of dietary protein on motor fluctuations in Parkinson's disease. , 1987, Archives of neurology.

[1105]  Patrick Pantel,et al.  Discovering word senses from text , 2002, KDD.

[1106]  Barbara Shukitt-Hale,et al.  Fruit Polyphenols and Their Effects on Neuronal Signaling and Behavior in Senescence , 2007, Annals of the New York Academy of Sciences.

[1107]  L. Pérez-Martínez,et al.  Tissue Inhibitor of Metalloproteinase-2 Promotes Neuronal Differentiation by Acting as an Anti-Mitogenic Signal , 2005, The Journal of Neuroscience.

[1108]  C J Epstein,et al.  Transgenic Murine Dopaminergic Neurons Expressing Human Cu/Zn Superoxide Dismutase Exhibit Increased Density in Culture, but No Resistance to Methylphenylpyridinium‐Induced Degeneration , 1997, Journal of neurochemistry.

[1109]  J. Watkins,et al.  Oxidative Stress in Rats After 60 Days of Hypergalactosemia or Hyperglycemia , 2003, International journal of toxicology.

[1110]  Monaenkov Am,et al.  Use of graded bicycle ergometry as a method for the objective evaluation of the efficacy of reflexotherapy in the early stages of hypertension , 1984 .

[1111]  Gary Williamson,et al.  Quercetin metabolism in the lens: role in inhibition of hydrogen peroxide induced cataract. , 2002, Free radical biology & medicine.

[1112]  Cecil M. Burchfiel,et al.  Environmental, life-style, and physical precursors of clinical Parkinson’s disease: recent findings from the Honolulu-Asia Aging Study , 2003, Journal of Neurology.

[1113]  Charles N Serhan,et al.  A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. , 2005, The Journal of clinical investigation.

[1114]  Jérôme Baufreton,et al.  D5 (Not D1) Dopamine Receptors Potentiate Burst-Firing in Neurons of the Subthalamic Nucleus by Modulating an L-Type Calcium Conductance , 2003, The Journal of Neuroscience.

[1115]  R. Bache,et al.  Coronary and Systemic Hemodynamic Effects of Tetramethylpyrazine in the Dog , 1985, Journal of cardiovascular pharmacology.

[1116]  Hyung-Won Kang,et al.  Neuroprotective effect of some plant extracts in cultured CT105-induced PC12 cells. , 2006, Biological & pharmaceutical bulletin.

[1117]  R J Truscott,et al.  Relationship between serum tryptophan and tryptophan metabolite levels after tryptophan ingestion in normal subjects and age-related cataract patients. , 1995, Clinical science.

[1118]  J. Bloomquist,et al.  Potentiating effect of the ATP-sensitive potassium channel blocker glibenclamide on complex I inhibitor neurotoxicity in vitro and in vivo. , 2006, Neurotoxicology.

[1119]  Q. Rogers,et al.  Histidine requirement of kittens for growth, haematopoiesis and prevention of cataracts , 1987, British Journal of Nutrition.

[1120]  Michael D. Gordon,et al.  Toward Discovery Support Systems: A Replication, Re-Examination, and Extension of Swanson's Work on Literature-Based Discovery of a Connection between Raynaud's and Fish Oil , 1996, J. Am. Soc. Inf. Sci..

[1121]  V. Bader,et al.  Sgk1, a cell survival response in neurodegenerative diseases , 2005, Molecular and Cellular Neuroscience.

[1122]  David Bernhard,et al.  Isogentisin--a novel compound for the prevention of smoking-caused endothelial injury. , 2007, Atherosclerosis.

[1123]  D. S. Albers,et al.  Energy Stress‐Induced Dopamine Loss in Glutathione Peroxidase‐Overexpressing Transgenic Mice and in Glutathione‐Depleted Mesencephalic Cultures , 1997, Journal of neurochemistry.

[1124]  Richard L. Doty,et al.  Olfactory dysfunction occurs in transgenic mice overexpressing human τ protein , 2004, Brain Research.

[1125]  Sylvie Gélinas,et al.  Neuroprotective effect of estradiol and phytoestrogens on MPP+‐induced cytotoxicity in neuronal PC12 cells , 2002, Journal of neuroscience research.

[1126]  Veronika Somoza,et al.  Five years of research on health risks and benefits of Maillard reaction products: an update. , 2005, Molecular nutrition & food research.

[1127]  R. Webb,et al.  Vascular reactivity and high dietary eicosapentaenoic acid. , 1982, Prostaglandins.

[1128]  Mark P. Mattson,et al.  Perturbed signal transduction in neurodegenerative disorders involving aberrant protein aggregation , 2007, NeuroMolecular Medicine.

[1129]  Roland Wolf,et al.  GSTπ expression mediates dopaminergic neuron sensitivity in experimental parkinsonism , 2007, Proceedings of the National Academy of Sciences.

[1130]  J. E. Bell,et al.  Evidence of a breakdown of corticostriatal connections in Parkinson’s disease , 2005, Neuroscience.

[1131]  Francesco Angelico,et al.  EICOSAPENTAENOIC ACID AND PREVENTION OF ATHEROSCLEROSIS , 1978, The Lancet.

[1132]  J. Steele,et al.  Observations About Amyotrophic Lateral Sclerosis and the Parkinsonism-Dementia Complex of Guam with Regard to Epidemiology and Etiology , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[1133]  J. Trojanowski,et al.  Transgenic Mouse Model of Tau Pathology in Astrocytes Leading to Nervous System Degeneration , 2005, The Journal of Neuroscience.

[1134]  Katarzyna Kalita,et al.  Estrogen receptor β , 2002 .

[1135]  A. Grover,et al.  5′ Splice Site Mutations in tau Associated with the Inherited Dementia FTDP-17 Affect a Stem-Loop Structure That Regulates Alternative Splicing of Exon 10* , 1999, The Journal of Biological Chemistry.

[1136]  Philip J. Thomas,et al.  A Precipitating Role for Truncated α-Synuclein and the Proteasome in α-Synuclein Aggregation , 2005, Journal of Biological Chemistry.

[1137]  Werner J. Schmidt,et al.  Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain , 2004, Experimental Neurology.

[1138]  Shu-Leong Ho,et al.  COX-2-deficient mice are less prone to MPTP-neurotoxicity than wild-type mice , 2003, Neuroreport.

[1139]  David P Cox,et al.  Lack of the DNA repair enzyme OGG1 sensitizes dopamine neurons to manganese toxicity during development. , 2005, Gene expression.

[1140]  R. Paisey,et al.  Association of Differing Dietary, Metabolic, and Clinical Risk Factors with Macrovascular Complications of Diabetes: A Prevalence Study of 503 Mexican Type II Diabetic Subjects. I , 1984, Diabetes Care.

[1141]  M Francisca Molina-Jimenez,et al.  Effect of fraxetin and myricetin on rotenone-induced cytotoxicity in SH-SY5Y cells: comparison with N-acetylcysteine. , 2003, European journal of pharmacology.

[1142]  Joachim Klose,et al.  Eye lens proteomics , 2006, Amino Acids.

[1143]  O Hockwin,et al.  Identification of metabolic risk factors for posterior subcapsular cataract. , 1986, Ophthalmic research.

[1144]  K A Frey,et al.  Synthesis and biological evaluation in mice of (2-[11C]methoxy)-6',7'-dihydrorotenol, a second generation rotenoid for marking mitochondrial complex I activity. , 1995, Nuclear medicine and biology.

[1145]  Ulrich Friedemann,et al.  BLOOD-BRAIN BARRIER , 1942 .

[1146]  R J Uitti.  Medical treatment of essential tremor and Parkinson's disease. , 1998, Geriatrics.

[1147]  T. Südhof,et al.  Role of α-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice , 2003, Neuroscience.

[1148]  Johannes Schwarz,et al.  1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism , 2000, Brain Research.

[1149]  Khalid Rahman,et al.  Garlic and aging: new insights into an old remedy , 2003, Ageing Research Reviews.

[1150]  Gang Liu,et al.  JNK: bridging the insulin signaling and inflammatory pathway. , 2005, Current opinion in investigational drugs.

[1151]  Balasubramaniem Ashokkumar,et al.  Effect of folate oversupplementation on folate uptake by human intestinal and renal epithelial cells. , 2007, The American journal of clinical nutrition.

[1152]  Richard Paylor,et al.  Synaptic Vesicle Depletion Correlates with Attenuated Synaptic Responses to Prolonged Repetitive Stimulation in Mice Lacking α-Synuclein , 2002, The Journal of Neuroscience.

[1153]  M. Karmazyn,et al.  Dantrolene blocks intracellular calcium release in smooth muscle: competitive antagonism of thromboxane A2. , 1978, Canadian journal of physiology and pharmacology.

[1154]  E. Faison,et al.  Pharmacology and receptor binding of atrial natriuretic factor in vascular smooth muscle. , 1985, Clinical and experimental hypertension. Part A, Theory and practice.

[1155]  Robert L Nussbaum,et al.  Alpha-synuclein gene deletion decreases brain palmitate uptake and alters the palmitate metabolism in the absence of alpha-synuclein palmitate binding. , 2005, Biochemistry.

[1156]  Nicolas Le Novère,et al.  Subunit Composition of Functional Nicotinic Receptors in Dopaminergic Neurons Investigated with Knock-Out Mice , 2003, The Journal of Neuroscience.

[1157]  Barbara Shukitt-Hale,et al.  Dietary supplementation with blueberry extract improves survival of transplanted dopamine neurons , 2006, Nutritional neuroscience.

[1158]  Peter Davies,et al.  Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides* , 2005, Journal of Biological Chemistry.

[1159]  I Ferrer,et al.  Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies. , 2005, Current Alzheimer research.

[1160]  Pasko Rakic,et al.  The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease , 2007, Proceedings of the National Academy of Sciences.

[1161]  T. Crombleholme,et al.  Transplantation of fetal cells. , 1991, American journal of obstetrics and gynecology.

[1162]  K H Rosler,et al.  Flavonoids with anti-cataract activity from Brickellia arguta. , 1984, Journal of natural products.

[1163]  C. la Vecchia,et al.  Food and nutrient intake and risk of cataract. , 1996, Annals of epidemiology.

[1164]  A. Whitworth,et al.  Drosophila models pioneer a new approach to drug discovery for Parkinson's disease. , 2006, Drug discovery today.

[1165]  R. F. Castilho,et al.  Protective effect of melatonin on rotenone plus Ca2+-induced mitochondrial oxidative stress and PC12 cell death. , 2005, Antioxidants & redox signaling.

[1166]  E. Hol,et al.  Frameshift proteins in Alzheimer's disease and in other conformational disorders: time for the ubiquitin-proteasome system. , 2006, Journal of Alzheimer's disease : JAD.

[1167]  J B Eells.  The control of dopamine neuron development, function and survival: insights from transgenic mice and the relevance to human disease. , 2003, Current medicinal chemistry.

[1168]  J. A. Dani,et al.  Potential applications of nicotinic ligands in the laboratory and clinic. , 2004, Bioorganic & medicinal chemistry letters.

[1169]  Wen-Lang Lin,et al.  Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein , 2000, Nature Genetics.

[1170]  Stephen J. Blackband,et al.  Quantitative measurement of neurodegeneration in an ALS–PDC model using MR microscopy , 2004, NeuroImage.

[1171]  Subramanian Rajagopalan,et al.  Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo A Novel Therapy for Parkinson's Disease , 2003, Neuron.

[1172]  A H Schapira,et al.  Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors. , 1997, Brain research.

[1173]  L Timmermann,et al.  Mucuna pruriens in Parkinson’s disease: a double blind clinical and pharmacological study , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[1174]  Neal Castagnoli,et al.  8-(3-Chlorostyryl)caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A2A Receptor Antagonism* , 2002, The Journal of Biological Chemistry.

[1175]  I. Kola,et al.  Targeted Expression of a Toxin Gene to D1 Dopamine Receptor Neurons by Cre-Mediated Site-Specific Recombination , 1998, The Journal of Neuroscience.

[1176]  Dwight C. German,et al.  Mitochondria mass is low in mouse substantia nigra dopamine neurons: Implications for Parkinson's disease , 2007, Experimental Neurology.

[1177]  R. Grimble,et al.  The effects of sulfur amino acid intake on immune function in humans. , 2006, The Journal of nutrition.

[1178]  M. S. Petrik,et al.  Examining the interaction of apo E and neurotoxicity on a murine model of ALS-PDC. , 2005, Canadian journal of physiology and pharmacology.

[1179]  P.-E. Chabrier,et al.  Nitric oxide synthases: targets for therapeutic strategies in neurological diseases , 1999, Cellular and Molecular Life Sciences CMLS.

[1180]  H U Nwanjo,et al.  Anti-lipid peroxidative activity of Gongronema latifolium in streptozotocin-induced diabetic rats. , 2010, Nigerian journal of physiological sciences : official publication of the Physiological Society of Nigeria.

[1181]  Danqing Xiao,et al.  Forebrain Adenosine A2A Receptors Contribute to l-3,4-Dihydroxyphenylalanine-Induced Dyskinesia in Hemiparkinsonian Mice , 2006, The Journal of Neuroscience.

[1182]  Leuenberger Pm.  [Diabetic cataract and flavonoids (first results) (author's transl)]. , 1978 .

[1183]  B. Derham,et al.  The effect of the presence of globular proteins and elongated polymers on enzyme activity. , 2006, Biochimica et biophysica acta.

[1184]  M Kojima,et al.  Morphological and biochemical changes in lenses of guinea pigs after vitamin-C-deficient diet and UV-B radiation. , 1995, Ophthalmic research.

[1185]  B. Alman,et al.  Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols , 2004, Neuromuscular Disorders.

[1186]  Yasukazu Yoshida,et al.  γ-Tocopherol attenuates MPTP-induced dopamine loss more efficiently than α-tocopherol in mouse brain , 2006, Neuroscience Letters.

[1187]  Heikki Tanila,et al.  Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in α‐synuclein knockout and A30P transgenic mice , 2006, Journal of neurochemistry.

[1188]  Douglas C. Wallace,et al.  A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase , 1998, Nature Genetics.

[1189]  Gang Wang,et al.  PACAP protects neuronal differentiated PC12 cells against the neurotoxicity induced by a mitochondrial complex I inhibitor, rotenone , 2005, FEBS letters.

[1190]  R. Berge,et al.  Cataract formation in Atlantic salmon, Salmo salar L., smolt relative to dietary pro- and antioxidants and lipid level. , 2003, Journal of fish diseases.

[1191]  A R Rosenthal,et al.  The prevalence of age related cataract in the Asian Community in Leicester: A community based study , 1990, Eye.

[1192]  Debasis Bagchi,et al.  Super CitriMax (HCA-SX) attenuates increases in oxidative stress, inflammation, insulin resistance, and body weight in developing obese Zucker rats , 2007, Molecular and Cellular Biochemistry.

[1193]  Jürgen Götz,et al.  A Decade of Tau Transgenic Animal Models and Beyond , 2007, Brain pathology.

[1194]  Sushil K. Sharma,et al.  Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson's disease and the neuroprotective role of coenzyme Q10 , 2006, Brain Research Bulletin.

[1195]  M. Naoi,et al.  Mitochondria determine the survival and death in apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, and neuroprotection by propargylamines , 2002, Journal of Neural Transmission.

[1196]  Yan Wang,et al.  Proteomic Identification of a Stress Protein, Mortalin/mthsp70/GRP75 , 2006, Molecular & Cellular Proteomics.

[1197]  R. Nitsch,et al.  Oligodendroglial tau filament formation in transgenic mice expressing G272V tau , 2001, The European journal of neuroscience.

[1198]  Christine Slingsby,et al.  Crystal structure and assembly of a eukaryotic small heat shock protein , 2001, Nature Structural Biology.

[1199]  S. Ho,et al.  Epidemiologic study of Parkinson's disease in Hong Kong , 1989, Neurology.

[1200]  J. Drago,et al.  Dose‐related neuroprotective effects of chronic nicotine in 6‐hydroxydopamine treated rats, and loss of neuroprotection in α4 nicotinic receptor subunit knockout mice , 2001, British journal of pharmacology.

[1201]  Jonathan Newmark,et al.  Vitamin D and Parkinson's disease—A hypothesis , 2007, Movement disorders : official journal of the Movement Disorder Society.

[1202]  N J Unakar,et al.  Sodium-potassium-dependent ATPase. I. Cytochemical localization in normal and cataractous rat lenses. , 1980, Investigative ophthalmology & visual science.

[1203]  H. Bergman,et al.  Adaptive acetylcholinesterase splicing patterns attenuate 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced Parkinsonism in mice , 2006, The European journal of neuroscience.

[1204]  K B Mulloy.  Two case reports of neurological disease in coal mine preparation plant workers. , 1996, American journal of industrial medicine.

[1205]  A. Ueki,et al.  Life style risks of Parkinson’s disease: Association between decreased water intake and constipation , 2004, Journal of Neurology.

[1206]  Xing-zu Zhu,et al.  Monocyte-mediated rotenone neurotoxicity towards human neuroblastoma SH-SY5Y: role of mitogen-activated protein kinases. , 2006, Biological & pharmaceutical bulletin.

[1207]  Xiaolin Hou,et al.  Determination of 19 elements in human eye lenses , 1996, Biological Trace Element Research.

[1208]  G. Kuttan,et al.  Antioxidant Potential of Biophytum sensitivum Extract In Vitro and In Vivo , 2006, Journal of basic and clinical physiology and pharmacology.

[1209]  G E Felton,et al.  Fibrinolytic and antithrombotic action of bromelain may eliminate thrombosis in heart patients. , 1980, Medical hypotheses.

[1210]  H. Joshi,et al.  Nardostachys jatamansi improves learning and memory in mice. , 2006, Journal of medicinal food.

[1211]  B. Sommer,et al.  Mouse models of α-synucleinopathy and Lewy pathology , 2000, Experimental Gerontology.

[1212]  Johannes Stegmann,et al.  Hypothesis generation guided by co-word clustering , 2004, Scientometrics.

[1213]  A. Tamaoka,et al.  [Amyloid beta protein]. , 1999, Nihon rinsho. Japanese journal of clinical medicine.

[1214]  C. Finch,et al.  A perspective on sporadic inclusion-body myositis , 2006, Neurology.

[1215]  Hideki Hayakawa,et al.  Caspase-11 Mediates Inflammatory Dopaminergic Cell Death in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson's Disease , 2004, The Journal of Neuroscience.

[1216]  R. Kim,et al.  Cytotoxic effects of repin, a principal sesquiterpene lactone of russian knapweed , 1997, Journal of neuroscience research.

[1217]  Qin Feng,et al.  Intervention effects of Jianpi Liqi Huoxue Decoction (健脾理气活血汤) on lipid peroxidative liver injury induced by alcohol , 2006, Chinese journal of integrative medicine.

[1218]  R. Hoerr,et al.  Treatment effects of EGb 761 and cholinesterase inhibitors--why available studies do not demonstrate superiority of the latter. , 2005, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[1219]  C von Schacky,et al.  Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. , 1985 .

[1220]  Stella Dracheva,et al.  Locomotor behavior of dopamine D1 receptor transgenic/D2 receptor deficient hybrid mice , 2001, Brain Research.

[1221]  J. Shih,et al.  MAO-A and -B gene knock-out mice exhibit distinctly different behavior. , 1999, Neurobiology.

[1222]  Muzamil Ahmad,et al.  Protective effects of ethanolic extract of Delphinium denudatum in a rat model of Parkinson's disease , 2006, Human & experimental toxicology.

[1223]  E. Masliah,et al.  Lysosomal pathology associated with α‐synuclein accumulation in transgenic models using an eGFP fusion protein , 2005, Journal of neuroscience research.

[1224]  L. Kellaway,et al.  Herbal Complement Inhibitors in the Treatment of Neuroinflammation: Future Strategy for Neuroprotection , 2005, Annals of the New York Academy of Sciences.

[1225]  Makoto Hashimoto,et al.  Development of a new treatment for alzheimer’s disease and parkinson’s disease using anti-aggregatory β-synuclein-derived peptides , 2002, Journal of Molecular Neuroscience.

[1226]  Wanda Pratt,et al.  Response to ''Validating discovery in literature-based discovery" , 2007, J. Biomed. Informatics.

[1227]  Katsuko Komatsu,et al.  Withanoside IV and its active metabolite, sominone, attenuate Aβ(25–35)‐induced neurodegeneration , 2006, The European journal of neuroscience.

[1228]  John W. Fara,et al.  Effects of gastrointestinal hormones on vascular smooth muscle , 1975, The American Journal of Digestive Diseases.

[1229]  Harald Steiner,et al.  Immature nicastrin stabilizes APH‐1 independent of PEN‐2 and presenilin: identification of nicastrin mutants that selectively interact with APH‐1 , 2004, Journal of neurochemistry.

[1230]  Tomoaki Ikeda,et al.  Protective effect of Toki‐shakuyaku‐san on amyloid β25–35‐induced neuronal damage in cultured rat cortical neurons , 2005, Phytotherapy research : PTR.

[1231]  M. Ansari,et al.  Neuroprotection by crocetin in a hemi-parkinsonian rat model , 2005, Pharmacology Biochemistry and Behavior.

[1232]  Michio Hashimoto,et al.  DOCOSAHEXAENOIC ACID‐INDUCED PROTECTIVE EFFECT AGAINST IMPAIRED LEARNING IN AMYLOID β‐INFUSED RATS IS ASSOCIATED WITH INCREASED SYNAPTOSOMAL MEMBRANE FLUIDITY , 2006, Clinical and experimental pharmacology & physiology.

[1233]  Christian Haass,et al.  Subcellular Localization of Wild-Type and Parkinson's Disease-Associated Mutant α-Synuclein in Human and Transgenic Mouse Brain , 2000, The Journal of Neuroscience.

[1234]  Robert S. Fisher,et al.  Functional (nonulcer) dyspepsia , 2002, Current treatment options in gastroenterology.

[1235]  Jean-François Dartigues,et al.  Vasodilators and Nootropics as Predictors of Dementia and Mortality in the PAQUID Cohort , 2007, Journal of the American Geriatrics Society.

[1236]  Jeffrey Rosenfeld,et al.  Sertoli cells improve survival of motor neurons in SOD1 transgenic mice, a model of amyotrophic lateral sclerosis , 2005, Experimental Neurology.

[1237]  D. O'Leary,et al.  Identification and developmental analysis of genes expressed by dopaminergic neurons of the substantia nigra pars compacta , 2004, Molecular and Cellular Neuroscience.

[1238]  M. Shinitzky,et al.  Alleviation of drug withdrawal symptoms by treatment with a potent mixture of natural lipids. , 1982, European journal of pharmacology.

[1239]  H. Iwata,et al.  Impaired metabolism of arachidonate in selenium-deficient animals , 2005, Experientia.

[1240]  Harald Steiner,et al.  Presenilin-dependent Intramembrane Proteolysis of CD44 Leads to the Liberation of Its Intracellular Domain and the Secretion of an Aβ-like Peptide* , 2002, The Journal of Biological Chemistry.

[1241]  S Fahn,et al.  Experience with tranylcypromine in early Parkinson's disease. , 1998, Journal of neural transmission. Supplementum.

[1242]  J. Schneider,et al.  Lifespan Extension and Rescue of Spongiform Encephalopathy in Superoxide Dismutase 2 Nullizygous Mice Treated with Superoxide Dismutase–Catalase Mimetics , 2001, The Journal of Neuroscience.

[1243]  Yaakov Stern,et al.  Mediterranean diet, Alzheimer disease, and vascular mediation. , 2006, Archives of neurology.

[1244]  S. Pulst,et al.  Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human , 2000, Nature Genetics.

[1245]  Garry Wong,et al.  Increased lifespan in transgenic Caenorhabditis elegans overexpressing human α-synuclein , 2006, Experimental Gerontology.

[1246]  R. A. Crowther,et al.  Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein , 2000, Acta Neuropathologica.

[1247]  Karl Folkers,et al.  BIOENERGETICS IN CLINICAL MEDICINE , 1976 .

[1248]  P. Srinivasan,et al.  Mining MEDLINE: Postulating a Beneficial Role for Curcumin Longa in Retinal Diseases , 2004, HLT-NAACL 2004.

[1249]  Jie Shen,et al.  Gene-targeting technologies for the study of neurological disorders , 2007, NeuroMolecular Medicine.

[1250]  A Berio,et al.  Enhanced biofilm-production in pathogens isolated from patients with rare metabolic disorders. , 2004, The new microbiologica.

[1251]  Marc Weeber,et al.  Case Report: Generating Hypotheses by Discovering Implicit Associations in the Literature: A Case Report of a Search for New Potential Therapeutic Uses for Thalidomide , 2003, J. Am. Medical Informatics Assoc..

[1252]  C V WINDER,et al.  Relative experimental coronary vasodilator potencies of papaverine and its ethyl analogue, ethaverine (diquinol, perparin). , 1950, The Journal of pharmacology and experimental therapeutics.

[1253]  C. Bates,et al.  Quantitation of vitamin E and a carotenoid pigment in cataractous human lenses, and the effect of a dietary supplement. , 1996, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[1254]  R. Gotti,et al.  Analysis of Amaryllidaceae alkaloids from Narcissus by GC-MS and capillary electrophoresis. , 2006, Journal of pharmaceutical and biomedical analysis.

[1255]  Esther Lipokatic-Takacs,et al.  Fibroblast Growth Factor (FGF)-2 and FGF Receptor 3 Are Required for the Development of the Substantia Nigra, and FGF-2 Plays a Crucial Role for the Rescue of Dopaminergic Neurons after 6-Hydroxydopamine Lesion , 2007, The Journal of Neuroscience.

[1256]  Na Li,et al.  Protective effects of ginsenoside Rg2 against glutamate-induced neurotoxicity in PC12 cells. , 2007, Journal of ethnopharmacology.

[1257]  Graeme Eisenhofer,et al.  3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells , 2000, Brain Research.

[1258]  Mark H. Ellisman,et al.  High-resolution large-scale mosaic imaging using multiphoton microscopy to characterize transgenic mouse models of human neurological disorders , 2007, Neuroinformatics.

[1259]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[1260]  Wilkinson Jm,et al.  New concepts in the treatment of Parkinson's disease. , 1990 .

[1261]  Nobuyuki Itoh,et al.  Preferential neurotrophic activity of fibroblast growth factor‐20 for dopaminergic neurons through fibroblast growth factor receptor‐1c , 2003, Journal of neuroscience research.

[1262]  Rosario Scopelliti,et al.  Bioactive diterpenes from the fruits of Detarium microcarpum. , 2006, Journal of natural products.

[1263]  N Bhattacharya,et al.  Fetal cell/tissue therapy in adult disease: a new horizon in regenerative medicine. , 2004, Clinical and experimental obstetrics & gynecology.

[1264]  Isidre Ferrer,et al.  Evidence of Oxidative Stress in the Neocortex in Incidental Lewy Body Disease , 2005, Journal of neuropathology and experimental neurology.

[1265]  C. Tanner.  Epidemiology of Parkinson’s Disease , 1992, Neurologic Clinics.

[1266]  Markku Heliövaara,et al.  Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis , 2007, Annals of the rheumatic diseases.

[1267]  E. Masliah,et al.  An antiaggregation gene therapy strategy for Lewy body disease utilizing β-synuclein lentivirus in a transgenic model , 2004, Gene Therapy.

[1268]  P. Livrea,et al.  Hyperhomocysteinemia in l‐dopa treated Parkinson's disease patients: effect of cobalamin and folate administration , 2005, European journal of neurology.

[1269]  E. Antman,et al.  Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. , 1983, Circulation.

[1270]  D. Balasubramanian,et al.  Oxidative damage to the eye lens caused by cigarette smoke and fuel smoke condensates. , 1994, Indian journal of biochemistry & biophysics.

[1271]  J. Trojanowski,et al.  Age-dependent synuclein pathology following traumatic brain injury in mice , 2003, Experimental Neurology.

[1272]  Neil R. Smalheiser,et al.  Information discovery from complementary literatures: categorizing viruses as potential weapons , 2001 .

[1273]  Sylvie Faucher,et al.  Involvement of Interferon-γ in Microglial-Mediated Loss of Dopaminergic Neurons , 2007, The Journal of Neuroscience.

[1274]  Xiaoping Pu,et al.  Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease. , 2007, European journal of pharmacology.

[1275]  R.K. Seth,et al.  Protective Function of Alpha-Tocopherol against the Process of Cataractogenesis in Humans , 1999, Annals of Nutrition and Metabolism.

[1276]  S. Yamagishi,et al.  Therapeutic potentials of unicellular green alga Chlorella in advanced glycation end product (AGE)-related disorders. , 2005, Medical hypotheses.

[1277]  J. Lucas,et al.  FTDP-17 Mutations in tau Transgenic Mice Provoke Lysosomal Abnormalities and Tau Filaments in Forebrain , 2001, Molecular and Cellular Neuroscience.

[1278]  F. ten Hoor.  Cardiovascular effects of dietary linoleic acid. , 1980 .

[1279]  Howard J. Federoff,et al.  Behavioral and Neurochemical Effects of Wild-Type and Mutated Human α-Synuclein in Transgenic Mice , 2002, Experimental Neurology.

[1280]  F. Billson,et al.  Intralenticular foreign bodies: case reports and surgical review. , 1995, Ophthalmic surgery.

[1281]  C G Coimbra,et al.  High doses of riboflavin and the elimination of dietary red meat promote the recovery of some motor functions in Parkinson's disease patients. , 2003, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[1282]  Michal K. Stachowiak,et al.  Immunodetection of Parkin protein in vertebrate and invertebrate brains: a comparative study using specific antibodies , 2001, Journal of Chemical Neuroanatomy.

[1283]  H. Chun,et al.  Manganese induces endoplasmic reticulum (ER) stress and activates multiple caspases in nigral dopaminergic neuronal cells, SN4741 , 2001, Neuroscience Letters.

[1284]  Z. Madar,et al.  Cataract development in diabetic sand rats treated with α‐lipoic acid and its γ‐linolenic acid conjugate , 2001 .

[1285]  Ronald N. Kostoff,et al.  Literature-Related Discovery (LRD): Introduction and background , 2008 .

[1286]  Angelo A. Izzo,et al.  The marijuana component cannabidiol inhibits β-amyloid-induced tau protein hyperphosphorylation through Wnt/β-catenin pathway rescue in PC12 cells , 2006, Journal of Molecular Medicine.

[1287]  K. Heidenreich,et al.  The pesticide rotenone induces caspase‐3‐mediated apoptosis in ventral mesencephalic dopaminergic neurons , 2003, Journal of neurochemistry.

[1288]  S. Ohta,et al.  Cytochrome P450 isozymes catalyzing 4‐hydroxylation of parkinsonism‐related compound 1,2,3,4‐tetrahydroisoquinoline in rat liver microsomes , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[1289]  G Giorgi,et al.  Protective effect of silymarin on oxidative stress in rat brain. , 2007, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[1290]  Chang-Ju Kim,et al.  Daidzein Activates Choline Acetyltransferase from MC-IXC Cells and Improves Drug-Induced Amnesia , 2006, Bioscience, biotechnology, and biochemistry.

[1291]  Fiorella Marcellini,et al.  Brain, aging and neurodegeneration: Role of zinc ion availability , 2005, Progress in Neurobiology.

[1292]  Erkan Yurtcu,et al.  Protective effect of ginkgo biloba against gossypol‐induced apoptosis in human lymphocytes , 2005, Cell biology international.

[1293]  Hiroshi Shibasaki,et al.  Proteasome Mediates Dopaminergic Neuronal Degeneration, and Its Inhibition Causes α-Synuclein Inclusions* , 2004, Journal of Biological Chemistry.

[1294]  Laurent Mosoni,et al.  Synergistic effects of caloric restriction with maintained protein intake on skeletal muscle performance in 21‐month‐old rats: a mitochondria‐mediated pathway , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[1295]  T. Oury,et al.  Manganese Superoxide Dismutase Protects against 6-Hydroxydopamine Injury in Mouse Brains* , 2005, Journal of Biological Chemistry.

[1296]  K. Takeshige,et al.  The Content of Intracellular Mitochondrial DNA Is Decreased by 1-Methyl-4-phenylpyridinium Ion (MPP+)* , 1997, The Journal of Biological Chemistry.

[1297]  A Hauge,et al.  Acute effects of acetazolamide on cerebral blood flow in man. , 1983, Acta physiologica Scandinavica.

[1298]  Joseph P. Huston,et al.  Evidence for resistance to MPTP in C57BL/6 × BALA/c F1 hybrids as compared with their progenitor strains , 2000, Neuroreport.

[1299]  Tung-Sheng Shih,et al.  Dopamine transporter binding study in differentiating carbon disulfide induced parkinsonism from idiopathic parkinsonism. , 2004, Neurotoxicology.

[1300]  S J Kish,et al.  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not destroy nigrostriatal neurons in the scorbutic guinea pig. , 1985, Life sciences.

[1301]  Richard Wade-Martins,et al.  RNA interference‐mediated knockdown of α‐synuclein protects human dopaminergic neuroblastoma cells from MPP+ toxicity and reduces dopamine transport , 2007, Journal of neuroscience research.

[1302]  K. Moore,et al.  Fibrillar Amyloid Protein Present in Atheroma Activates CD36 Signal Transduction* , 2004, Journal of Biological Chemistry.

[1303]  W Martin,et al.  The beriberi analogy to myocardial infarction. , 1983, Medical hypotheses.

[1304]  M R Kilbourn,et al.  Synthesis of (2-[11C]methoxy)rotenone, a marker of mitochondrial complex I activity. , 1995, Nuclear medicine and biology.

[1305]  K Gustafsson,et al.  Older women and dietary advice: occurrence, comprehension and compliance. , 2005, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[1306]  H. Emrich,et al.  Cannabis in Movement Disorders , 1999, Complementary Medicine Research.

[1307]  Pavlos Koukoulomatis,et al.  Ethmoidal Sinus Adenocarcinoma with Orbital Invasion , 2004, International Ophthalmology.

[1308]  Robert Edwards,et al.  Lipid Rafts Mediate the Synaptic Localization of α-Synuclein , 2004, The Journal of Neuroscience.

[1309]  J. Pincus,et al.  Plasma levels of amino acids correlate with motor fluctuations in parkinsonism. , 1987, Archives of neurology.

[1310]  F C Holder,et al.  [Vascular perfusion of an intestinal segment in the catfish (Ictalurus melas, R): demonstration of the vasoactive effects of mammalian VIP and of gastrointestinal extracts from teleost fish]. , 1983, Comptes rendus des seances de l'Academie des sciences. Serie III, Sciences de la vie.

[1311]  Guo-qiang Lu,et al.  Genistein protects dopaminergic neurons by inhibiting microglial activation , 2005, Neuroreport.

[1312]  H. Joshi,et al.  Cholinergic basis of memory-strengthening effect of Foeniculum vulgare Linn. , 2006, Journal of medicinal food.

[1313]  Won-Hee Choi,et al.  Protective effect of Polygonum multiflorum Thunb on amyloid beta-peptide 25-35 induced cognitive deficits in mice. , 2006, Journal of ethnopharmacology.

[1314]  Johannes Schwarz,et al.  D2 Dopamine Receptors Colocalize Regulator of G-Protein Signaling 9-2 (RGS9-2) via the RGS9 DEP Domain, and RGS9 Knock-Out Mice Develop Dyskinesias Associated with Dopamine Pathways , 2005, The Journal of Neuroscience.

[1315]  M. Beal,et al.  Neuroprotective effects of oral administration of triacetyluridine against MPTP neurotoxicity , 2007, NeuroMolecular Medicine.

[1316]  Hongjun Song,et al.  Accumulation of the Authentic Parkin Substrate Aminoacyl-tRNA Synthetase Cofactor, p38/JTV-1, Leads to Catecholaminergic Cell Death , 2005, The Journal of Neuroscience.

[1317]  J. Andersen,et al.  Role of oxidative stress in paraquat‐induced dopaminergic cell degeneration , 2005, Journal of neurochemistry.

[1318]  Sriram Subramaniam,et al.  Electron tomography of degenerating neurons in mice with abnormal regulation of iron metabolism. , 2005, Journal of structural biology.

[1319]  M. Chesselet,et al.  Variable effects of chronic subcutaneous administration of rotenone on striatal histology , 2004, The Journal of comparative neurology.

[1320]  Masaki Wakabayashi,et al.  Inhibitors of amyloid beta-protein aggregation mediated by GM1-containing raft-like membranes. , 2007, Biochimica et biophysica acta.

[1321]  A Kokossis,et al.  A semantically enabled formalism for the knowledge management of Parkinson's disease , 2006, Medical informatics and the Internet in medicine.

[1322]  So-Young Jeon,et al.  3,4-Dihydroxybenzoic acid from Smilacis chinae rhizome protects amyloid β protein (25–35)-induced neurotoxicity in cultured rat cortical neurons , 2007, Neuroscience Letters.

[1323]  B. Manyam,et al.  Neuroprotective effects of the antiparkinson drug Mucuna pruriens , 2004, Phytotherapy research : PTR.

[1324]  P Galan,et al.  IANA task force on nutrition and cognitive decline with aging. , 2007, The journal of nutrition, health & aging.

[1325]  David Benton,et al.  Selenium Intake, Mood and Other Aspects of Psychological Functioning , 2002, Nutritional neuroscience.

[1326]  A. Spielman,et al.  Role of mosquito saliva in blood vessel location. , 1984, The Journal of experimental biology.

[1327]  John Robbins,et al.  The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. , 2006, Contemporary clinical trials.

[1328]  B. Shukitt-Hale,et al.  Oxidative Stress and Inflammation in Brain Aging: Nutritional Considerations , 2005, Neurochemical Research.

[1329]  W. Woodward,et al.  The effect of dietary protein on the efficacy of L‐dopa , 1989, Neurology.

[1330]  X. Li,et al.  Paraquat induced activation of transcription factor AP-1 and apoptosis in PC12 cells , 1999, Journal of Neural Transmission.

[1331]  Naoaki Saito,et al.  Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation , 2005, FEBS letters.

[1332]  J. Sage,et al.  Tomatoes and Parkinson's disease. , 1989, Medical hypotheses.

[1333]  Philippa Marrack,et al.  Xenografts of MHC-Deficient Mouse Embryonic Mesencephalon Improve Behavioral Recovery in Hemiparkinsonian Rats , 2002, Cell transplantation.

[1334]  P. Calabresi,et al.  A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine–acetylcholine synaptic balance , 2006, The Lancet Neurology.

[1335]  W. Schalch,et al.  Vitamin C and human health--a review of recent data relevant to human requirements. , 1996, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[1336]  Jean Féger,et al.  Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe , 2003, Journal of neurochemistry.

[1337]  B. Manyam,et al.  Bacopa monniera extract reduces amyloid levels in PSAPP mice. , 2006, Journal of Alzheimer's disease : JAD.

[1338]  G. Korbutt,et al.  Genetically engineered Sertoli cells are able to survive allogeneic transplantation , 2004, Gene Therapy.

[1339]  M. Low,et al.  Dopamine D4 Receptor-Knock-Out Mice Exhibit Reduced Exploration of Novel Stimuli , 1999, The Journal of Neuroscience.

[1340]  Miguel A Hernán,et al.  Folate intake and risk of Parkinson's disease. , 2004, American journal of epidemiology.

[1341]  Jae-Eun Pie,et al.  Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate. , 2002, Neurotoxicology.

[1342]  Yukio Yoneda,et al.  Methoxyflavones protect cells against endoplasmic reticulum stress and neurotoxin. , 2007, American journal of physiology. Cell physiology.

[1343]  Yuki Nakajima,et al.  Amyloid-beta-induced cytotoxicity of PC-12 cell was attenuated by Shengmai-san through redox regulation and outgrowth induction. , 2007, Journal of pharmacological sciences.

[1344]  Keum Hee Hwang,et al.  Promoting effect and recovery activity from physical stress of the fruit of Morus alba , 2004, BioFactors.

[1345]  M. Smidt,et al.  Strategies to unravel molecular codes essential for the development of meso‐diencephalic dopaminergic neurons , 2006, The Journal of physiology.

[1346]  D. Stambolian,et al.  Cataracts in patients heterozygous for galactokinase deficiency. , 1986, Investigative ophthalmology & visual science.

[1347]  R. Ravid,et al.  Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice* , 2005, Journal of Biological Chemistry.

[1348]  S. Mandel,et al.  Multifunctional Activities of Green Tea Catechins in Neuroprotection , 2005, Neurosignals.

[1349]  R Busse,et al.  [Regulation of vascular tone by the endothelium]. , 1985, Zeitschrift fur Kardiologie.

[1350]  Pin-Der Duh,et al.  Comparison of protective effects between cultured Cordyceps militaris and natural Cordyceps sinensis against oxidative damage. , 2006, Journal of agricultural and food chemistry.

[1351]  H. Zoghbi,et al.  Identification of genes that modify ataxin-1-induced neurodegeneration , 2000, Nature.

[1352]  Rolf Andersson,et al.  Antifouling activity of brominated cyclopeptides from the marine sponge Geodia barretti. , 2004, Journal of natural products.

[1353]  Y Hokama,et al.  In vitro inhibition of platelet aggregation with low dalton compounds from aqueous dialysates of edible fungi. , 1981, Research communications in chemical pathology and pharmacology.

[1354]  R J Williams,et al.  The nutritional teamwork approach: prevention and regression of cataracts in rats. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[1355]  Masato Hasegawa,et al.  Biochemistry and molecular biology of tauopathies , 2006, Neuropathology : official journal of the Japanese Society of Neuropathology.

[1356]  Peter Bruza,et al.  A Bare Bones Approach to Literature-Based Discovery: An Analysis of the Raynaud's/Fish-Oil and Migraine-Magnesium Discoveries in Semantic Space , 2005, Discovery Science.

[1357]  Q. Bone,et al.  On the filter-feeding of Doliolum (Tunicata: Thaliacea) , 1997 .

[1358]  Todd B. Sherer,et al.  Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein Aggregation , 2003, Experimental Neurology.

[1359]  Jeffrey A. Johnson,et al.  Nrf2-mediated protection against 6-hydroxydopamine , 2007, Brain Research.

[1360]  Yang Sun,et al.  Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells. , 2007, European journal of pharmacology.

[1361]  Byung-Soo Koo,et al.  Salviae miltiorrhizae Radix Inhibits Superoxide Generation by Activated Rat Microglias and Mimics the Action of Amphetamine on in vitro Rat Striatal Dopamine Release , 2004, Neurochemical Research.

[1362]  Tsutomu Uruno,et al.  Banana juice reduces bioavailability of levodopa preparation. , 2005, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[1363]  D. Grandy,et al.  Interactions between Metabotropic Glutamate 5 and Adenosine A2A Receptors in Normal and Parkinsonian Mice , 2005, The Journal of Neuroscience.

[1364]  Bin Liu,et al.  Critical Role for Microglial NADPH Oxidase in Rotenone-Induced Degeneration of Dopaminergic Neurons , 2003, The Journal of Neuroscience.

[1365]  Todd B. Sherer,et al.  Selective microglial activation in the rat rotenone model of Parkinson's disease , 2003, Neuroscience Letters.

[1366]  Wei Duan,et al.  Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier. , 2007, Current drug metabolism.

[1367]  Guangjun Nie,et al.  Distinct effects of tea catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells. , 2002, Archives of biochemistry and biophysics.

[1368]  W. Weiner,et al.  From fruit fly to bedside: translating lessons from Drosophila models of neurodegenerative disease , 2003, Current opinion in neurology.

[1369]  T. Dawson,et al.  Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons , 2001, The European journal of neuroscience.

[1370]  M. Aregullin,et al.  Recent studies on the zoopharmacognosy, pharmacology and neurotoxicology of sesquiterpene lactones. , 1995, Planta medica.

[1371]  Clemens R Scherzer,et al.  Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease. , 2003, Human molecular genetics.

[1372]  K. Igarashi,et al.  Studies on the pyrrolinone metabolites derived from the tobacco alkaloid 1-methyl-2-(3-pyridinyl)pyrrole (beta-nicotyrine). , 1999, Chemical research in toxicology.

[1373]  John Shi,et al.  Bioavailability and synergistic effects of tea catechins as antioxidants in the human diet , 2006 .

[1374]  K Suzuki,et al.  Effect of antianginal agents on arteriolar diameter in normal and cholesterol-fed rabbits. , 1984, International journal of microcirculation, clinical and experimental.

[1375]  Ronald N. Kostoff,et al.  Validating discovery in literature-based discovery , 2007, J. Biomed. Informatics.

[1376]  Chen Bo,et al.  Clinical observation and mechanism study on treatment of senile dementia with Naohuandan , 2005 .

[1377]  Matthew P Frosch,et al.  The Formation of Highly Soluble Oligomers of α-Synuclein Is Regulated by Fatty Acids and Enhanced in Parkinson's Disease , 2003, Neuron.

[1378]  D. Sibley,et al.  New insights into dopaminergic receptor function using antisense and genetically altered animals. , 1999, Annual review of pharmacology and toxicology.

[1379]  J Onodera,et al.  Synthesis of 8-C-glucosylflavones. , 2001, Carbohydrate research.

[1380]  Gurpreet Kaur,et al.  Eruca sativa seeds possess antioxidant activity and exert a protective effect on mercuric chloride induced renal toxicity. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[1381]  Hideo Fujiwara,et al.  Hyperphosphorylation and insolubility of α‐synuclein in transgenic mouse oligodendrocytes , 2002 .

[1382]  M. Pallàs,et al.  Inhibition of CDKs: A Strategy for Preventing Kainic Acid‐Induced Apoptosis in Neurons , 2003, Annals of the New York Academy of Sciences.

[1383]  P. Gonzalez-Cabrera,et al.  Mice expressing the α1B‐adrenergic receptor induces a synucleinopathy with excessive tyrosine nitration but decreased phosphorylation , 2002, Journal of neurochemistry.

[1384]  Debomoy K Lahiri,et al.  Neuroprotection from Complement‐Mediated Inflammatory Damage , 2004, Annals of the New York Academy of Sciences.

[1385]  E T Poehlman,et al.  Assessment of energy requirements in elderly populations , 2000, European journal of clinical nutrition.

[1386]  J. Ríos,et al.  Tiliroside and gnaphaliin inhibit human low density lipoprotein oxidation. , 2007, Fitoterapia.

[1387]  S. Mandel,et al.  Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (‐)‐epigallocatechin‐3‐gallate: implications for neurodegenerative diseases , 2004, Journal of neurochemistry.

[1388]  C. Bates,et al.  Effect of vitamin C on sorbitol in the lens of guinea-pigs made diabetic with streptozotocin , 1992, British Journal of Nutrition.

[1389]  Jon Kleinberg,et al.  Authoritative sources in a hyperlinked environment , 1999, SODA '98.

[1390]  M. Breteler,et al.  Epidemiology of Parkinson's disease , 2006, The Lancet Neurology.

[1391]  D Spiegelman,et al.  A prospective study of carotenoid intake and risk of cataract extraction in US men. , 1999, The American journal of clinical nutrition.

[1392]  N. Persson,et al.  A novel semi‐synthetic sulphated polysaccharide with potent antithrombin activity , 1982, British journal of haematology.

[1393]  E. Giani,et al.  Heated fat, vitamin E and vascular eicosanoids , 1985, Lipids.

[1394]  I. Nathan,et al.  Studies of the effect of auranofin, a new antiarthritic agent, on platelet aggregation , 1982, Inflammation.

[1395]  Lisa M Eubanks,et al.  A molecular link between the active component of marijuana and Alzheimer's disease pathology. , 2006, Molecular pharmaceutics.

[1396]  Trisha Gura.  Trigger Found for Synapse Formation , 2000, Science.

[1397]  G Salen,et al.  Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS) , 1997, American journal of medical genetics.

[1398]  S. Barr,et al.  Effect of daytime protein restriction on nutrient intakes of free-living Parkinson's disease patients. , 1992, The American journal of clinical nutrition.

[1399]  S. West,et al.  Epidemiology of risk factors for age-related cataract. , 1995, Survey of ophthalmology.

[1400]  Makoto M Taketo,et al.  Loss of anti-cataleptic effect of scopolamine in mice lacking muscarinic acetylcholine receptor subtype 4. , 2003, European journal of pharmacology.

[1401]  H Mibu,et al.  A study on lipid peroxide-induced lens damage in vitro. , 1994, Experimental eye research.

[1402]  Michio Hashimoto,et al.  Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid beta-infused rats relates to the decreases of amyloid beta and cholesterol levels in detergent-insoluble membrane fractions. , 2005, Biochimica et biophysica acta.

[1403]  Akira Nakashima,et al.  PHARMACOLOGY AND , 2006 .

[1404]  G. Romano,et al.  Characterization of five evolutionary conserved regions of the human tyrosine hydroxylase (TH) promoter: Implications for the engineering of a human TH minimal promoter assembled in a self‐inactivating lentiviral vector system , 2005, Journal of cellular physiology.

[1405]  Paolo Bigini,et al.  Tumor necrosis factor‐α receptor 1 (p55) knockout only transiently decreases the activation of c‐Jun and does not affect the survival of axotomized dopaminergic nigral neurons , 2005, The European journal of neuroscience.

[1406]  Claudia M Testa,et al.  Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures. , 2005, Brain research. Molecular brain research.

[1407]  R. Palmiter,et al.  Dopamine Depletion Does Not Protect against Acute 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Toxicity In Vivo , 2005, The Journal of Neuroscience.

[1408]  Kiran Madura,et al.  Proteasome dysfunction in aged human α-synuclein transgenic mice , 2006, Neurobiology of Disease.

[1409]  Dong-Kug Choi,et al.  Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease , 2002, The Journal of Neuroscience.

[1410]  A John,et al.  Differential modulation of growth and glutathione metabolism in cultured rat astrocytes by 4-hydroxynonenal and green tea polyphenol, epigallocatechin-3-gallate. , 2002, Neurotoxicology.

[1411]  C. Shaw,et al.  Novel environmental toxins: Steryl glycosides as a potential etiological factor for age‐related neurodegenerative diseases , 2007, Journal of neuroscience research.

[1412]  Simon Melov,et al.  Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice , 2003, Journal of neurochemistry.

[1413]  Tai Hing Lam,et al.  Diet synergies and mortality--a population-based case-control study of 32,462 Hong Kong Chinese older adults. , 2006, International journal of epidemiology.

[1414]  Ronald N. Kostoff,et al.  Literature-related discovery (LRD): Water purification , 2008 .

[1415]  Masahiro Yamaguchi,et al.  Generation of Dopaminergic Neurons in the Adult Brain from Mesencephalic Precursor Cells Labeled with a nestin-GFP Transgene , 2001, The Journal of Neuroscience.

[1416]  J. Andersen,et al.  Use of genetically engineered mice as models for exploring the role of oxidative stress in neurodegenerative diseases. , 1998, Frontiers in bioscience : a journal and virtual library.

[1417]  Jay D. Coffman,et al.  Pathogenesis and treatment of Raynaud's phenomenon , 2004, Cardiovascular Drugs and Therapy.

[1418]  Y Srivastava,et al.  Effect of Momordica charantia Linn. pomous aqueous extract on cataractogenesis in murrin alloxan diabetics. , 1988, Pharmacological research communications.

[1419]  Wolfgang Wurst,et al.  A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo , 2006, Development.

[1420]  E Méndez-Alvarez,et al.  Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke. , 1997, Life Science.

[1421]  I. Ferrer,et al.  Stress kinases involved inTau phosphorylation in alzheimer’s disease, tauopathies and APP transgenic mice , 2009, Neurotoxicity Research.

[1422]  D. Truong,et al.  Activation of adenosine triphosphate‐sensitive potassium channels confers protection against rotenone‐induced cell death: Therapeutic implications for Parkinson's disease , 2002, Journal of neuroscience research.

[1423]  Amy Chan,et al.  Dietary and genetically-induced oxidative stress alter tau phosphorylation: influence of folate and apolipoprotein E deficiency. , 2006, Journal of Alzheimer's disease : JAD.

[1424]  Vellareddy Anantharam,et al.  Protein Kinase Cδ Negatively Regulates Tyrosine Hydroxylase Activity and Dopamine Synthesis by Enhancing Protein Phosphatase-2A Activity in Dopaminergic Neurons , 2007, The Journal of Neuroscience.

[1425]  H. Tanila,et al.  Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice , 2006, Neurobiology of Disease.

[1426]  Susan E Hankinson,et al.  The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. Overview. , 2002, The Journal of nutrition.

[1427]  Makoto Hashimoto,et al.  Development of new treatments for Parkinson's disease in transgenic animal models: a role for beta-synuclein. , 2002, Neurotoxicology.

[1428]  G. Rumsey,et al.  Differentiation of soluble proteins in cataracts caused by deficiencies of methionine, riboflavin or zinc in diets fed to Atlantic salmon, Salmo salar, rainbow trout, Salmo gairdneri, and lake trout, Salvelinus namaycush. , 1982, The Cornell veterinarian.

[1429]  A. Schapira,et al.  Pramipexole protects against apoptotic cell death by non‐dopaminergic mechanisms , 2004, Journal of neurochemistry.

[1430]  A Quevauviller,et al.  [Activity of the principal alkaloids of Polyalthia oliveri Engler (Annonaceac) on the central nervous system and the cardiovascular system]. , 1977, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles.

[1431]  Yoshikuni Mizuno,et al.  Genetic vitamin E deficiency does not affect MPTP susceptibility in the mouse brain , 2006, Journal of neurochemistry.

[1432]  N. Tomita,et al.  Isohumulones Derived from Hops Ameliorate Renal Injury via an Anti-Oxidative Effect in Dahl Salt-Sensitive Rats , 2007, Hypertension Research.

[1433]  Markus Glatzel,et al.  Accumulation of mutant neuroserpin precedes development of clinical symptoms in familial encephalopathy with neuroserpin inclusion bodies. , 2007, The American journal of pathology.

[1434]  Magdolna Pákáski,et al.  Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis , 2006, Neurochemistry International.

[1435]  John Q Trojanowski,et al.  Enhanced neurofibrillary tangle formation, cerebral atrophy, and cognitive deficits induced by repetitive mild brain injury in a transgenic tauopathy mouse model. , 2005, Journal of neurotrauma.

[1436]  K. Black,et al.  The protective effects of dietary fish oil on focal cerebral infarction. , 1979, Prostaglandins and medicine.

[1437]  O. Andreassen,et al.  Mice Deficient in Cellular Glutathione Peroxidase Show Increased Vulnerability to Malonate, 3-Nitropropionic Acid, and 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine , 2000, The Journal of Neuroscience.

[1438]  J. Merrill,et al.  DHEA supplementation: the claims in perspective. , 2005, Cleveland Clinic journal of medicine.

[1439]  F E Preston,et al.  The effects of dietary omega-3 polyunsaturated fatty acids on erythrocyte membrane phospholipids, erythrocyte deformability and blood viscosity in healthy volunteers. , 1985, Atherosclerosis.

[1440]  A Kamei,et al.  The evaluation of therapeutic efficacy of hachimi-jio-gan (traditional Chinese medicine) to mouse hereditary cataract. , 1988, Journal of ocular pharmacology.

[1441]  Georg Auburger,et al.  Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background , 2005, Neurobiology of Aging.

[1442]  Tim-Rasmus Kiehl,et al.  Generation and characterization of Sca2 (ataxin-2) knockout mice. , 2006, Biochemical and biophysical research communications.

[1443]  Rita Banzi,et al.  Fish oil and mental health: the role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders , 2006, International clinical psychopharmacology.

[1444]  Linda Capjack,et al.  Clothing as protection from ultraviolet radiation: which fabric is most effective? , 1997, International journal of dermatology.

[1445]  S. Leurgans,et al.  Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally , 2004, Experimental Neurology.

[1446]  Benjamin M Craig,et al.  Bmc Complementary and Alternative Medicine Is Complementary and Alternative Medicine (cam) Cost-effective? a Systematic Review , 2004 .

[1447]  M. Kivipelto,et al.  Cholesterol as a risk factor for Alzheimer's disease – epidemiological evidence , 2006, Acta neurologica Scandinavica. Supplementum.

[1448]  Sadakazu Aiso,et al.  Involvement of tyrosine kinases and STAT3 in Humanin-mediated neuroprotection. , 2005, Life sciences.

[1449]  Charles J. Wilson,et al.  RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion , 2006, Nature Neuroscience.

[1450]  D. Wallace,et al.  Maternal germ-line transmission of mutant mtDNAs from embryonic stem cell-derived chimeric mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[1451]  Su Guo,et al.  Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease. , 2004, Neurotoxicology and teratology.

[1452]  Yun-Lian Lin,et al.  Neuroprotective Flavonoids from Flemingia macrophylla , 2005, Planta medica.

[1453]  S K Gupta,et al.  Topical aspirin provides protection against galactosemic cataract. , 1997, Indian journal of ophthalmology.

[1454]  Gary W Miller,et al.  Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[1455]  David Oakes,et al.  The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and α‐tocopherol , 1997 .

[1456]  P Jeffrey Conn,et al.  Group III Metabotropic Glutamate Receptor-Mediated Modulation of the Striatopallidal Synapse , 2003, The Journal of Neuroscience.

[1457]  Colin L Masters,et al.  Linker histone H1 binds to disease associated amyloid-like fibrils. , 2006, Journal of molecular biology.

[1458]  Charles N. Serhan,et al.  Altered Fatty Acid Composition of Dopaminergic Neurons Expressing α-Synuclein and Human Brains with α-Synucleinopathies* , 2003, Journal of Biological Chemistry.

[1459]  O. Halbach,et al.  Modeling Neurodegenerative Diseases in vivo Review , 2005 .

[1460]  Nicolas Simon,et al.  The effects of a normal protein diet on levodopa plasma kinetics in advanced Parkinson's disease. , 2004, Parkinsonism & related disorders.

[1461]  E R Nadel,et al.  Effect of hydration state of circulatory and thermal regulations. , 1980, Journal of applied physiology: respiratory, environmental and exercise physiology.

[1462]  G. Giraud,et al.  Use of a specific mesenteric vasodilator peptide, urotensin I, to reduce afterload in the dog. , 1980, Canadian journal of physiology and pharmacology.

[1463]  Y. Choi,et al.  Water extract of Aralia elata prevents cataractogenesis in vitro and in vivo. , 2005, Journal of ethnopharmacology.

[1464]  Neil Hazon,et al.  Regulation of expression of two aquaporin homologs in the intestine of the European eel: effects of seawater acclimation and cortisol treatment. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[1465]  Akihiko Takashima,et al.  Altered depression-related behavior and neurochemical changes in serotonergic neurons in mutant R406W human tau transgenic mice , 2005, Brain Research.

[1466]  Lin Xie,et al.  Nigrostriatal Dopaminergic Neurodegeneration in the Weaver Mouse Is Mediated via Neuroinflammation and Alleviated by Minocycline Administration , 2006, The Journal of Neuroscience.

[1467]  C. Gerfen,et al.  Altered striatal function in a mutant mouse lacking D1A dopamine receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[1468]  John Q. Trojanowski,et al.  Ubiquitination of α-Synuclein Is Not Required for Formation of Pathological Inclusions in α-Synucleinopathies , 2003 .

[1469]  N. Biswas,et al.  Evaluation of Ophthacare® eye drops—a herbal formulation in the management of various ophthalmic disorders , 2001, Phytotherapy research : PTR.

[1470]  M. Beal,et al.  Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases , 1999, BioFactors.

[1471]  J B Schulz,et al.  Sensitivity to MPTP is not increased in Parkinson's disease‐associated mutant α‐synuclein transgenic mice , 2001, Journal of neurochemistry.

[1472]  Hyunsu Bae,et al.  Effects of yukmijihwang-tang derivatives (YMJd) on ibotenic acid- induced amnesia in the rat , 2006 .

[1473]  J. Baron,et al.  Cigarette smoking and Parkinson's disease , 1986, Neurology.

[1474]  Jonathan Salcedo,et al.  Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-Synuclein , 2004, The Journal of Neuroscience.

[1475]  Shirley Hansen,et al.  2-Phenylpyridine and 3-phenylpyridine, constituents of tea, are unlikely to cause idiopathic Parkinson's disease , 1988, Journal of the Neurological Sciences.

[1476]  George R Uhl,et al.  Dopamine transporter: Basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism , 2003, Movement disorders : official journal of the Movement Disorder Society.

[1477]  Tianhong Pan,et al.  Effects of green tea polyphenols on dopamine uptake and on MPP+ -induced dopamine neuron injury. , 2003, Life sciences.

[1478]  H. Ellgring,et al.  Predictors of freezing in Parkinson's disease: A survey of 6,620 patients , 2007, Movement disorders : official journal of the Movement Disorder Society.

[1479]  P. Karstaedt,et al.  Protein redistribution diet remains effective in patients with fluctuating parkinsonism. , 1992, Archives of neurology.

[1480]  K. Mohanakumar,et al.  Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease , 2005, Brain Research.

[1481]  A. Elberger,et al.  Corpus callosum and visual cortex of mice with deletion of the NMDA-NR1 receptor. II. Attenuation of prenatal alcohol exposure effects. , 2003, Brain research. Developmental brain research.

[1482]  C. Coudray,et al.  Effects of inulin-type fructans of different chain length and type of branching on intestinal absorption and balance of calcium and magnesium in rats , 2003, European journal of nutrition.

[1483]  A Giacosa,et al.  High-risk subjects for vitamin deficiency , 1997, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[1484]  L T Chylack,et al.  Elemental and structural studies of the rat galactose cataract. , 1989, Lens and eye toxicity research.

[1485]  R. Levine,et al.  Extrapyramidal and other neurologic manifestations associated with carbon disulfide fumigant exposure. , 1988, Archives of neurology.

[1486]  Rajnish Kumar Chaturvedi,et al.  Ginkgo biloba affords dose‐dependent protection against 6‐hydroxydopamine‐induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences , 2005, Journal of neurochemistry.

[1487]  B. Manyam,et al.  Effect of antiparkinson drug HP‐200 (Mucuna pruriens) on the central monoaminergic neurotransmitters , 2004, Phytotherapy research : PTR.

[1488]  B. Ames,et al.  Oxidants, antioxidants, and the degenerative diseases of aging. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[1489]  Chen Xu,et al.  Antioxidant properties and PC12 cell protective effects of APS-1, a polysaccharide from Aloe vera var. chinensis. , 2006, Life sciences.

[1490]  E. Perry,et al.  Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson’s disease and Alzheimer’s disease and in relation to neuroleptic medication , 2000, Neuroscience.

[1491]  Michel Goedert,et al.  Tau protein and neurodegeneration. , 2004, Seminars in cell & developmental biology.

[1492]  Todd B. Sherer,et al.  Mechanism of Toxicity in Rotenone Models of Parkinson's Disease , 2003, The Journal of Neuroscience.

[1493]  Joseph A. Helpern,et al.  In Vivo NMR Studies of Neurodegenerative Diseases in Transgenic and Rodent Models , 2003, Neurochemical Research.

[1494]  R. Khorasani,et al.  Protection by Ziziphora clinopoides of acetic acid-induced toxic bowel inflammation through reduction of cellular lipid peroxidation and myeloperoxidase activity , 2006, Human & experimental toxicology.

[1495]  D. Dexter,et al.  Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease , 2001, Neuroreport.

[1496]  S Suzuki,et al.  Vasodilating effect of crude platycodin in anesthetized dogs. , 1973, Japanese journal of pharmacology.

[1497]  Y Furuta,et al.  [Effects of fusaric acid and its derivative on the cardiovascular system]. , 1976, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[1498]  G. Chiou,et al.  Effects of some natural products on sugar cataract studied with nuclear magnetic resonance spectroscopy. , 1992, Journal of ocular pharmacology.

[1499]  D. Higgins,et al.  Quantitative Autoradiography of Dihydrorotenone Binding to Complex I of the Electron Transport Chain , 1992, Journal of neurochemistry.

[1500]  S. Mandel,et al.  Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases. , 2004, The Journal of nutritional biochemistry.

[1501]  Young Ae Kim,et al.  Activity of wen-pi-tang, and purified constituents of rhei rhizoma and glycyrrhizae radix against glucose-mediated protein damage. , 2005, The American journal of Chinese medicine.

[1502]  A Beyer-Mears,et al.  Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor. , 1985, Pharmacology.

[1503]  D. Sulzer,et al.  α-Synuclein Overexpression Increases Cytosolic Catecholamine Concentration , 2006, The Journal of Neuroscience.

[1504]  Hideaki Soya,et al.  Effect of Acanthopanax senticosus Harms on biogenic monoamine levels in the rat brain , 2002, Phytotherapy research : PTR.

[1505]  J. Rocha,et al.  Commonly used tropical medicinal plants exhibit distinct in vitro antioxidant activities against hepatotoxins in rat liver. , 2007, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[1506]  J. Freudenheim,et al.  Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease , 1997, Movement disorders : official journal of the Movement Disorder Society.

[1507]  John D Lambris,et al.  Dysregulation of stathmin, a microtubule-destabilizing protein, and up-regulation of Hsp25, Hsp27, and the antioxidant peroxiredoxin 6 in a mouse model of familial amyotrophic lateral sclerosis. , 2004, The American journal of pathology.

[1508]  M. Billiard,et al.  Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis , 1993, Acta neurologica Scandinavica.

[1509]  D F Horrobin,et al.  A new concept of lifestyle-related cardiovascular disease: the importance of interactions between cholesterol, essential fatty acids, prostaglandin E1 and thromboxane A2. , 1980, Medical hypotheses.

[1510]  J. Juncos,et al.  Management of psychotic aspects of Parkinson's disease. , 1999, The Journal of clinical psychiatry.

[1511]  Charles Ramassamy,et al.  Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. , 2006, European journal of pharmacology.

[1512]  Marisa Hobbs,et al.  The 2001 assessment of nutritional influences on risk of cataract. , 2001, Nestle Nutrition workshop series. Clinical & performance programme.

[1513]  Jeffrey H Kordower,et al.  Proteasome inhibition and Parkinson's disease modeling , 2006, Annals of neurology.

[1514]  M. Vila,et al.  L‐3‐hydroxyacyl‐CoA dehydrogenase II protects in a model of Parkinson's disease , 2004, Annals of neurology.

[1515]  David L. Felten,et al.  Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged-Fischer-344 rats , 1992, Neurobiology of Aging.

[1516]  Ying-Bo Shui,et al.  Vitrectomy surgery increases oxygen exposure to the lens: a possible mechanism for nuclear cataract formation. , 2005, American journal of ophthalmology.

[1517]  L. Tretter,et al.  Quantitative relationship between inhibition of respiratory complexes and formation of reactive oxygen species in isolated nerve terminals , 2002, Journal of neurochemistry.

[1518]  Qi Dai,et al.  Fruit and vegetable juices and Alzheimer's disease: the Kame Project. , 2006, The American journal of medicine.

[1519]  Peter Engels,et al.  Influence of Different Promoters on the Expression Pattern of Mutated Human α-Synuclein in Transgenic Mice , 2005, Neurodegenerative Diseases.

[1520]  Bernd Stratmann,et al.  Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. , 2007, The American journal of clinical nutrition.

[1521]  R. Tomanin,et al.  Why do we need new gene therapy viral vectors? Characteristics, limitations and future perspectives of viral vector transduction. , 2004, Current gene therapy.

[1522]  O. Isacson,et al.  Enhanced axonal growth from fetal human bcl-2 transgenic mouse dopamine neurons transplanted to the adult rat striatum , 2001, Neuroscience.

[1523]  C. Tanner,et al.  Association of coffee and caffeine intake with the risk of Parkinson disease. , 2000, JAMA.

[1524]  Per G. Söderberg,et al.  Vitamin E Can Protect against Ultraviolet Radiation-Induced Cataract in Albino Rats , 2004, Ophthalmic Research.

[1525]  Keyang Wang,et al.  Dietary caloric restriction may delay the development of cataract by attenuating the oxidative stress in the lenses of Brown Norway rats. , 2004, Experimental eye research.

[1526]  Seung U. Kim,et al.  Overexpression of midbrain-specific transcription factor Nurr1 modifies susceptibility of mouse neural stem cells to neurotoxins , 2002, Neuroscience Letters.

[1527]  J. Trevithick,et al.  Modelling cortical cataractogenesis. XI. Vitamin C reduces gamma-crystallin leakage from lenses in diabetic rats. , 1990, Experimental eye research.

[1528]  Lawrence K Duffy,et al.  Total antioxidant power in sled dogs supplemented with blueberries and the comparison of blood parameters associated with exercise. , 2006, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[1529]  N. Inestrosa,et al.  Hyperforin prevents β-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-β-deposits , 2006, Molecular Psychiatry.

[1530]  M. Mattson,et al.  Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults , 1999, Annals of neurology.

[1531]  Jesús Avila,et al.  Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model. , 2003, Journal of Alzheimer's disease : JAD.

[1532]  S Moncada,et al.  The role of prostacyclin in vascular tissue. , 1979, Federation proceedings.

[1533]  M. Mattson,et al.  Dietary restriction and 2‐deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease , 1999, Journal of neuroscience research.

[1534]  F. Cicchetti,et al.  Immune parameters relevant to neural xenograft survival in the primate brain , 2003, Xenotransplantation.

[1535]  C. Rountree,et al.  Blockade of carcinoid flush with cimetidine and clonidine. , 1982, Archives of dermatology.

[1536]  J. Watkins,et al.  Effects of low-carbohydrate diet and Pycnogenol treatment on retinal antioxidant enzymes in normal and diabetic rats. , 2006, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[1537]  B. Aggarwal,et al.  Curcumin: the Indian solid gold. , 2007, Advances in experimental medicine and biology.

[1538]  Ali Samii,et al.  Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis , 2005, The Lancet Neurology.

[1539]  David W. Miller,et al.  Motor dysfunction and gliosis with preserved dopaminergic markers in human α-synuclein A30P transgenic mice , 2003, Neurobiology of Aging.

[1540]  G E Dallal,et al.  Moderate caloric restriction delays cataract formation in the Emory mouse , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[1541]  Yona Levites,et al.  Involvement of Protein Kinase C Activation and Cell Survival/ Cell Cycle Genes in Green Tea Polyphenol (−)-Epigallocatechin 3-Gallate Neuroprotective Action* , 2002, The Journal of Biological Chemistry.

[1542]  G. D. Imes,et al.  Disseminated protothecosis in a dog , 1977 .

[1543]  Subramanian Rajagopalan,et al.  Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration , 2007, Brain Research.

[1544]  N. Bonini,et al.  Drosophila models of human neurodegenerative disease , 2000, Cell Death and Differentiation.

[1545]  M H Saier,et al.  Structure and evolution of a multidomain multiphosphoryl transfer protein. Nucleotide sequence of the fruB(HI) gene in Rhodobacter capsulatus and comparisons with homologous genes from other organisms. , 1990, Journal of molecular biology.

[1546]  Makoto Hashimoto,et al.  β-Synuclein Inhibits α-Synuclein Aggregation A Possible Role as an Anti-Parkinsonian Factor , 2001, Neuron.

[1547]  B Balachandran,et al.  Role of Oxidative Stress and Antioxidants in Neurodegenerative Diseases , 2002, Nutritional neuroscience.

[1548]  Herbert C. Friedmann.  Flavine Adenine Dinucleotide , 1965 .

[1549]  R. Garruto,et al.  Histochemical and X-ray microanalytical localization of aluminum in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam , 2004, Acta Neuropathologica.

[1550]  David Murphy,et al.  Autophagy is a prosurvival mechanism in cells expressing an autosomal dominant familial neurohypophyseal diabetes insipidus mutant vasopressin transgene , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[1551]  N. Ende,et al.  Parkinson's disease mice and human umbilical cord blood. , 2002, Journal of medicine.

[1552]  Robert A Hauser,et al.  Use of nutritional supplements in Parkinson's disease patients , 2006, Movement disorders : official journal of the Movement Disorder Society.

[1553]  Miho Murata,et al.  Pharmacokinetics of L-dopa , 2006 .

[1554]  Y. Ho,et al.  Age‐dependent modulation of hippocampal long‐term potentiation by antioxidant enzymes , 2006, Journal of neuroscience research.

[1555]  Angelo A. Izzo,et al.  The Spice Sage and Its Active Ingredient Rosmarinic Acid Protect PC12 Cells from Amyloid-β Peptide-Induced Neurotoxicity , 2006, Journal of Pharmacology and Experimental Therapeutics.

[1556]  Annie Nicole,et al.  Overproduction of Cu/Zn-Superoxide Dismutase or Bcl-2 Prevents the Brain Mitochondrial Respiratory Dysfunction Induced by Glutathione Depletion , 1999, Experimental Neurology.

[1557]  Z. Pei,et al.  Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neurons , 2005, Journal of Neural Transmission.

[1558]  P. Holt,et al.  Intestinal Malabsorption in the Elderly , 2007, Digestive Diseases.

[1559]  M. Ebadi,et al.  Metallothioneins 1 and 2 Attenuate Peroxynitrite-Induced Oxidative Stress in Parkinson Disease , 2006, Experimental biology and medicine.

[1560]  N. Thakor,et al.  Parkin Facilitates the Elimination of Expanded Polyglutamine Proteins and Leads to Preservation of Proteasome Function* , 2003, Journal of Biological Chemistry.

[1561]  M. C. Leske,et al.  Lens opacities, demographic factors and nutritional supplements in the Barbados Eye Study. , 1997, International journal of epidemiology.

[1562]  A. Tomkins,et al.  Diet, body size and micronutrient status in Parkinson's disease. , 1992, European journal of clinical nutrition.

[1563]  E M Milioli,et al.  Effect of acute administration of hydroalcohol extract of Ilex paraguariensis St Hilaire (Aquifoliaceae) in animal models of Parkinson's disease , 2007, Phytotherapy research : PTR.

[1564]  S. Kulkarni,et al.  Quercetin, a bioflavonoid, reverses haloperidol-induced catalepsy. , 2004, Methods and findings in experimental and clinical pharmacology.

[1565]  Pamela Maher,et al.  Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6‐methyl‐phenyl‐tetrahydropyridine toxicity , 2005, Journal of neurochemistry.

[1566]  Yoko Hirata,et al.  Differential effect of nerve growth factor on dopaminergic neurotoxin‐induced apoptosis , 2006, Journal of neurochemistry.

[1567]  Sylvie Gélinas,et al.  Effects of estradiol, phytoestrogens, and ginkgo biloba extracts against 1-methyl-4-phenyl-pyridine-induced oxidative stress , 2003, Endocrine.

[1568]  Fusheng Yang,et al.  Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic anti-oxidant interventions , 2005, Neurobiology of Aging.

[1569]  S Brandner,et al.  Neuroectodermal grafting: a new tool for the study of neurodegenerative diseases. , 1996, Histology and histopathology.

[1570]  G Brooser,et al.  Vasodilating effect of ethyl apovincaminate on conjunctival vessels and simultaneous observation of parameters indicating adverse effect. , 1976, Arzneimittel-Forschung.

[1571]  S. Mandel,et al.  Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. , 2004, Free radical biology & medicine.

[1572]  J. Wess,et al.  M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related central nervous system pathologies , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[1573]  J F Williams,et al.  The effect of an unsaturated-fat diet on cataract formation in streptozotocin-induced diabetic rats , 1976, British Journal of Nutrition.

[1574]  Ronald N. Kostoff,et al.  Assessment of China's and India's science and technology literature — introduction, background, and approach , 2007 .

[1575]  B. E. Staveley,et al.  Mutant α-synuclein-induced degeneration is reduced by parkin in a fly model of Parkinson's disease , 2006 .

[1576]  S. Shankar,et al.  Low-calcium, high-aluminum diet-induced motor neuron pathology in cynomolgus monkeys , 2004, Acta Neuropathologica.

[1577]  Ronald N. Kostoff,et al.  Literature-related discovery (LRD): Potential treatments for Raynaud's Phenomenon☆ , 2008 .

[1578]  Sang-Hyun Kim,et al.  Artemisia iwayomogi Inhibits Immediate-Type Allergic Reaction and Inflammatory Cytokine Secretion , 2006, Immunopharmacology and immunotoxicology.

[1579]  Kazuhiko Yamamoto,et al.  Effects of hachimi-jio-gan (ba-wei-di-huang-wan) on blood flow in the human central retinal artery. , 2003, The American journal of Chinese medicine.

[1580]  Vellareddy Anantharam,et al.  Dieldrin-induced neurotoxicity: relevance to Parkinson's disease pathogenesis. , 2005, Neurotoxicology.

[1581]  C. Maier,et al.  Book Review: Role of Superoxide Dismutases in Oxidative Damage and Neurodegenerative Disorders , 2002 .

[1582]  Knut Schmidt-Nielsen,et al.  Diabetes Mellitus in the Sand Rat Induced by Standard Laboratory Diets , 1964, Science.

[1583]  Amy Chan,et al.  Folate deprivation increases presenilin expression, gamma‐secretase activity, and Abeta levels in murine brain: potentiation by ApoE deficiency and alleviation by dietary S‐adenosyl methionine , 2007, Journal of neurochemistry.

[1584]  Jun Tan,et al.  ADAM10 Activation Is Required for Green Tea (–)-Epigallocatechin-3-gallate-induced α-Secretase Cleavage of Amyloid Precursor Protein* , 2006, Journal of Biological Chemistry.

[1585]  C. C. Johnson,et al.  Adult nutrient intake as a risk factor for Parkinson's disease. , 1999, International journal of epidemiology.

[1586]  Robert M. Silva,et al.  CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism , 2005, Journal of neurochemistry.

[1587]  Y. Hiraku,et al.  Mechanism for generation of hydrogen peroxide and change of mitochondrial membrane potential during rotenone-induced apoptosis. , 2003, Life sciences.

[1588]  Wolfgang Wurst,et al.  Fate of Midbrain Dopaminergic Neurons Controlled by the Engrailed Genes , 2001, The Journal of Neuroscience.

[1589]  Bin Zhang,et al.  Axonal Degeneration Induced by Targeted Expression of Mutant Human Tau in Oligodendrocytes of Transgenic Mice That Model Glial Tauopathies , 2005, The Journal of Neuroscience.

[1590]  J. S. Harrington,et al.  Cataract formation in newborn rats from feeding a liquid protein diet during gestation. , 1983, Experimental eye research.

[1591]  L Missotten,et al.  Eye diseases and the causes of blindness in the southwestern Equator (equatorial forest) in Zaire, data from an eye camp in three rural centers. , 1997, Bulletin de la Societe belge d'ophtalmologie.

[1592]  T. Sherer,et al.  The rotenone model of Parkinson's disease: genes, environment and mitochondria. , 2003, Parkinsonism & related disorders.

[1593]  J T Greenamyre,et al.  Assay of [3H]dihydrorotenone binding to complex I in intact human platelets. , 1995, Analytical biochemistry.

[1594]  R. Guerrero,et al.  Suppression of Parkin enhances nigrostriatal and motor neuron lesion in mice over-expressing human-mutated tau protein. , 2006, Human molecular genetics.

[1595]  David S. Park,et al.  Regulation of Dopaminergic Loss by Fas in a 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease , 2004, The Journal of Neuroscience.

[1596]  B. Volpe,et al.  APP knockout attenuates microglial activation and enhances neuron survival in substantia nigra compacta after axotomy , 2002, Glia.

[1597]  Tony Wyss-Coray,et al.  A role for TGF-beta signaling in neurodegeneration: evidence from genetically engineered models. , 2006, Current Alzheimer research.

[1598]  Jay F. Levine,et al.  Antihemostatic, Antiinflammatory, and Immunosuppressive Properties of the Saliva of Tick, Ixodes Dammini a A. Spielman , 1985 .

[1599]  Weipeng Cao,et al.  Gypenosides protect primary cultures of rat cortical cells against oxidative neurotoxicity , 2006, Brain Research.

[1600]  K. Shimoke,et al.  Nerve growth factor prevents 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced cell death via the Akt pathway by suppressing caspase‐3‐like activity using PC12 cells: Relevance to therapeutical application for parkinson's disease , 2001, Journal of neuroscience research.

[1601]  K. Walton,et al.  GDNF: a novel factor with therapeutic potential for neurodegenerative disorders. , 1999, Molecular neurobiology.

[1602]  R Altman,et al.  Identification of platelet inhibitor present in the melon (Cucurbitacea cucumis melo). , 1985, Thrombosis and haemostasis.

[1603]  Francis C. Lau,et al.  The beneficial effects of fruit polyphenols on brain aging , 2005, Neurobiology of Aging.

[1604]  Heikki Tanila,et al.  Brain reward in the absence of alpha-synuclein , 2006, Neuroreport.

[1605]  S. Appel,et al.  Role of Fcγ Receptors in Nigral Cell Injury Induced by Parkinson Disease Immunoglobulin Injection into Mouse Substantia Nigra , 2002, Experimental Neurology.

[1606]  Sylvain Doré,et al.  Unique Properties of Polyphenol Stilbenes in the Brain: More than Direct Antioxidant Actions; Gene/Protein Regulatory Activity , 2005, Neurosignals.

[1607]  Yanjue Wu,et al.  Soy isoflavone glycitein protects against beta amyloid-induced toxicity and oxidative stress in transgenic Caenorhabditis elegans , 2005, BMC Neuroscience.

[1608]  J. Goudreau,et al.  Alpha‐Synuclein induces hyperphosphorylation of Tau in the MPTP model of Parkinsonism , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[1609]  N. Kolosova,et al.  [Dietary supplementation with bilberry extract prevents macular degeneration and cataracts in senesce-accelerated OXYS rats]. , 2008, Advances in gerontology = Uspekhi gerontologii.

[1610]  Paul Greengard,et al.  Critical Involvement of cAMP/DARPP-32 and Extracellular Signal-Regulated Protein Kinase Signaling in l-DOPA-Induced Dyskinesia , 2007, The Journal of Neuroscience.

[1611]  D. Wei,et al.  Neuroprotective effects of Hypericum perforatum on trauma induced by hydrogen peroxide in PC12 cells. , 2004, The American journal of Chinese medicine.

[1612]  A Beyer-Mears,et al.  Dietary myo-inositol effect on sugar cataractogenesis. , 1989, Pharmacology.

[1613]  O. Thastrup,et al.  Coronary vasodilatory, spasmolytic and cAMP-Phosphodiesterase inhibitory properties of dihydropyranocoumarins and dihydrofuranocoumarins. , 1983, Planta medica.

[1614]  Ghufran Ahmad,et al.  Synthesis of novel benzofuran isoxazolines as protein tyrosine phosphatase 1B inhibitors. , 2006, Bioorganic & medicinal chemistry letters.

[1615]  Tatsushi Toda,et al.  Protein transduction domain-mediated delivery of QBP1 suppresses polyglutamine-induced neurodegeneration in vivo. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[1616]  H. Feldman,et al.  Treating vascular risk factors and maintaining vascular health: Is this the way towards successful cognitive ageing and preventing cognitive decline? , 2006, Postgraduate Medical Journal.

[1617]  P. Kahle,et al.  Alpha‐synuclein transgenic mice: Relevance to multiple system atrophy , 2005, Movement disorders : official journal of the Movement Disorder Society.

[1618]  Chadi Touma,et al.  Prominent corticosteroid disturbance in experimental prion disease , 2006, The European journal of neuroscience.

[1619]  P Aebischer,et al.  Attenuation of 6‐OHDA‐induced neurotoxicity in glutathione peroxidase transgenic mice , 1998, The European journal of neuroscience.

[1620]  Hong Miao,et al.  Prevention of oxidative injury by flavonoids from stems and leaves of Scutellaria Baicalensis georgi in PC12 cells , 2006, Phytotherapy research : PTR.

[1621]  D L Sparks,et al.  Influence of water quality on cholesterol induced systemic pathology. , 2007, The journal of nutrition, health & aging.

[1622]  M Taskov,et al.  On the coronary and cardiotonic action of crataemon. , 1977, Acta physiologica et pharmacologica Bulgarica.

[1623]  Padmini Srinivasan,et al.  Text mining: Generating hypotheses from MEDLINE , 2004, J. Assoc. Inf. Sci. Technol..

[1624]  M. Gurney,et al.  Metabolic Dysfunction in Familial, but Not Sporadic, Amyotrophic Lateral Sclerosis , 1998, Journal of neurochemistry.

[1625]  Sanford P. Markey,et al.  2‐Amino‐3‐(methylamino)‐propanoic acid (BMAA) in cycad flour , 1990, Neurology.

[1626]  Zhiming Wen,et al.  Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[1627]  Y Inamori,et al.  [The coronary vasodilatory and hypotensive effects of 3,3',4,5'-tetrahydroxystilbene and its derivatives]. , 1984, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[1628]  M. Mena,et al.  Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline , 2006, Journal of neurochemistry.

[1629]  D W Ross,et al.  The effect of cell hydration on the deformability of normal and sickle erythrocytes , 1982, American journal of hematology.

[1630]  S. Imai,et al.  Effects of Etafenone and Antiarrhythmic Drugs on Na and Ca Channels of Guinea Pig Atrial Muscle , 1979, Journal of cardiovascular pharmacology.

[1631]  D. Higgins,et al.  In Vivo Labeling of Mitochondrial Complex I (NADH:UbiquinoneOxidoreductase) in Rat Brain Using [3H]Dihydrorotenone , 2000, Journal of neurochemistry.

[1632]  R. Liu,et al.  Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. , 2003, The American journal of clinical nutrition.

[1633]  P. Derost,et al.  Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation. , 2007, Brain : a journal of neurology.

[1634]  P. Fürst,et al.  Antioxidant vitamins in prevention. , 1997, Clinical nutrition.

[1635]  Makoto Hashimoto,et al.  Transgenic Models of α‐Synuclein Pathology , 2003 .

[1636]  Rossana Migheli,et al.  Glucocorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[1637]  S A Kiss,et al.  Magnesium inhibits the harmful effects on plants of some toxic elements. , 1991, Magnesium research.

[1638]  W R Woodward,et al.  Influence of fluctuations of plasma large neutral amino acids with normal diets on the clinical response to levodopa. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[1639]  Khaled Radad,et al.  Use of ginseng in medicine with emphasis on neurodegenerative disorders. , 2006, Journal of pharmacological sciences.

[1640]  Laura C. Greaves,et al.  Mitochondrial DNA Mutations and Aging , 2007, Annals of the New York Academy of Sciences.

[1641]  M. Nydahl,et al.  Five-day food intake in elderly female outpatients with Parkinson's disease, rheumatoid arthritis or stroke. , 2004, The journal of nutrition, health & aging.

[1642]  R. Ransohoff,et al.  Natalizumab for multiple sclerosis. , 2007, The New England journal of medicine.

[1643]  T. Holmøy,et al.  Immunopathogenesis of multiple sclerosis: concepts and controversies , 2007, Acta neurologica Scandinavica. Supplementum.

[1644]  Hiroshi Kase,et al.  Industry forum: Progress in pursuit of therapeutic A2A antagonists , 2003, Neurology.

[1645]  Miquel Vila,et al.  Engineered modeling and the secrets of Parkinson's disease , 2001, Trends in Neurosciences.

[1646]  S F Yang,et al.  Protective effect and mechanism of Ginkgo biloba leaf extracts for Parkinson disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 2001, Acta pharmacologica Sinica.

[1647]  M. Beal,et al.  Bioenergetic approaches for neuroprotection in Parkinson's disease , 2003, Annals of neurology.

[1648]  Masahiro Akishita,et al.  Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis. , 2007, Atherosclerosis.

[1649]  J. Selhub,et al.  The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. , 2006, The Journal of nutrition.

[1650]  Parvesh Bubber,et al.  Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3‐nitropropionic acid neurotoxicity , 2004, Journal of neurochemistry.

[1651]  S K Gupta,et al.  Lens aldose reductase inhibiting potential of some indigenous plants. , 2003, Journal of ethnopharmacology.

[1652]  N J Unakar,et al.  Sodium-potassium--dependent ATPase. II. Cytochemical localization during the reversal of galactose cataracts in rat. , 1980, Investigative ophthalmology & visual science.

[1653]  Kazuto Kobayashi,et al.  Granulocyte‐colony stimulating factor is neuroprotective in a model of Parkinson's disease , 2006, Journal of neurochemistry.

[1654]  Alen J Salerian,et al.  Cooler biologically compatible core body temperatures may prolong longevity and combat neurodegenerative disorders. , 2006, Medical hypotheses.

[1655]  Marcy J. Balunas,et al.  Drug discovery from medicinal plants. , 2005, Life sciences.

[1656]  E Vorontsova,et al.  Motor and associative deficits in D2 dopamine receptor knockout mice , 2002, International Journal of Developmental Neuroscience.

[1657]  Bin Liu,et al.  Critical role of microglial NADPH oxidase‐derived free radicals in the in vitro MPTP model of Parkinson's disease , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[1658]  Zheng Feng,et al.  Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease. , 2006, Free radical biology & medicine.

[1659]  M. Zimecki,et al.  Milk-derived proteins and peptides of potential therapeutic and nutritive value. , 2007, Journal of experimental therapeutics & oncology.

[1660]  Walter Sekundo,et al.  Nutritional supplementation to prevent cataract formation. , 2005, Developments in ophthalmology.

[1661]  Manish S Lavhale,et al.  Evaluation of free radical scavenging activity of Butea monosperma Lam. , 2007, Indian journal of experimental biology.

[1662]  Yaakov Stern,et al.  Mediterranean diet and Alzheimer disease mortality , 2007, Neurology.

[1663]  W. Endres,et al.  Inherited metabolic diseases affecting the carrier , 1997, Journal of Inherited Metabolic Disease.

[1664]  B. Reboussin,et al.  Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study. , 1998, Ophthalmology.

[1665]  P. Calabresi,et al.  Nigrostriatal Dopaminergic Deficits and Hypokinesia Caused by Inactivation of the Familial Parkinsonism-Linked Gene DJ-1 , 2005, Neuron.

[1666]  K Tsutsumi,et al.  Suppression of hyperlipidemia-associated cataracts in diabetic rats with the lipoprotein lipase activator NO-1886. , 1996, Biological & pharmaceutical bulletin.

[1667]  Julia Thom Oxford,et al.  Calpain-Cleavage of α-Synuclein : Connecting Proteolytic Processing to Disease-Linked Aggregation , 2007 .

[1668]  M. Tarnopolsky,et al.  Potential benefits of creatine monohydrate supplementation in the elderly , 2000, Current opinion in clinical nutrition and metabolic care.

[1669]  K. Hara,et al.  Implantation of xenogeneic transgenic neural plate tissues into parkinsonian rat brain. , 1997, Cell transplantation.

[1670]  Jochen Roeper,et al.  K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons , 2005, Nature Neuroscience.

[1671]  S. Kölker,et al.  Bioenergetics in Glutaryl-Coenzyme A Dehydrogenase Deficiency , 2005, Journal of Biological Chemistry.

[1672]  M T Lin,et al.  Effects of Shan-dou-gen (Euchresta formosana) on metabolic, respiratory and vasomotor activities as well as body temperature in rats. , 1980, The American journal of Chinese medicine.

[1673]  Teiichi Furuichi,et al.  Localization and Expression of Group I Metabotropic Glutamate Receptors in the Mouse Striatum, Globus Pallidus, and Subthalamic Nucleus: Regulatory Effects of MPTP Treatment and Constitutive Homer Deletion , 2007, The Journal of Neuroscience.

[1674]  E Sylvester Vizi,et al.  Involvement of Cannabinoid Receptors in the Regulation of Neurotransmitter Release in the Rodent Striatum: A Combined Immunochemical and Pharmacological Analysis , 2005, The Journal of Neuroscience.

[1675]  C. Shults.  Lewy bodies. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[1676]  Leo X. Liu,et al.  Similar Patterns of Mitochondrial Vulnerability and Rescue Induced by Genetic Modification of α-Synuclein, Parkin, and DJ-1 in Caenorhabditis elegans* , 2005, Journal of Biological Chemistry.

[1677]  O Altinkurt.  [The relaxant and antispasmotic effects of streptidin on smooth muscles]. , 1970, Turk hijiyen ve tecrubi biyoloji dergisi.

[1678]  M. Saarma,et al.  Neurotrophins and ciliary neurotrophic factor: their biology and pathology. , 1994, Annals of medicine.

[1679]  P. Malherbe,et al.  Monoamine oxidases: from brain maps to physiology and transgenics to pathophysiology. , 1998, Journal of neural transmission. Supplementum.

[1680]  W. Burke,et al.  Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria. , 2001, Free radical biology & medicine.

[1681]  Patrice K. Held,et al.  L-2-Oxothiazolidine-4-carboxylate supplementation in murine γ-GT deficiency , 2003 .

[1682]  Halfdan Ihlen,et al.  Effects of Bed Rest and Prazosin in Congestive Heart Failure , 2009 .

[1683]  V Marcaud,et al.  Maladie de Refsum avec 35 ans de recul , 2002 .

[1684]  Sachiko Takahama,et al.  Magnesium deficiency over generations in rats with special references to the pathogenesis of the parkinsonism–dementia complex and amyotrophic lateral sclerosis of Guam , 2006, Neuropathology : official journal of the Japanese Society of Neuropathology.

[1685]  Makito Hirano,et al.  Increased vulnerability to l-DOPA toxicity in dopaminergic neurons from VMAT2 heterozygote knockout mice , 2007, Journal of Molecular Neuroscience.

[1686]  R Sack,et al.  Comparative diets of a idiopathic senile cataract and normal population: dietary risk factors in cataractogenesis. , 1987, Metabolic, pediatric, and systemic ophthalmology.

[1687]  A Hofman,et al.  Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease , 2006, Neurology.

[1688]  A Pieroni,et al.  Antioxidant activity of five vegetables traditionally consumed by south‐Asian migrants in Bradford, Yorkshire, UK , 2005, Phytotherapy research : PTR.

[1689]  Chris J Hass,et al.  Resistance Training With Creatine Monohydrate Improves Upper-Body Strength in Patients With Parkinson Disease: A Randomized Trial , 2007, Neurorehabilitation and neural repair.

[1690]  Gary W Miller,et al.  Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson’s disease , 2007, Journal of neurochemistry.

[1691]  Michel Goedert,et al.  Mutations causing neurodegenerative tauopathies. , 2005, Biochimica et biophysica acta.

[1692]  Isidro Ferrer,et al.  Increased sensitivity to MPTP in human α-synuclein A30P transgenic mice , 2006, Neurobiology of Aging.

[1693]  Ronald N. Kostoff,et al.  Literature-related discovery (LRD): Potential treatments for Multiple Sclerosis , 2008 .

[1694]  C. Johnston,et al.  Vasopressin in circulatory control and hypertension. , 1985, Journal of hypertension.

[1695]  Z. Kiss,et al.  Nursing time to program and assess deep brain stimulators in movement disorder patients. , 2005, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

[1696]  G. Pierce,et al.  Codelivery of a tea extract prevents morbidity and mortality associated with oral vanadate therapy in streptozotocin-induced diabetic rats. , 2004, Metabolism: clinical and experimental.

[1697]  D. Fontaine,et al.  α-Synuclein from platelets is not phosphorylated at serine 129 in Parkinson's disease and multiple system atrophy , 2006, Neuroscience Letters.

[1698]  F E Preston,et al.  Beneficial effect of fish oil on blood viscosity in peripheral vascular disease. , 1984, British medical journal.

[1699]  Neil R. Smalheiser,et al.  A Quantitative Model for Linking Two Disparate Sets of Articles in Medline , 2022 .

[1700]  Kazuyuki Takata,et al.  Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4‐phenylbutyrate, a chemical chaperone , 2007, Journal of neurochemistry.

[1701]  C. Molgaard,et al.  Induction of cytochrome P-450 enzymes via tobacco smoke: a potential mechanism for developing resistance to environmental toxins as related to parkinsonism and other neurologic diseases. , 1993, Neuroepidemiology.

[1702]  Sergio Tufik,et al.  Acute stressor-selective effects on homocysteine metabolism and oxidative stress parameters in female rats , 2006, Pharmacology Biochemistry and Behavior.

[1703]  A. R. Cools,et al.  Efferent projections of the retrorubral nucleus to the substantia nigra and ventral tegmental area in cats as shown by anterograde tracing , 1996, Brain Research Bulletin.

[1704]  Kazutaka Miyatake,et al.  Inhibitory Effect of Perillosides A and C, and Related Monoterpene Glucosides on Aldose Reductase and Their Structure-Activity Relationships. , 1995 .

[1705]  T. Fahrig,et al.  A Synthetic Derivative of the Natural Product Rocaglaol Is a Potent Inhibitor of Cytokine-Mediated Signaling and Shows Neuroprotective Activity in Vitro and in Animal Models of Parkinson's Disease and Traumatic Brain Injury , 2005, Molecular Pharmacology.

[1706]  J. Um,et al.  Anti-inflammatory effect of jeongshintang through suppression of p38 activation in human astrocytoma, U373MG cells. , 2006, Experimental and molecular pathology.

[1707]  C. P. Hsieh,et al.  Comparison of vascular effects of gastrointestinal hormones on various organs. , 1977, The American journal of physiology.

[1708]  J. Ribeiro,et al.  Platelet antiaggregating activity in the salivary secretion of the blood sucking bugRhodnius prolixus , 1981, Experientia.

[1709]  Isidro Ferrer,et al.  α-Synuclein Expression Levels Do Not Significantly Affect Proteasome Function and Expression in Mice and Stably Transfected PC12 Cell Lines* , 2004, Journal of Biological Chemistry.

[1710]  Atilla Bayer,et al.  Doxorubicin-induced cataract formation in rats and the inhibitory effects of hazelnut, a natural antioxidant: a histopathological study. , 2005, Medical science monitor : international medical journal of experimental and clinical research.

[1711]  Britton Chance,et al.  Ketone Bodies, Potential Therapeutic Uses , 2001, IUBMB life.

[1712]  G. C. Mishra,et al.  Studies on the host-parasite interaction and role of esterases during biting of the Indian cattle leech, Poecilobdella granulosa , 1976, Zeitschrift für Parasitenkunde.

[1713]  Marc C. Deller,et al.  Cell Surface Receptors , 2000 .

[1714]  Irene Litvan,et al.  Update on epidemiological aspects of progressive supranuclear palsy , 2003, Movement disorders : official journal of the Movement Disorder Society.

[1715]  Rossana Salerno-Kennedy,et al.  Relationship between dementia and nutrition-related factors and disorders: an overview. , 2005, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[1716]  J. G. Nutt,et al.  Amount and distribution of dietary protein affects clinical response to levodopa in Parkinson's disease , 1989, Neurology.

[1717]  Anthony Trewavas,et al.  Paradoxical effects of chemicals in the diet on health. , 2003, Current opinion in plant biology.

[1718]  X M Cheng,et al.  A case-control study on the environmental risk factors of Parkinson's disease in Tianjin, China. , 1993, Neuroepidemiology.

[1719]  Bertrand Friguet,et al.  Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease , 2003, Journal of neurochemistry.

[1720]  M. Youdim,et al.  Iron involvement in neural damage and microgliosis in models of neurodegenerative diseases. , 2000, Cellular and molecular biology.

[1721]  Neil R. Smalheiser,et al.  Artificial Intelligence An interactive system for finding complementary literatures : a stimulus to scientific discovery , 1995 .

[1722]  Doron Steinberg,et al.  Cranberry high molecular weight constituents promote Streptococcus sobrinus desorption from artificial biofilm. , 2005, International journal of antimicrobial agents.

[1723]  D Piñero,et al.  Variations in dietary iron alter behavior in developing rats. , 2001, The Journal of nutrition.

[1724]  M. Beal,et al.  Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[1725]  M. Mena,et al.  Life‐threatening parkinsonism induced by kava‐kava , 2002, Movement disorders : official journal of the Movement Disorder Society.

[1726]  Rieko Setsuie,et al.  Accumulation of β- and γ-synucleins in the ubiquitin carboxyl-terminal hydrolase L1-deficient gad mouse , 2004, Brain Research.

[1727]  V. Preedy,et al.  Scottish Intercollegiate Guidelines Network , 2010 .

[1728]  Kwang-Soo Kim,et al.  Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice. , 2003, Brain research. Molecular brain research.

[1729]  P. Jacques,et al.  Relationship in humans between ascorbic acid consumption and levels of total and reduced ascorbic acid in lens, aqueous humor, and plasma. , 1991, Current eye research.

[1730]  Dean P. Jones,et al.  Diet and apoptosis. , 2003, Annual review of nutrition.

[1731]  Darrick S. H. L. Kim,et al.  Alzheimer's disease drug discovery from herbs: neuroprotectivity from beta-amyloid (1-42) insult. , 2007, Journal of alternative and complementary medicine.

[1732]  F. Fang,et al.  Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress , 2005, Acta Pharmacologica Sinica.

[1733]  H. McDade,et al.  Dysphagia and dementia in subjects with Parkinson's disease , 2004, Dysphagia.

[1734]  J. Cummings,et al.  A potential role of the curry spice curcumin in Alzheimer's disease. , 2005, Current Alzheimer research.

[1735]  J. Grover,et al.  Pharmacological actions and potential uses of Momordica charantia: a review. , 2004, Journal of ethnopharmacology.

[1736]  Denis A. Evans,et al.  Fish consumption and cognitive decline with age in a large community study. , 2005, Archives of neurology.

[1737]  Mauro Piacentini,et al.  Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders , 2007, Journal of neurochemistry.

[1738]  S. Mandel,et al.  Green tea polyphenol (–)‐epigallocatechin‐3‐gallate prevents N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced dopaminergic neurodegeneration , 2001, Journal of neurochemistry.

[1739]  S A McFadden,et al.  Phenotypic variation in xenobiotic metabolism and adverse environmental response: focus on sulfur-dependent detoxification pathways. , 1996, Toxicology.

[1740]  Ken-ichi Isobe,et al.  An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH‐SY5Y cells , 2003, Journal of neuroscience research.

[1741]  Muzamil Ahmad,et al.  Dose‐dependent protective effect of selenium in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences , 2003, Journal of neurochemistry.

[1742]  Keith Hyland,et al.  Distinct Mechanisms of Neurodegeneration Induced by Chronic Complex I Inhibition in Dopaminergic and Non-dopaminergic Cells* , 2004, Journal of Biological Chemistry.

[1743]  Steffen Jung,et al.  Control of microglial neurotoxicity by the fractalkine receptor , 2006, Nature Neuroscience.

[1744]  M. Stevens,et al.  Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens. , 1999, Investigative ophthalmology & visual science.

[1745]  Werner Poewe,et al.  Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. , 2005, The American journal of pathology.

[1746]  Jean-Pierre Julien,et al.  Ceruloplasmin Regulates Iron Levels in the CNS and Prevents Free Radical Injury , 2002, The Journal of Neuroscience.

[1747]  B. E. Staveley,et al.  parkin counteracts symptoms in a Drosophila model of Parkinson's disease , 2004, BMC Neuroscience.

[1748]  D. Laub,et al.  The effect on health of alternate day calorie restriction: eating less and more than needed on alternate days prolongs life. , 2006, Medical hypotheses.

[1749]  Z Madar,et al.  Cataract development in sand and galactosemic rats fed a natural tomato extract. , 1999, Journal of agricultural and food chemistry.

[1750]  J. Wood,et al.  Transgenic zebrafish model of neurodegeneration , 2002, Journal of neuroscience research.

[1751]  Brian J Bacskai,et al.  Plaque-Derived Oxidative Stress Mediates Distorted Neurite Trajectories in the Alzheimer Mouse Model , 2006, Journal of neuropathology and experimental neurology.

[1752]  P. Huijgens,et al.  The influence of citrate on platelet aggregation and malondialdehyde production. , 2009, Scandinavian journal of haematology.

[1753]  S. Mandel,et al.  Gene and Protein Expression Profiles of Anti‐ and Pro‐apoptotic Actions of Dopamine, R‐Apomorphine, Green Tea Polyphenol (−)‐Epigallocatechine‐3‐gallate, and Melatonin , 2003, Annals of the New York Academy of Sciences.

[1754]  Beibei Cai,et al.  Rotenone-induced apoptosis is mediated by p38 and JNK MAP kinases in human dopaminergic SH-SY5Y cells. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[1755]  John Sharkey,et al.  Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of γ‐synuclein, α‐synuclein and double α/γ‐synuclein null mutant mice , 2004 .

[1756]  Gavin Giovannoni,et al.  Multiple sclerosis: the environment and causation , 2007, Current opinion in neurology.

[1757]  Emmanuel Cuny,et al.  Effects of subthalamic nucleus deep brain stimulation and levodopa on energy production rate and substrate oxidation in Parkinson's disease , 2005, British Journal of Nutrition.

[1758]  R. Cumming,et al.  Use of vitamin supplements and cataract: the Blue Mountains Eye Study. , 2001, American journal of ophthalmology.

[1759]  L Zhang,et al.  Dietary factors and smoking as risk factors for PD in a rural population in China: a nested case–control study , 2006, Acta neurologica Scandinavica.

[1760]  D. Swanson.  Somatomedin C and Arginine: Implicit Connections between Mutually Isolated Literatures , 2015, Perspectives in biology and medicine.

[1761]  R. Liem,et al.  CHIP-ping away at tau. , 2007, The Journal of clinical investigation.

[1762]  Paul Alan Cox,et al.  BMAA selectively injures motor neurons via AMPA/kainate receptor activation , 2006, Experimental Neurology.

[1763]  Amy Chan,et al.  Supplementation with apple juice attenuates presenilin-1 overexpression during dietary and genetically-induced oxidative stress. , 2006, Journal of Alzheimer's disease : JAD.

[1764]  C Zhao,et al.  Histocytological study on the possible mechanism of acetaminophen cataractogenesis in mouse eye. , 1995, Experimental and molecular pathology.

[1765]  D. Butterfield,et al.  Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. , 2007, Frontiers in bioscience : a journal and virtual library.

[1766]  Lloyd A Greene,et al.  RTP801 Is Elevated in Parkinson Brain Substantia Nigral Neurons and Mediates Death in Cellular Models of Parkinson's Disease by a Mechanism Involving Mammalian Target of Rapamycin Inactivation , 2006, The Journal of Neuroscience.

[1767]  Jun Wang,et al.  Caloric intake and Alzheimer's disease. Experimental approaches and therapeutic implications. , 2007, Interdisciplinary topics in gerontology.

[1768]  N. Chauhan,et al.  Effect of aged garlic extract on APP processing and tau phosphorylation in Alzheimer's transgenic model Tg2576. , 2006, Journal of ethnopharmacology.

[1769]  Qing Guo.  When good Cdk5 turns bad. , 2006, Science of aging knowledge environment : SAGE KE.

[1770]  Subramaniam Pennathur,et al.  Ablation of the Inflammatory Enzyme Myeloperoxidase Mitigates Features of Parkinson's Disease in Mice , 2005, The Journal of Neuroscience.

[1771]  C. Alves da Costa.  Recent Advances on α-Synuclein Cell Biology: Functions and Dysfunctions , 2003 .

[1772]  A. Bojarski,et al.  Protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of rotenone. , 2004, The international journal of neuropsychopharmacology.

[1773]  A. Ferrús,et al.  Parkin and relatives: the RBR family of ubiquitin ligases. , 2004, Physiological genomics.

[1774]  Wanda Pratt,et al.  Using statistical and knowledge-based approaches for literature-based discovery , 2006, J. Biomed. Informatics.

[1775]  Erzsebet Kokovay,et al.  Bone marrow-derived microglia contribute to the neuroinflammatory response and express iNOS in the MPTP mouse model of Parkinson's disease , 2005, Neurobiology of Disease.

[1776]  Wang Hao,et al.  Up-regulation of M1 muscarinic receptors expressed in CHOm1 cells by panaxynol via cAMP pathway , 2005, Neuroscience Letters.

[1777]  D. Hanger,et al.  Behavioral effects of dopamine agonists and antagonists in MPTP-lesioned D3 receptor knockout mice , 2003, Pharmacology Biochemistry and Behavior.

[1778]  U Hayashi,et al.  Relationship between natto-added feed and blood pressure of SHR: experiment in feeding of propagation type natto Bacilli. , 1978, Japanese heart journal.

[1779]  Mitsunobu Yoshii,et al.  α-Synuclein aggregation and neurodegenerative diseases , 2003 .

[1780]  E. Richfield,et al.  The gestational environment and Parkinson's disease: evidence for neurodevelopmental origins of a neurodegenerative disorder. , 2007, Reproductive toxicology.

[1781]  A L Muggleton-Harris,et al.  Rescue of developmental lens abnormalities in chimaeras of noncataractous and congenital cataractous mice. , 1987, Development.

[1782]  M. Lagarde,et al.  Dihomogammalinolenic acid (20:3ω6) is more anti-aggregatory than eicosapentaenoic (20:5ω3) in a platelet-endothelial cell mixture , 1980 .

[1783]  Michael A. Rogawski,et al.  Neuroprotective and disease-modifying effects of the ketogenic diet , 2006, Behavioural Pharmacology.

[1784]  Takashi Morihara,et al.  Dietary n‐3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease , 2005, The European journal of neuroscience.

[1785]  M Mohanasundari,et al.  Modulating effect of Hypericum perforatum extract on astrocytes in MPTP induced Parkinson's disease in mice. , 2007, European review for medical and pharmacological sciences.

[1786]  Ming Xu,et al.  The dopamine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotion , 2007, Pharmacology Biochemistry and Behavior.

[1787]  George Perry,et al.  Indices of Metabolic Dysfunction and Oxidative Stress , 2007, Neurochemical Research.

[1788]  Tianhong Pan,et al.  Age-dependent dopaminergic dysfunction in Nurr1 knockout mice , 2005, Experimental Neurology.

[1789]  Nobutaka Hattori,et al.  Decline of striatal dopamine release in parkin‐deficient mice shown by ex vivo autoradiography , 2006, Journal of neuroscience research.

[1790]  K Matsuno,et al.  Further studies on the effects of flavine adenine dinucleotide on the platelet functions. , 1983, The Tohoku journal of experimental medicine.

[1791]  R. Hauser,et al.  Advances in the Pharmacologic Management of Early Parkinson Disease , 2007, The neurologist.

[1792]  H. Soininen,et al.  Fat Intake at Midlife and Risk of Dementia and Alzheimer’s Disease: A Population-Based Study , 2006, Dementia and Geriatric Cognitive Disorders.

[1793]  S. Asgary,et al.  Evaluation of hepatoprotective potential of HESA-A (a marine compound) pretreatment against thioacetamide-induced hepatic damage in rabbits. , 2005, Drugs under experimental and clinical research.

[1794]  M. Biasi,et al.  Nicotinic receptor mutant mice in the study of autonomic function. , 2002 .

[1795]  S. Birman,et al.  Chronic Exposure to Rotenone Models Sporadic Parkinson's Disease in Drosophila melanogaster , 2004, The Journal of Neuroscience.

[1796]  William H Stuart,et al.  Clinical management of multiple sclerosis: the treatment paradigm and issues of patient management. , 2004, Journal of managed care pharmacy : JMCP.

[1797]  D M Desiderio,et al.  Antihypertensive lipids from the kidney: alkyl ether analogs of phosphatidylcholine. , 1981, Federation proceedings.

[1798]  Ronald N. Kostoff,et al.  Global nanotechnology research metrics , 2007, Scientometrics.

[1799]  J Alcala,et al.  Reversal of the limited proteolysis of MP26 during the reversal and prevention of the galactose cataract in rat lenses. , 1990, Current eye research.

[1800]  G. Miller,et al.  Reduced MPTP toxicity in noradrenaline transporter knockout mice , 2004, Journal of neurochemistry.

[1801]  B. Zhu.  CNS dopamine oxidation and catechol-O-methyltransferase: importance in the etiology, pharmacotherapy, and dietary prevention of Parkinson's disease. , 2004, International journal of molecular medicine.

[1802]  C. Chinopoulos,et al.  Depolarization of In Situ Mitochondria Due to Hydrogen Peroxide‐Induced Oxidative Stress in Nerve Terminals , 1999, Journal of neurochemistry.

[1803]  Toru Itakura,et al.  Metabolic inhibition enhances selective toxicity of l-DOPA toward mesencephalic dopamine neurons in vitro , 1997, Brain Research.

[1804]  J. White,et al.  Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function. , 1983, Biochemical and biophysical research communications.

[1805]  Y. Natori,et al.  Antioxidant and anti-cataract effects of Chlorella on rats with streptozotocin-induced diabetes. , 2003, Journal of nutritional science and vitaminology.

[1806]  Uwe Siebert,et al.  Systematic assessment of decision models in Parkinson's disease. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[1807]  Alexander Piechot,et al.  Identification, design, synthesis, and pharmacological activity of (4-ethyl-piperazin-1-yl)-phenylmethanone derivatives with neuroprotective properties against β-amyloid-induced toxicity , 2005, Neuropharmacology.

[1808]  R. Nitsch,et al.  In Vivo Analysis of Wild‐type and FTDP‐17 Tau Transgenic Mice , 2000, Annals of the New York Academy of Sciences.

[1809]  Anthony W S Chan,et al.  Reproductive Biology and Endocrinology Open Access Transgenic Nonhuman Primates for Neurodegenerative Diseases , 2022 .

[1810]  Bocai Cheng,et al.  Synergistic effects of Lactobacillus rhamnosus ZDY114 and bovine colostrums on the immunological function of mouse in vivo and in vitro , 2007, Applied Microbiology and Biotechnology.

[1811]  T. Langer,et al.  Application of the in combo screening approach for the discovery of non-alkaloid acetylcholinesterase inhibitors from Cichorium intybus. , 2005, Current drug discovery technologies.

[1812]  Omar Cauli,et al.  Brain edema and inflammatory activation in bile duct ligated rats with diet‐induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis , 2006, Hepatology.

[1813]  D. Berson,et al.  Identification of digitalis-like compounds in human cataractous lenses. , 1993, European journal of biochemistry.

[1814]  R. T. Coutts,et al.  Polymorphic Cytochromes P450 and Drugs Used in Psychiatry , 1999, Cellular and Molecular Neurobiology.

[1815]  J. Dormandy,et al.  Red cell deformability. , 1983, European neurology.

[1816]  Kenjiro Ono,et al.  The anti-amyloidogenic effect is exerted against Alzheimer's beta-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure. , 2007, Biochemistry.

[1817]  Wenjie Xie,et al.  Microglial Activation and Dopaminergic Cell Injury: An In Vitro Model Relevant to Parkinson's Disease , 2001, The Journal of Neuroscience.

[1818]  A. Schlager,et al.  Heat trapped under paper and plastic ophthalmic drapes during eye surgery using local anesthesia. , 1999, Journal of cataract and refractive surgery.

[1819]  H. Rossman,et al.  Managing the symptoms of multiple sclerosis: a multimodal approach. , 2006, Clinical therapeutics.

[1820]  A G Renwick,et al.  The influence of protein containing meals on the pharmacokinetics of levodopa in healthy volunteers. , 1991, British journal of clinical pharmacology.

[1821]  V. La Bella,et al.  New insights on the pathogenesis of neurodegenerative disorders. , 1992, Acta neurologica.

[1822]  Todd B. Sherer,et al.  An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage , 2002, The Journal of Neuroscience.

[1823]  Sarwat Sultana,et al.  Acorus calamus extracts and nickel chloride , 2006, Biological Trace Element Research.

[1824]  N. Bogdanovic,et al.  Antioxidative Effects of Plant Polyphenols , 2007, Annals of the New York Academy of Sciences.

[1825]  P Chambon,et al.  Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. , 1998, Science.

[1826]  S D Varma,et al.  Prevention of galactose cataract by pyruvate. , 1992, Lens and eye toxicity research.

[1827]  P. Riederer,et al.  Caenorhabditis elegans MPP+ Model of Parkinson’s Disease for High-Throughput Drug Screenings , 2004, Neurodegenerative Diseases.

[1828]  H. Kishida,et al.  Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. , 2005, Journal of agricultural and food chemistry.

[1829]  Mehrdad Roghani,et al.  Effect of Naringenin on Intracerebroventricular Streptozotocin-Induced Cognitive Deficits in Rat: A Behavioral Analysis , 2006, Pharmacology.

[1830]  Yuan Luo,et al.  Alzheimer's disease, the nematode Caenorhabditis elegans, and ginkgo biloba leaf extract. , 2006, Life sciences.

[1831]  S. Reich,et al.  The use of alternative therapies by patients with Parkinson’s disease , 2001, Neurology.

[1832]  A-K Dubey,et al.  Ginkgo biloba--an appraisal. , 2004, Kathmandu University medical journal.

[1833]  Bernard G. Schreurs,et al.  Cholesterol enhances classical conditioning of the rabbit heart rate response , 2007, Behavioural Brain Research.

[1834]  J. Menéndez,et al.  Effects of cinnarizine, a calcium antagonist that produces human parkinsonism, in parkin knock out mice , 2005, Neuropharmacology.

[1835]  B. Crain,et al.  Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. , 1993, Genomics.

[1836]  M. Pallàs,et al.  Inhibition of cyclin-dependent kinases is neuroprotective in 1-methyl-4-phenylpyridinium-induced apoptosis in neurons , 2007, Neuroscience.

[1837]  P. S. St George-Hyslop,et al.  Cytosolic Proteins Regulate α-Synuclein Dissociation from Presynaptic Membranes* , 2006, Journal of Biological Chemistry.

[1838]  Xinyuan Liu,et al.  Combination of ZD55-MnSOD therapy with 5-FU enhances antitumor efficacy in colorectal cancer , 2007, Journal of Cancer Research and Clinical Oncology.

[1839]  M. Evatt,et al.  Nutritional therapies in Parkinson’s disease , 2007, Current treatment options in neurology.

[1840]  H E Poulsen,et al.  [The effect on health of dietary antioxidants and antioxidant supplements]. , 1994, Ugeskrift for laeger.

[1841]  Alexis Elbaz,et al.  Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study , 1999, The Lancet.

[1842]  J W Langston,et al.  Impaired glutamate clearance as a consequence of energy failure caused by MPP(+) in astrocytic cultures. , 1999, Toxicology and applied pharmacology.

[1843]  Paul M Coates,et al.  Dietary supplements and related products: a brief summary. , 2006, Life sciences.

[1844]  Huaxi Xu,et al.  Estrogen, β‐Amyloid Metabolism/Trafficking, and Alzheimer's Disease , 2006, Annals of the New York Academy of Sciences.

[1845]  K A Head,et al.  Natural therapies for ocular disorders, part two: cataracts and glaucoma. , 2001, Alternative medicine review : a journal of clinical therapeutic.

[1846]  W. Christen,et al.  Antioxidant vitamins and age-related eye disease. , 1999, Proceedings of the Association of American Physicians.

[1847]  Bin Zhang,et al.  Amyotrophic Lateral Sclerosis/Parkinsonism Dementia Complex: Transgenic Mice Provide Insights into Mechanisms Underlying a Common Tauopathy in an Ethnic Minority on Guam , 2002, Experimental Neurology.

[1848]  Anthony Windust,et al.  Omega-3 fatty acids, energy substrates, and brain function during aging. , 2006, Prostaglandins, leukotrienes, and essential fatty acids.

[1849]  E W Salzman,et al.  Inhibition of platelet function by cis-unsaturated fatty acids. , 1984, Blood.

[1850]  O Gona,et al.  Cytoarchitectural changes in lens epithelium of galactose-fed rats. , 1984, Experimental eye research.

[1851]  E. Wegman,et al.  5 - Text Data Mining with Minimal Spanning Trees , 2005 .

[1852]  J. Nakamura,et al.  Cataract surgery training using pig eyes filled with chestnuts of various hardness. , 1999, Journal of cataract and refractive surgery.

[1853]  Zoe Katsarou,et al.  Endothelial function markers in parkinsonian patients with hyperhomocysteinemia , 2005, Journal of Clinical Neuroscience.

[1854]  J L Beaumont,et al.  Comparative effects of canbra oil and butter on lipdemia, vitamin A tolerance and thrombosis factors in man. , 1978, Journal of medicine.

[1855]  A Carlsson,et al.  'On‐off' phenomenon in Parkinson's disease , 1988, Neurology.

[1856]  C. Tanner,et al.  Frequency of bowel movements and the future risk of Parkinson’s disease , 2001, Neurology.

[1857]  N. Wolf,et al.  Response of lens epithelial cells to hydrogen peroxide stress and the protective effect of caloric restriction. , 1998, Experimental cell research.

[1858]  D. Fuchs,et al.  Homocysteine but not neopterin declines in demented patients on B vitamins , 2006, Journal of Neural Transmission.

[1859]  S. Papapetropoulos,et al.  Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-l-alanine (BMAA) paradigm , 2007, Neurochemistry International.

[1860]  N. Lois,et al.  Diabetic-like corneal sensitivity loss in galactose-fed rats ameliorated with aldose reductase inhibitors. , 1998, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[1861]  Peri T Kurshan,et al.  Locomotor activity is regulated by D2‐like receptors in Drosophila: An anatomic and functional analysis , 2007, Developmental neurobiology.

[1862]  Ted M. Dawson,et al.  MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity , 2007, Neurobiology of Disease.

[1863]  T. C. Dickson,et al.  Alpha-synuclein is upregulated in neurones in response to chronic oxidative stress and is associated with neuroprotection , 2006, Experimental Neurology.

[1864]  Da-You Zhao,et al.  Chemistry, Distribution, and Metabolism of Tomato Carotenoids and Their Impact on Human Health , 2002, Experimental biology and medicine.

[1865]  Volkan Hurmeric,et al.  Ingestion of IH636 grape seed proanthocyanidin extract to prevent selenite‐induced oxidative stress in experimental cataract , 2006, Journal of cataract and refractive surgery.

[1866]  H. Wagner,et al.  Extraction of bioactive principles from Mucuna pruriens seeds. , 2007, Indian journal of biochemistry & biophysics.

[1867]  George Suji,et al.  Glucose, glycation and aging , 2004, Biogerontology.

[1868]  R M Rapoport,et al.  Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP. , 1983, Journal of cyclic nucleotide and protein phosphorylation research.

[1869]  E. Berlin,et al.  Influence of dietary fats on the fluidity of the lipid domains of rabbit plasma lipoproteins. , 1980, Atherosclerosis.

[1870]  C Zhao,et al.  Prevention of acetaminophen-induced cataract by a combination of diallyl disulfide and N-acetylcysteine. , 1998, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[1871]  G. Kisby,et al.  Content of the neurotoxins cycasin (methylazoxymethanol β‐D‐glucoside) and BNLAA (β‐N‐methylamino‐L‐alanine) in cycad flour prepared by Guam Chamorros , 1992, Neurology.

[1872]  Angelika Richter,et al.  Chronic rotenone treatment induces behavioral effects but no pathological signs of parkinsonism in mice , 2007, Journal of neuroscience research.

[1873]  K Iwasa,et al.  Transformations of (+-)-salsolinol into optically active O- and/or N-methylated derivatives by several Papaveraceae plants and their tissue-cultured cells. , 1992, Journal of natural products.

[1874]  I. G. Shvyrkova,et al.  Proteolytic specificity of plasmin toward adhesive proteins , 2000, Russian Journal of Bioorganic Chemistry.

[1875]  Catherine A McCarty,et al.  Vitamin E supplementation and cataract: randomized controlled trial. , 2004, Ophthalmology.

[1876]  A. Ludolph,et al.  Neurologic diseases associated with use of plant components with toxic potential. , 1993, Environmental research.

[1877]  A Bender,et al.  Creatine supplementation in Parkinson disease: A placebo-controlled randomized pilot trial , 2006, Neurology.

[1878]  K. Dąbrowski,et al.  Interaction between vitamins C and E affects their tissue concentrations, growth, lipid oxidation, and deficiency symptoms in yellow perch (Perca flavescens). , 2003, The British journal of nutrition.

[1879]  H. Holmsen,et al.  Effects of Sodium Azide on Platelet Function , 1977, Thrombosis and Haemostasis.

[1880]  C. Epstein,et al.  CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA) , 1994, Brain Research.